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ABSTRACT
INFLUENCE OF EXPECTATIONS OF AGING ON OLDER WOMEN’S USE OF DIETARY
SUPPLEMENTS USING THE HEALTH PROMOTION THEORY

by
Barbara E. Hekel
The University of Wisconsin-Milwaukee, 2017
Under the Supervision of Professor Christine Kovach

The use of vitamins, minerals and herbal supplements by older adults is increasing and
changing. There are concerns about supplement quality, safety, and vitamin D overuse. Little is
known about supplement use by nursing home residents and about factors that influence older
women to use supplements. The current study describes the supplement use of 247 nursing
home residents and 110 independent living women 65 years or older in the Midwestern United
States. A secondary analysis of 247 medication administration records describes the prevalence
of vitamin, mineral, and herbal supplement use of nursing home residents. Using the health
promotion theory, the author examined factors that influence independent living older women’s
use of supplements. The research hypothesis for the study was: controlling for age, comorbidity
and education level, expectations of aging, self-efficacy, and prior related behavior will predict
vitamin, mineral and herbal supplement use. A cross-sectional descriptive survey included
expectations regarding aging, general self-efficacy, the Self-Administered Comorbidity
Questionnaire, a 24-hour supplement recall and an inventory of supplement use in the past
month. A multiple regression model was used to determine predictors of vitamin, mineral and
herbal supplement use. Education level, prior use of VMS, and expectations of aging are
significant predictors of supplement use in the model and explain 27 % of the variance. Prior use
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is the strongest predictor of current use followed by expectations of aging. Ninety-two percent
of the independent living women and 94 % of nursing home residents are taking a vitamin,
mineral or herbal supplement. Vitamin D is the most frequently reported supplement for both
independent living women and nursing home residents. Independent living women report 0 to
16 supplements in a month and 31% use herbals. Seventy-five percent of the independent living
women take vitamin D. Seven percent of independent living women are taking vitamin D at or
above the Tolerable Upper Intake Level recommended by the Food and Nutrition Board. Health
care and food and nutritional professionals should be aware of overuse and high-dose use of
supplements. Findings suggest expectations of aging may be an important consideration to
understand older women’s health behavior.
Keywords: health promotion theory, aging, supplement, expectations of aging, vitamin D
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Chapter 1
This chapter begins with an introduction to the potential problems regarding supplement
use by older adults. What is known about the prevalence of supplement use and characteristics
of users is briefly described. Vitamin D is the supplement of interest in the study. Vitamin D
function, controversy, measurement, and current research is provided. Definitions of
supplement, supplement categories, dietary terms and terms used in the Health Promotion Model
(HPM) are included. A review of older adults’ expectations regarding aging and the possible
influence of these expectations on health behavior is provided. Models of physiological
homeostasis and aging are also described because changes associated with aging and illness also
influence supplement use and make older adults more likely to be harmed by the inappropriate
use of supplements. Based on the premise that factors unrelated to medical need, such as
expectations regarding aging, may explain the high use of supplements in older adults, the Health
Promotion Model (HPM) is introduced to elucidate factors that may influence the use of
supplements. Gaps in current knowledge are outlined. Finally, the research questions and
hypothesis that guide the study complete the chapter.
Introduction of Problem
Older adults are using more vitamins, minerals, and herbal supplements (VMS) than ever
before. VMS are often taken for purposes that are not supported by research (Hossein-nezhad &
Holick, 2013). The National Health and Nutrition Examination Survey (NHANES) does not
include older adults in nursing homes (Ahluwalia, Dwyer, Terry, Moshfegh, & Johnson, 2016).
In recent years, a number of geriatric health care professionals and organizations have voiced
concerns regarding VMS and older adults; type and amount of VMS taken and reasons why
VMS are used.
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VMS have potential health benefits, health risks, drug interactions and safety concerns
(Kennedy, 2005; Timbo, Ross, McCarthy, & Lin, 2006). Vitamin D is a supplement of
particular interest due to increased use, dosage concerns, and current controversies (AschemannWitzel & Grunert, 2015; Bailey et al., 2011; Cohen, 2012; Dietary Guidelines Advisory
Committee, 2015; Nutrition Business Journal, 2012). Expectations of aging has been found to
influence health behaviors including physical activity and seeking health care ( Sarkisian,
Prohaska, Wong, Hirsch, & Mangione, 2005a; Sarkisian, Hays, & Mangione, 2002a). It is the
purpose of this dissertation study to examine if expectations of aging influences supplement use.
Additional information on what VMS older adults are taking and what influences older adults
use of supplements is needed.
Vitamins and minerals are required for healthy functioning yet too little or too much may
potentially cause deficiencies or damage respectively. Health problems from VMS have been
reported from; adverse reactions to the active ingredients, improper use, drug interactions, and
defects of the product (Timbo et al., 2006). Some VMS have been implicated in liver failure
(Navarro et al., 2014) and the elimination of supplements may burden the kidneys. Liver injury
is more severe from vitamin, mineral and herbal supplements than from medications and may
result in the need for transplantation or death (Navarro et al., 2014).
It is more probable that an older adult would be on medication than a younger person
(Gallagher, Barry, & O' Mahony, 2007). Polypharmacy is used to describe the use of multiple
medicines and is common among older adults (Gallagher et al., 2007; Loya, González-Stuart, &
Rivera, 2009). Polypharmacy, increases the risk of adverse drug interactions with VMS
(Gallagher et al., 2007; Gardiner, Phillips, & Shaughnessy, 2008; Loya et al., 2009). VMS may
also increase or decrease drug activity (Gardiner et al., 2008). Many older adults with chronic
2

medical conditions use supplements and are likely to be taking prescription medications which
may lead to an increased risk of interactions (Mehta, Gardiner, Phillips, & McCarthy, 2008).
Among community dwelling older adults who were on a prescription medication, 52% (95%CI,
48.8%=55.5%) concurrently used dietary supplements (Qato et al., 2008). Long term use of
some medications by older adults directly affects vitamin status (Joshi, 2015). Vitamin D levels
are affected by anticonvulsants, cholestyramine, rifampin, corticosteroids and levodopa (Joshi,
2015).
The potential for adverse reactions from VMS include drug interactions, interactions
from the ingredients within the VMS, and other adverse effects (Geller et al., 2015; Kutz, 2010;
Nahin et al., 2009; Timbo et al., 2006). VMS have also been found to be adulterated with
hazardous contaminants including lead, arsenic, mercury, cadmium, and pesticides (Kutz, 2010).
In 2000 the FDA reported that since 1993 there were 2,797 reports of adverse effects due to
supplements which included 105 deaths (U.S. General Accounting Office, 2000). It has been
estimated that over 23,000 emergency department visits each year are credited to VMS adverse
events (Geller et al., 2015).
Prevalence of Supplement Use in Older Adults
Supplement use among older adults is changing. The National Health and Nutrition
Examination Survey (NHANES) has shown steadily increasing use of dietary supplements over
the last 40 years among older adults in the United States (Bailey et al., 2011; Gahche et al., 2011;
Radimer et al., 2004). A report using NHANES data from 2003-2006 found that 70% of adults
over the age of 71 years use VMS and a third of them use a multivitamin, multimineral dietary
supplement (Bailey et al., 2011). Vitamin D use is increasing and the money spent on vitamin D
supplements has increased sharply over the last 15 years (Nutrition Business Journal, 2015).
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Older women are taking more VMS than in the past (Park, Harnack, & Jacobs, 2009; Timbo et
al., 2006).
Characteristics of Supplement Users
Results from national surveys and other research reports that adults who view themselves
as healthy appear to be using VMS (Bailey et al., 2011; Conner, Kirk, Cade, & Barrett, 2003).
Adults who use VMS are more likely to be in good health, have health insurance, use alcohol in
moderation, exercise more frequently, and do not smoke cigarettes (Bailey, Gahche, Miller,
Thomas, & Dwyer, 2013). People who take VMS also tend to have higher incomes and be better
educated (Dickinson & MacKay, 2014). VMS users tend to have better dietary patterns, have
healthy weight or have a lower BMI than people who do not use VMS (Dickinson & Mackay,
2014). There appears to be a contradiction between need for and use of VMS in older adults
(Bailey et al., 2011; Conner et al., 2003).
VMS use appears to be prevalent in adults who need supplements the least, this has been
termed the ‘inverse supplement hypothesis’ (Conner et al., 2003). Results of studies appear to
support the inverse supplement hypothesis as VMS users have been found to have higher dietary
nutrient intakes than VMS non-users (Braun & Venter, 2008; Kirk, Cade, Barrett, & Conner,
1999; Kofoed, Christensen, Dragsted, Tjønneland, & Roswall, 2015; Sebastian, Cleveland,
Goldman, & Moshfegh, 2007). However, one study which explored an individual nutrient,
resveratrol, did not confirm the inverse supplement hypothesis (Aschemann-Witzel & Grunert,
2015). Instead a strong belief in favorable health effects and use of complementary and
alternative medicine positively affect the use of resveratrol (Aschemann-Witzel & Grunert,
2015).
There are a variety of reasons for people to take dietary supplements. VMS are taken to
4

decrease susceptibility to chronic health problems (Mehta et al., 2008). Improved nutrition has
been attributed to lengthening of the lifespan (Vaupel, 2010). VMS are used as a part of
preventive health care to maintain health (U.S. General Accounting Office, 2000). One study
found the three most common reasons older adults use VMS were: to preserve a healthy life, to
prevent a disease, or a recommendation by a health professional (Albright et al., 2012). The
most common reason to use VMS in the 2007-2010 NHANES was to “improve” or “maintain”
health (Bailey et al., 2013).
Older adults were more likely to use supplements for site-specific reasons (Bailey et al.,
2013). Site-specific reasons are when a supplement is taken for specific body site. Sites of the
body older adults’ mention include heart health, eye health, bone health, or joint health (Bailey et
al., 2013). Men tend to take a supplement for “heart or to lower cholesterol” while women tend
to use calcium products for “bone health” (Bailey et al., 2013). Another study, with primary care
patients as the sample participants, found the top three conditions for supplement use were: heart
hearth/cholesterol, cold/sinus, followed by joint pain (Gray & Rutledge, 2013).
Vitamin D: Function, Controversy, and Current Research
Vitamin D is the supplement of interest in this study due to concerns regarding use and
current controversies. Vitamin D is essential for skeletal health and has a wide range of other
functions. One function of vitamin D is to maintain serum calcium and phosphorus
concentrations which in turn maintains bone health (Committee to Review Dietary Reference
Intakes for Vitamin D and Calcium, Food and Nutrition Board, & Institute of Medicine, 2011).
The vitamin D receptor is found in most tissues and cells in the body including skeletal muscle
tissue (Holick et al., 2011; Holick, 2007). Vitamin D has a role in cellular death, cellular
proliferation, cellular differentiation, and insulin stimulating production (Holick et al., 2011).
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Vitamin D has been reported to have wide-ranging health benefits but not all the health
benefits are supported by research (Hossein-nezhad & Holick, 2013). Researchers have
suggested vitamin D may have a potential role in preventing cardiovascular disease, some types
of cancer and other chronic disease such as diabetes (Manson, Bassuk, & Buring, 2017; Manson
& Buring, 2016; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium et
al., 2011). Research suggests that vitamin D may influence cognitive decline, depression,
autoimmunity, allergy and frailty, however the evidence is not conclusive at this time
(Committee to Review Dietary Reference Intakes for Vitamin D and Calcium et al., 2011).
Current controversies include different recommendations for Tolerable Upper Intake
Level, blood levels, dosage of vitamin D, and benefits of vitamin D. While current evidence
suggests that adults with limited sun exposure require a vitamin D supplement, there exists
controversy among organizations regarding vitamin D dosage (Holick et al., 2011; Hosseinnezhad & Holick, 2013). A recent study of frail elderly with severe vitamin D deficiency
contrasted supplementation with the dosage at the Recommended Daily Allowance (RDA) and
an individual loading dose regimen. The frail elderly on the RDA dose regimen took longer to
reach a target level and fewer reached the target than those on an individual loading dose
regimen and it is suggested that some current guidelines for supplementation doses are too low
for the frail elderly with severe vitamin D deficiency (Wijnen, Salemink, Roovers, Taekema, &
Boer, 2015).
Currently there are 153 studies recruiting participants in the United States under the
search terms “vitamin D and seniors” on the U.S. National Institutes of Health Clinical Trials
website. Topics of research include both vitamin D2 and vitamin D3, a wide variety of diseases,
delivery methods, and dosage levels. The Vitamin D and Omega-3 Trial (VITAL) at Brigham
6

and Women’s Hospital, an affiliate of Harvard Medical School is an ongoing five-year study of
25,874 people who are taking vitamin D or a placebo (Manson & Buring, 2016). The VITAL
study is investigating if vitamin D or omega-3 fatty acids reduce the risk for developing heart
disease, cancer and stroke (Manson & Buring, 2016). The Finnish Vitamin D Trial (FIND) is
another five-year placebo-controlled study of vitamin D regarding prevention of cancer and
cardiovascular disease (U.S. National Institutes of Health, 2016a). The Sunshine 2 Study for
Women with Diabetes is currently recruiting participants, this is also a placebo controlled study
to determine the effectiveness of vitamin D3 on self-management, blood pressure, and depressive
symptoms (U.S. National Institutes of Health, 2016b).
Vitamin D: Serum Levels and Intake
Vitamin D, as measured by serum 25-hydroxyvitamin D (25[OH]D), is defined as
deficiency at levels less than 12 ng/mL (NIH, Office of Dietary Supplements, 2016). Levels of
vitamin D less than 12 ng/mL is associated with osteomalacia in adults and is inadequate for
bone health. Levels of 25(OH)D between 12 to < 20 ng/mL are considered inadequate for
overall health and bone in healthy individuals. Levels of 25(OH)D between 20 and 50 ng/mL
are considered adequate for overall health and bone health for healthy individuals. Emerging
evidence links low and high levels of 25(OH)D (above 50 ng/mL) to adverse effects (NIH,
Office of Dietary Supplements, 2016).
Older adults frequently consume less vitamin D than recommended (Dietary Guidelines
Advisory Committee, 2015). When vitamin D intake is calculated from food and beverage most
adults over the age of 71 had intakes of vitamin D below the estimated average requirement; 97
percent of females and about 93 percent of males (Dietary Guidelines Advisory Committee,
2015). When vitamin D supplements are included the total intake of vitamin D increases
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markedly to about 52 percent of adequate intake levels (Dietary Guidelines Advisory Committee,
2015). The Dietary Guidelines Advisory Committee named vitamin D as a nutrition of public
health concern as the under-consumption of vitamin D has been linked to adverse health
outcomes (2015).
There is also a health concern regarding over-consumption of vitamin D (Dietary
Guidelines Advisory Committee, 2015). Vitamin D toxicity, hypervitaminosis D, occurs from
excessive vitamin D intake. With hypervitaminosis D, the calcium levels can increase in the
blood leading to damage to heart, kidney and blood vessels (NIH, Office of Dietary
Supplements, 2016). Overconsumption of vitamin D is found especially among those who take
high-dose supplements (Dietary Guidelines Advisory Committee, 2015). Vitamin D is sold over
the counter and comes in a wide variety of dosages and combinations with other supplements.
The amount of vitamin D taken from diet and supplements should not exceed the Tolerable
Upper Intake Level (UL) unless directed by a health care professional. If the supplement dose
exceeds the UL then monitoring by a health care professional is warranted (Dietary Guidelines
Advisory Committee, 2015). The concern regarding deficiency, under-consumption and
overconsumption of vitamin D highlights the importance of gathering information regarding
vitamin D dosages in this population.
Definitions of Supplement, Supplement Categories, Dietary Terms, Independent Living
Women and HPM
There is a lack of standardized categories and definitions for supplements (Comerford,
2013). Lack of clarity is one of the problems. Some definitions allow for inclusion of products
that contradict the primary designated ingredient, such as a product with several B vitamins
being labeled a multi-vitamin/ mineral. To provide clarity and ease of comparison to other
8

studies, similar language is helpful. The United States Dietary Supplement Health and
Education Act of 1994 (DSHEA) definition of ‘supplement’ is provided as well as a
classification system for dietary supplement categories (Bailey et al., 2013).
Definition of Supplement
For this dissertation study, the Dietary Supplement Health and Education Act (DSHEA)
definition of dietary supplement will be used. Dietary supplements will be referred to as VMS
(vitamin, mineral, or herbal supplement). Dietary supplements were defined by the DSHEA in
1994 as:
a product (other than tobacco) that is intended to supplement the diet which bears or
contains one or more of the following dietary ingredients: a) a vitamin, b) a mineral, c) an
herb or other botanical, d) an amino acid, e) a dietary substance for use by man to
supplement the diet by increasing the total daily intake, or f) a concentrate, metabolite,
constituent, extract, or combination of any ingredient described in clause (a), (b), (c), (d),
or (e) (NIH, Office of Dietary Supplements, 2015a).
Classification System for Dietary Supplement Categories
Bailey et al. (2013) examined the 2007 to 2010 NHANES data using a classification
system that includes clear definitions with examples. The classification system used for this
study is based the system used by Bailey et al. (2013) and is provided in Appendix A along with
examples for each category.
Multi-vitamin, multi-mineral (MVMM). Contains 3 or more vitamins and contains 1
or more mineral.
Multi-vitamin (MV). Contains 2 or more vitamins, does not contain minerals and not
classified a MVMM.
9

Multi-mineral (MM). Contains 2 or more minerals and does not contain vitamins, not
classified a MVMM, and calcium was not main ingredient.
Herbals. Contains a botanical ingredient, such as melatonin, cranberry, or coenzyme Q10.
Fatty acids. Contains omega-3 or fatty acids as primary ingredient.
Calcium-containing. The primary ingredient is calcium, and may have other minerals or
vitamins; but not classified as a MVMM. This contains antacid products if calcium is the
primary ingredient.
Joint supplements. Contains containing glucosamine, chondroitin, or a combination.
Protein and sports. Contains protein, amino-acids, may be intended to enhance athletic
performance.
Fiber and colon health. Contains fiber as primary ingredient or laxative in name.
Probiotics are classified in this category.
Single nutrient supplements. Stand alone, single nutrient supplement products not
otherwise categorized.
Definitions of Dietary Terms
The Institute of Medicine (IOM) Food and Nutrition Board provides Dietary Reference
Intakes (DRIs). DRIs are the set of reference values to assess nutrient intakes for healthy
individuals. The DRIs for vitamin D were established to provide sufficient vitamin D to
maintain bone health and calcium metabolism for healthy people. There are no differences in
values for men or women for the DRIs for vitamin D. The DRIs are reported in International
Units (IUs) and micrograms (mcg), for vitamin D, 1 mcg is equal to 40 IUs (Institute of
Medicine Panel on Macronutrients, Dietary Fiber & Standing Committee on the Scientific
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Evaluation of Dietary Reference Intakes, 2005; NIH, Office of Dietary Supplements, 2016).
Adequate Intake (AI). The AI is the level assumed to ensure nutritional adequacy when
the evidence is insufficient for RDA.
Estimated Average Requirement (EAR). The EAR is the average daily intake level of
the nutrient that is estimated to meet the requirements for half of the healthy individuals in a
particular gender and life stage. The EAR for adults over the age of 51 years for Vitamin D is
400 IU.
Recommended Daily Allowance (RDA). The RDA is the average daily level of intake
that is sufficient to meet the nutritional needs of nearly all healthy people. The RDA for adults
51-70 years for vitamin D is 600 IU and for adults over 70 years the RDA is 800 IU.
Tolerable Upper Intake Level (UL). The Tolerable Upper Intake Level is the
maximum daily intake that is not likely to cause adverse health effects. The UL for vitamin D is
4,000 IU for adults over the age of 51 years.
Definition of Independent Living Women
For this dissertation study the term independent living women is used to describe women
who live in the community or an independent living setting in a Continuing Care Retirement
Community (CCRC). Independent living older women in a CCRC are in the independent living
apartments and are not in assisted living or skilled nursing care.
Health Promotion Model Definitions
The HPM has been used to research variables influencing a given health behavior
(Pender, Murdaugh, & Parsons, 2011). The definitions of the components of the HPM included
in the framework (see Appendix B) for the proposed study are given below.
Individual characteristics and experiences. The individual characteristics and
11

experiences are experience factors and innate factors (such as gender or age) which are generally
unmodifiable (Pender, Murdaugh, & Parsons, 2015; Srof & Velsor-Friedrich, 2006). These
factors contain prior related behavior and personal factors (Pender, 2006; Pender et al., 2011).
Prior related behavior. The frequency of a similar or the same behavior in the past.
Personal factors. Include psychological, biological or sociocultural general
characteristics of the individual that influence the health behavior.
Behavior-specific cognitions and affect. Contain the variables within the HPM that are
believed to have major motivational significance. The behavior-specific cognitions and affect in
the model include perceived benefits of action and self-efficacy.
Perceived benefits of action- Expectations of Aging. Contain the perceptions of the
reinforcing or positive consequences or benefits of partaking in a specific health behavior. It is
proposed that perceived benefits motivate the behavior. The hypothesis is that older adults with
positive expectations of aging would be more likely to engage in taking VMS for perceived
positive benefits.
Perceived self-efficacy. Perceived self-efficacy relates to an individual’s belief or
judgement of their ability to succeed in a situation or accomplish a task (Pender et al., 2015).
Behavioral outcome- health promoting behavior. This is the specific health behavior,
the desired behavioral outcome of health decision-making, and preparation for action.
Expectations Regarding Aging and Influence on Health Behavior
Expectations of aging are the older adult’s perceptions of aging (Sarkisian, Steers, Hays,
& Mangione, 2005b). Expectations regarding aging (ERA) has been defined as the expectations
of achievement and maintenance of physical, mental, and cognitive health (Sarkisian et al.,
2005b). Expectations regarding aging has been used to examine relationships between health
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behaviors, perceptions of aging, and outcomes (Sarkisian et al., 2005b). An individual’s
expectations of aging has been found to influence specific health behaviors (Goodwin, Black, &
Satish, 1999; Leventhal & Prohaska, 1986; Rakowski & Hickey, 1992; Sarkisian et al., 2002a).
Perceptions and expectations of aging vary and have been examined from both a more
negative and a positive perspective (Levy, Slade, Kunkel, & Kasl, 2002; Rakowski & Hickey,
1992). In one study, the older adults who attributed illness to old age reported less routine health
maintenance behaviors at a 2 year follow up (Stewart, Chipperfield, Perry, & Weiner, 2012).
Some of the health behaviors they were less likely to engage in included: eating a healthy
nutritious diet, getting a regular check-up, making health a priority, exercise, and getting enough
sleep (Stewart et al., 2012). Attributing urinary incontinence to aging was associated with selftreatment and self-management of incontinence (Locher, Burgio, Goode, Roth, & Rodriguez,
2002). Older adults are less likely to seek treatment or report to their health professional if they
attribute symptoms of illness to aging (Brody & Kleban, 1981; Brody, Kleban, & Moles, 1983;
Morgan, Pendleton, Clague, & Horan, 1997). Holding the expectation that health problems are
an inevitable part of old age may create barriers to seeking care, delay the start of care, impact
current choices for care, delay changes in health behaviors, and delay treatment (Locher et al.,
2002; Stewart et al., 2012).
A negative expectation of aging may lead to a delay in: seeking care, treatment, care
decisions, or practicing preventive health behaviors (Goodwin et al., 1999; Leventhal &
Prohaska, 1986; Sarkisian, Lee-Henderson, & Mangione, 2003; Stewart, Chipperfield, Perry, &
Hamm, 2016). The older adults who attributed illness to old age had twice the probability of
death (36% vs. 14%) than those who did not (Stewart et al., 2012). There was a risk of adverse
health events when the association between attributing health problems to aging and mortality
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was examined (adjusted odds ratio = 1.78, CI = 1.05, 3.00, Rakowski & Hickey, 1992). Another
longitudinal study found increases in mortality and disability for older adults with diabetes and
lower cognitive function (McGuire, Ford, & Ajani, 2006). Attributing a specific health
condition, heart attack or stroke, to old age was associated with less likely to change their
lifestyle, a double probability of future hospitalization, and saw their physician more often
(Stewart et al., 2016). This suggests there is a potential for adverse consequences of attributing
some health problems to old age. The older adult may perpetuate the expectation that aging has
a negative trajectory (Rakowski & Hickey, 1992).
Expectations of aging can also be viewed from a positive perspective. Older adults with
positive self-perception of aging lived 7.5 years longer than older adults with less positive selfperceptions of aging (Levy et al., 2002). The impact of self-perceptions of aging appears to have
an association with health behaviors and length of life (Levy et al., 2002). Another study found
that when expectations regarding aging are high or positive the individuals were more likely to
have had a health physical in the preceding two years (Meisner & Baker, 2013). Expectations
towards aging has been documented to influence current health behaviors (Goodwin et al., 1999;
Sarkisian et al., 2005a) and future health (Leventhal & Prohaska, 1986; Levy et al., 2002;
Rakowski & Hickey, 1992). Expectations of aging has an impact on seeking health care, health
behaviors, and health outcomes.
Theoretical Framework
This study is based on two central premises: 1) Older adults have a higher risk for
complications from under or over consumption of VMS due to physiological changes of aging
and aging’s impact on physiological homeostasis; and 2) Factors unrelated to medical need may
explain VMS use. Expectations regarding aging has an impact on current health behaviors,
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expectations regarding aging may have an impact on older women’s use of supplements. The
Health Promotion Model (HPM) provides a framework to conduct research to explore what
motivates older women to engage in supplement use. Covariate, independent and dependent
variables are also identified.
Physiological Homeostasis
The model of physiologic homeostasis is commonly used in geriatrics and is helpful to
understand the impact supplements can have on older adults. Physiologic homeostasis balances
metabolic activity and regenerative responses (Wang, Karpac, & Jasper, 2014). Aging causes
widespread loss of and difficulty maintaining, homeostasis (Wang et al., 2014). The
physiological changes of aging have an impact on all organ systems. The kidney and liver have
decreased function with aging and there is reduced regenerative capacity of the liver
(Navaratnarajah & Jackson, 2013; Schmucker, 2005). Liver function may be impacted due to
aging changes, polypharmacy, use of multiple supplements, or overconsumption of VMS. Age
related changes alter physiology, body composition, and the pharmacokinetic and
pharmacodynamics which may increase the risk of adverse events (Castelino, Hilmer, Bajorek,
Nishtala, & Chen, 2010; Hamilton, Gallagher, & O'Mahony, 2009). Older adults are at higher
risk from vitamin dosages above the UL in part due to decreased liver and kidney function
(Dietary Guidelines Advisory Committee, 2015).
In summary, older adults have a higher risk for complications from under or over
consumption of vitamin D due to the physiological changes of aging and aging’s impact on
physiological homeostasis. The process of aging occurs at different rates and the homeostatic
reserves vary greatly between people. Older adults often have comorbid conditions which are
accompanied with multiple prescription medications increasing the risk of adverse events
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(Castelino et al., 2010). The potential burden of supplements on organs are not clearly
understood. Specific physiological changes associated with aging and with illnesses common
with aging, make it more likely that older adults may be particularly vulnerable to adverse effects
from supplements.
Health Promotion Model
The HPM is an interpersonal level theory that is useful for research of health behaviors
and the development of interventions (Pender et al., 2015). HPM is suitable for health behaviors
where ‘threat’ is not the most important source of motivation (Pender, 1996). Health behavior
motivation for the individual is unique and often has combinations of health promotion and
health protection motives. A health protective behavior aims to decrease the likelihood of
disease or to stabilize health while a health promotion behavior sustains or increases well-being
(Pender, 1996). Together these health promotion and health protective behaviors are
complementary parts of a healthy lifestyle (Pender, 1996). Supplements such as vitamin D are
taken for a variety of health promotion and health protection reasons.
The HPM postulates that individual characteristics and experiences influence behavior
specific cognitions and affect which leads to a health promoting behavior (Pender, 2006; Pender
et al., 2011; Pender et al., 2015). The variables of interest included in the model are: individual
characteristics and experiences (prior related behavior and personal factors), behavior-specific
cognitions and affect (perceived benefits of action-ERA and self-efficacy) and the health
promoting behavior VMS use.
Individual Characteristics and Experiences
Prior related behavior is one of the best predictors of behavior (Pender, 1996). Prior
related behavior in this study is past use of VMS. The regular habit of taking a supplement in the
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past influences the possibility of taking VMS.
Personal factors are predictive and determined by the target behavior of supplement use
(Pender, 2006; Pender et al., 2011). Personal factors found in the literature which may be
associated with and confound the relationship between ERA and supplement use include
comorbidity, age, and education level (de Groot, Beckerman, Lankhorst, & Bouter, 2003;
Johnson, Angela J.M. Donkin, Morgan, Neale, & Lilley, 2000; Kim, 2009; Levy et al., 2002;
Meisner & Baker, 2013; Sebastian et al., 2007; Valderas, Starfield, Sibbald, Salisbury, &
Roland, 2009). Chronic diseases are lasting, non-communicable, recurrent diseases which do not
have a microbial cause (Egger, 2012). As people age the chance of having multiple chronic
disease increases (Egger, 2012; Marengoni et al., 2011). Comorbidity may have a confounding
influence on studies (de Groot et al., 2003; Valderas et al., 2009). Supplement use has been
found to increase with age (Bailey et al., 2011; Dickinson & MacKay, 2014; Gahche et al., 2011;
Radimer et al., 2004). Educational level is a representation of income and may predict
supplement use (Dickinson & MacKay, 2014; Johnson et al., 2000; Meisner & Baker, 2013).
Personal factors will be measured and if related to outcome measure will be used as control
variables.
Behavior-Specific Cognitions and Affect
The behavior-specific cognitions and affect for the current model are perceived benefits
of action-ERA and perceived self-efficacy (Pender et al., 2011). Perceived benefits of action are
the perception of the positive consequence of using supplements. The literature supports that
ERA has been documented to influence health behaviors (Goodwin et al., 1999; Sarkisian et al.,
2003; Sarkisian et al., 2005a). This study proposes that when an older adult has positive ERA
those anticipated outcomes influence the current health behavior of supplement use.
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Perceived self-efficacy is the perception of the personal capability to accomplish
supplement use. Self-efficacy is the judgement that one is able to execute the task (Pender,
2002; Pender et al., 2011). If an individual has a higher level of self-efficacy they are more
likely to engage in a health behavior (Pender et al., 2015). It is proposed that individuals with
high self-efficacy are more likely to engage in supplement use.
Behavioral Outcomes
The behavioral outcome for the proposed study is supplement use. The classification
system (Appendix A) assists with defining nonusers and users of dietary supplements and for
measurement of the dependent variable, supplement use.
Gaps in Knowledge
New supplements are flooding the market at the same time supplement use is increasing
in the elderly population. There is insufficient understanding regarding how and why
supplements are used and why supplements continue to be used when there is no improvement in
health. More information is needed on supplement adverse interactions and supplement and
medication interactions. Currently there are concerns regarding under-consumption and
overconsumption of vitamin D.
There is also debate regarding updating the Recommended Daily Allowance (RDA) for
certain supplements. The RDA is the average daily level of intake that is sufficient to meet the
nutritional needs of nearly all healthy people. Also, not all supplements have a Dietary
Reference Intake (DRI) which specifies the amount required for optimal health. Effective and
safe dosages for different ages and disease states do not exist for all supplements. An example of
difficulty in determining effective and safe dosages is vitamin D. The RDA for vitamin D for
adults over 70 years for male and female is 800 IU and this was determined for optimal bone
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health. The Endocrine Society has provided clinical guidelines for vitamin D use with some
chronic health issues and disease (Holick et al., 2011). But further research is needed to
determine optimal vitamin D levels for chronic health issues and diseases for all ages including
older adults.
Additional details of the physiological impact of supplement dosages used above RDA
along with the prevalence of overconsumption of supplements would be beneficial. While
adverse physiological interactions of supplements on the liver have been reported, it has been
very difficult to identify causality due to simultaneous use of products and products with
multiple ingredients (Navarro et al., 2014). While studies have looked at reported liver damage
from all ages, there are insufficient studies focusing on older adults in independent living,
assisted living and nursing homes (Navarro et al., 2014).
Supplement use has been tracked since the 1970’s using the NHANES. Only
noninstitutionalized U.S. citizens are included in the NHANES sampling design (Ahluwalia et
al., 2016). Despite concerns about underuse, overuse, drug interactions, physiological burden on
the body, and safety, current information on institutionalized older adults’ use of vitamins and
dietary supplements is limited. Why supplements are used and what influences older adults has
not been thoroughly explored.
The impact of how older adults’ ERA impacts supplement use has not been previously
examined. It is important to understand the impact perceptions of future health has on health
behaviors such as supplement use. This understanding can assist nurses’ and other health
professionals in providing individualized care to help promote a healthy lifestyle. Knowledge of
how ERA influences current health behaviors may also guide development of interventions to
optimize use of safe levels of supplements for personal health care of older adults. There is a
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need for up to date information on what supplements older adults are taking with an emphasis on
vitamin D and dosage.
Gaps Bridged by this Study
The gaps this study seeks to address include: 1) what supplements are older independent
living women in the community dwelling or CCRC currently taking and what supplements are
older adults in nursing homes prescribed, 2) is use of vitamin D dosage at or above the Tolerable
Upper Intake Level present in this population, and 3) how does ERA influence supplement use
by older women. The target population is women age 65 years and older. The overall program
of research is aimed at optimizing use of VMS by older individuals whose health care abilities,
needs, and physiologic burdens are changing. Understanding the factors which impact the use of
VMS such as expectations of aging may aid in understanding the behavior of supplement use in
the community dwelling or independent living older adult.
Purpose of Proposed Study
This study proposes that a positive expectation of aging is associated with supplement
use. The purpose is to describe prevalence of VMS use, prevalence of vitamin D use above the
UL, and how ERA and self-efficacy influences supplement use behavior of older women.
Quantitative methods will be used to answer the research questions. Variables of age, education,
and comorbid conditions that show statistically significance differences will be included as
covariates in the regression models.
Research Questions
1. What is the prevalence of VMS use among older adults?
2. What are older women’s levels of general self-efficacy and expectations of aging?
3. Is higher age associated with increased number of supplements taken?
20

4. Do women with higher and lower levels of education differ in their supplement use?
5. Do older women with high, medium and low levels of comorbid conditions differ in their
supplement use?
6.

What percentage of older women are taking vitamin D at and above the Tolerable Upper
Intake Level?

7.

Are older women cognizant of their vitamin D dosage?
Research Hypothesis

1. Expectations of aging will predict high VMS use.
Controlling for age, comorbidity, and education level; prior supplement use, high expectations of
aging and high general self-efficacy will predict VMS use by older women.
Chapter Summary
This chapter introduced the problem of supplement use in older adults and the need to
understand how an older individual’s expectations of aging may influence health promoting
behaviors such as supplement use. The dissertation study will examine whether factors unrelated
to medical need explain the use of VMS in older women. Theoretical models of physiologic
homeostasis and health promotion are described which inform the central premise of the study.
Using the Health Promotion Model (HPM), this study proposes that positive ERA and high selfefficacy are associated with supplement use.
Dissertation Structure
Three manuscripts in the dissertation are: 1) a report of an original descriptive study of
frequency and types of supplements used by residents of three Midwestern nursing homes, 2) a
descriptive manuscript describing older women’s supplement use with an emphasis on vitamin
D, and 3) a theoretical manuscript describing the results of the hypothesis of this dissertation
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study. The descriptive study of frequency and types of supplements used by residents of three
Midwestern nursing homes is presented in Chapter 2. The methodology for the study is
described in Chapter 3. The descriptive vitamin D manuscript and the theoretical manuscript
describing the results of the hypothesis of this dissertation study are presented in Chapter 4. The
implications for future research, practice, policy, and the summary are presented in Chapter 5.
References are located at the end of the dissertation.
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Chapter 2
This chapter will elucidate the HPM theory more comprehensively and present the
manuscript Supplement Use by Frail Elderly in Nursing Homes. While the theory was
introduced in Chapter 1, expansion of the details of this complex theory are presented. This
chapter begins with the background and theoretical constructs of the theory that informs this
study. The variables included in the theoretical framework for the study are clarified. The
manuscript provides a more comprehensive review of supplement use by nursing home residents,
VMS facts and requirements and a secondary analysis of data regarding VMS use by residents of
three Midwestern nursing homes. This study was done as a part of requirements for completion
of a doctoral degree in nursing. The manuscript is in response to the first research question and
describes prevalence of VMS use by older institutionalized adults. The results of the
noninstitutionalized adults surveyed regarding prevalence of VMS use will be reported in
Chapter 4, the data manuscript.
Pender’s Health Promotion Model to Explore Factors Which Predict Older Adults
Use of Dietary Supplements
Health behaviors are the actions individuals employ to maintain or enhance their health.
The World Health Organization (WHO) produced a glossary of terms to help clarify the
meanings and relations between terms used in health promotion (Nutbeam, 1998). The WHO
(Nutbeam, 1998) defined health behavior as “any activity undertaken by an individual, regardless
of actual or perceived health status, for the purpose of promoting, protecting or maintaining
health, whether or not such behavior is objectively effective towards that end” (p.355). This
widely acknowledged definition of health behavior is congruent with the HPM concept of health
behavior (Pender et al., 2015).
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Older adults incorporate a wide variety of health behaviors into their lives. Health
professionals are interested in promoting those health behaviors which preserve, protect, or
sustain health during the aging process. Conceptual models are useful for exploring and
examining phenomena (Meleis, 2012). The use of conceptual models and theory can advance
science and move the nursing discipline forward (Meleis, 2012). When current practice and
research engages with conceptual models the discipline advances not only with new knowledge
but refined understanding of the conceptual models (Meleis, 2012).
The Health Promotion Model (HPM) is a framework that is useful to the study of health
behaviors (Pender et al., 2011; Pender et al., 2015). Health behaviors have been examined using
a wide variety of models and theories (Glanz, Rimer, & Viswanath, 2008). Key information
guiding theories of health behavior include the factors which influence the behavior and the
determinants that may lead to changes in behavior to improve health. Health behavior is
influenced at multiple levels and the available health behavior theories reflect this complexity
(Glanz et al., 2008). The HPM explores factors which influence health behaviors and is suitable
for research concerning VMS use (Pender, 2006).
Health Promotion Model
In the 1980’s the Health Promotion Model (HPM) was proposed as a framework to
explore processes that motivate people to engage in health behaviors to enhance health (Pender,
1996; Pender et al., 2011). The HPM is an individual level mid-range theory that has been used
to explore a variety of health behaviors, interventions, and counseling (Pender, 1996). The HPM
is applicable across the life span, and has been used with older adults (Pender, 1996; Sousa,
Gaspar, Vaz, Gonzaga, & Dixe, 2015). A wide variety of health behaviors have also been
studied including hearing protection, physical activity, and nutrition (Lusk, Ronis, & Hogan,
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1997; Mohebi et al., 2013; Wu & Pender, 2002). A central assumption of the HPM is that
positive health behaviors have the potential to create healthy lifestyles and healthy outcomes.
Theoretical Underpinnings of the HPM
The HPM incorporates constructs from Social Cognitive theory and expectancy-values
theory (Pender et al., 2011). These constructs are based within a nursing perspective of holistic
functioning and are central to the theoretical framework for the current study. The Social
Cognitive theory is based on the perspective that people are not just reactive but are selfreflecting, self-regulating, self-organizing, and proactive (Bandura, 2001). Social Cognitive
theory examines the determinants and psychosocial mechanisms which influence cognition,
affect and action (Bandura, 2001). An individual’s behavior is not driven just by inner thought
or by external stimuli. Behavioral determinants, personal determinants, and environmental
determinants are interactive and can augment or constrain one another in an interactive dynamic
manner (Bandura, 2001; Pender, 1996). Social Cognitive theory posits that self-beliefs are
formed through observation and self-reflective thought. The self-beliefs include self-efficacy,
self-evaluation, and self-attribution. Self-efficacy is a core component of the Social Cognitive
theory. Self-efficacy concerns the belief of personal ability to change health behavior (Pender et
al., 2015). The Social Cognitive theory provides a foundation for considering how ERA are
formed and influence the individual.
Expectancy-values theories of human motivation suggest that behavior is economical and
rational (Pender, 2006). It holds that if the outcome of an action has positive personal value and
if it is known that the action will cause a desired outcome then the person will be likely to
engage in the action. Thus, the goal of the action needs to have value and be achievable. Two
important concepts in this model are subjective value of change and the subjective expectancy of
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successfully obtaining the change (Pender, 1996; Pender, 2006). The subjective value of change
is comparable to the individuals’ perception of benefits of the health behavior. The subjective
expectancy of successfully obtaining the change comes from knowledge of personal success or
others success in attaining the outcome and the belief that the individual will be able to so the
same (Pender, 1996; Pender, 2006). Both concepts deal with motivational significance and both
support the supposition of the study, when ERA are viewed positively, the older adult views a
positive health outcome as achievable and is more likely to take actions to support future health.
Expectancy-values model supports the postulation that how the older adults views their future
life to be, may influence and motivate supplement use. When a positive ERA is held, then the
current ‘action’ of supplement use is more likely to be done.
Evolution of HPM
The HPM has gone through revision as studies have tested the power of the component
constructs to explain and predict health behaviors (Pender, 1996). Three variables were deleted
from the original model (cues to action, importance of health, and perceived control of health)
and three new variables were added (Pender, 1996). Other variables were repositioned within
the model (Pender, 1996). Cues to action were found to be difficult to measure with reliability,
hard to identify, and transient. Importance of health ranked so high in value that it was not
useful as a predictor. Perceived control of health was inconsistent and did not contribute to
explaining specific health behaviors. The revision also included three new variables: activityrelated affect, commitment to a plan of action, and immediate competing demands and
preferences (Pender, 1996). The most recent revision and the explanation of the original HPM
model can be obtained in the literature (Pender, 1982; Pender, 1987; Pender, 1996; Pender et al.,
2015). In studies testing the HPM 5 to 12 variables have been included (Pender, 1996). The
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specific variables selected from the HPM to test as predictors of VMS use are explained in the
next section.
Components of the HPM to Study VMS
The HPM consists of three areas: individual characteristics and experiences, behavior
specific cognitions and affects, and behavioral outcome (Pender et al., 2015).
Individual Characteristics and Experiences
The individual characteristics and experiences consist of prior related behavior and
personal factors which influence health behavior. The HPM allows for flexibility to include
individual characteristics and experience variables that are highly relevant to a specific health
behavior. This allows the HPM to capture variables that are relevant to specific health behavior
(Pender, 2006; Pender et al., 2011).
Prior related behavior.
Prior related behavior is proposed to have direct and indirect effects on likelihood of
engaging in future health behaviors. Similar behavior in the past is one of the best predictors of
engaging in a behavior (Pender, 1996). Past ability to formulate habits predisposes one to
engage in a behavior automatically. Strength of the habit builds each time the behavior occurs
and happens best with repetition of the behavior (Pender et al., 2015).
Perceptions of self-efficacy through prior behavior is consistent with social cognitive
theory. Undertaking the behavior with the associated feedback is a major source of skill
information and a major source of efficacy (Pender, 1996). Actual enactment of a behavior and
the feedback reinforces the behavior (Pender, 2002). Prior related experience also may provide
“outcome expectations”, benefits experienced from the prior behavior. Prior related behavior for
the purposes of this study is use of a supplement in the past. The regular habit of taking a
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supplement in the past to improve or protect health influences the possibility of taking
supplements in the future.
Personal factors.
Personal factors can be biological, sociocultural, or psychological (Pender et al., 2015).
Personal factors are predictive and determined by the target behavior under study (Pender, 2006;
Pender et al., 2011). Personal factors found in the literature which may predict VMS use include
age, comorbidity and education. VMS use is higher in older age groups (Timbo et al., 2006) and
those who are better educated (Dickinson & MacKay, 2014). Supplement users have been
described as older and well-educated (Bailey et al., 2011; Conner et al., 2003). Comorbidity can
have a confounding influence on studies and it is common for older individuals to have
comorbidity (de Groot et al., 2003; Egger, 2012; Marengoni et al., 2011; Valderas et al., 2009).
Behavior-specific Cognitions and Affect
Behavior-specific cognitions and affect are the behaviors that are considered to be of
major motivational significance (Pender, 2002; Pender, 2006). These variables are considered
critical as they are modifiable through interventions (Pender et al., 2015; Srof & VelsorFriedrich, 2006). These are the variables can be targeted for intervention to influence change in
occurrence or commitment of a health promoting behavior (Pender et al., 2015). The behavior
specific cognitions and affect include ERA (perceived benefits to action) and perceived selfefficacy (Pender et al., 2015).
Perceived benefits of action- ERA.
Perceived benefits of action directly motivate behavior and are the perception of the
positive consequence of undertaking a health behavior (Pender, 2006; Pender et al., 2011).
Anticipated outcomes of a health behavior influence the choice to carry out a health behavior.
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The motivational importance of the expected benefits of the health behavior is based on
observational learning. Expectancy-value theories holds that if the outcome of an action has
positive personal value and if it is known that the action will cause a desired outcome then the
person will be likely to do the action (Pender, 2002; Pender, 2006).
Perceptions and interpretations of an individual’s experience directly affect behavior
(Pender, 2006). Older adults’ have varying expectations regarding their own aging. Attitudes
towards aging such as expectations of aging have been documented to influence health behaviors
(Goodwin et al., 1999; Sarkisian et al., 2003; Sarkisian et al., 2005a). When an older adult has
positive expectations of aging those anticipated outcomes may influence VMS use. Perceived
benefits of action is a variable that has been consistently found to be an important predictor in
tests of the HPM (Lusk et al., 1997; Pender et al., 2015).
Perceived self-efficacy.
Perceived self-efficacy is key in human functioning and the judgement of capability.
Self-efficacy plays a central role in a person’s belief in their ability to engage in a behavior
(Schwarzer, 1992). Self-efficacy beliefs are the result of a cognitive process that depends on
diverse efficacy information (Bandura, 1992). Self-beliefs regarding personal self-efficacy are
important determinants of action, motivation, affect and thought (Bandura, 1992; Bandura,
2006).
Perceived self-efficacy differs from outcome expectations. Outcome expectations is a
judgement of the benefits or costs of the result of the health behavior. It is not skill based but the
judgement of what one can do with what they have available. While perceived self-efficacy
contains perceptions of skill, competence, and perceptions of efficacy (Pender et al., 2015). Selfefficacy is important to initiation and maintenance of health behavior change (Glanz et al.,
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2008).
The HPM postulates that perceived self-efficacy is influenced by the activity-related
affect, that is the more positive the affect the greater the perception of efficacy (Pender, 2002).
Higher efficacy is posited to decrease perception of barriers to the performance of the targeted
health behavior (Pender, 2002). Perceived self-efficacy has a role in self-development,
adaptation, and change and has been found to be a powerful determining factor of actual health
behavior (Bandura, 2006; Pender et al., 2015). In a study of physical activity among Taiwanese
adolescents using the HPM, self-efficacy was found to be the most important predictor of
physical activity (Wu & Pender, 2002). If an individual has a higher level of self-efficacy they
are more likely to engage in the targeted health behavior (Pender et al., 2015). Self-efficacy has
robust support as a predictor in the HPM (Pender, 1996).
Behavioral Outcome
Health promoting behavior is the desired outcome of health decision-making, it is the
desired targeted behavior (Pender et al., 2015). The health behavior should result in improved
health, enhanced function, and better quality of life (Pender, 2002; Pender, 2006). The
behavioral outcome in this study is VMS use.
Research and the HPM
In Google Scholar between 2012 and 2013 over 150 papers using the HPM were
documented (Pender et al., 2015). The HPM model has been used to study oral health, nutrition,
physical activity, hearing protection , exercise, weight loss, bicycle helmet use and colorectal
cancer prevention (Pender, 2006; Pender et al., 2015). The HPM has been used with a variety of
populations; older adults, males in cardiac rehabilitation, adolescent females, black university
students, rural females, older Seventh-day Adventists adults, incarcerated males, military women
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with children, and Spanish speaking Hispanic adults, Taiwanese elderly, expatriates in Indonesia,
blue-collar workers, and a variety of others (Pender, 2006). The HPM constructs were also
effective in the development of a nutritional education intervention (Dehdari, Rahimi, Aryaeian,
& Gohari, 2014; Pender et al., 2015).
The choice of theory is important. Theory provides the framework to organize research
planning, direct analysis, and develop interventions (Meleis, 2012). Effective health behavior
research relies on use of the most appropriate theory (Glanz et al., 2008). Different theories are
suited to different types of health behavior, level of threat, or focus of research questions. The
choice of the theory should begin with alignment with the problem, goal of research, and be
consistent with observations of the behavior (Glanz et al., 2008). Constructs within the HPM
have been consistent over different health behaviors (Lusk et al., 1997). Supplement use is a
health behavior that has considerable attention focused on prevalence and characteristics but the
influences predicting supplement use have not received the same attention. HPM has constructs
that align with VMS use behavior and are logical and relevant. HPM is a competence or
approach-orientated model which depicts the interaction as a person pursues health (Pender,
1996).
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Abstract
Despite concerns about the overuse and safety of supplements, little is known about
specific product use by nursing home residents. This descriptive study describes frequency and
types of supplements used and examines whether gender, body mass index or length of stay
predict the use of specific products. Data were abstracted from the records of 247 residents in
three Midwestern nursing homes and categorized as a vitamin, mineral, nutrition or herbal
supplement. Ninety-four percent (n=233) of residents were taking a vitamin, mineral, nutrition
or herbal supplement. Eighty-one percent (n=201) were taking some type of vitamin, 77%
(n=192) were taking a mineral, 43% (n=106) were taking a nutritional supplement and 25%
(n=62) were taking an herbal supplement. Vitamin D was the most commonly taken supplement.
Health care professionals and food and nutritional professionals should be aware of rising
numbers and types of supplements used.
Introduction
Supplements are big business. More than thirty-two billion dollars are spent on
supplements each year (Cohen, 2014). Over 100 million Americans use dietary supplements in
the form of vitamins, minerals, nutrition supplements, and herbals (Cohen, 2012). Use of
supplements is expected to rise as an interest in maintaining health or preventing illness (Bailey
et al., 2013; U.S. General Accounting Office, 2000). Older adults residing in nursing homes are
not included in the National Health and Nutrition Examination Survey (Ahluwalia et al., 2016).
While supplement use has been documented in the community dwelling elderly, it is important to
investigate supplement use in the frail elderly in the nursing home setting. Hence, the purpose of
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this study is to describe the use of vitamin, mineral, nutrition, and herbal supplements (VMNHS)
in nursing home residents.
Despite concerns about overuse and safety, current information on nursing home
residents’ use of VMNHS is limited (Goorang, Thorpe, Baillod, & Whiting, 2015; Goorang,
Ausman, Houser, & Whiting, 2015). Vitamins are commonly used in nursing homes (Avorn &
Gurwitz, 1995; Nygaard, Naik, Ruths, & Straand, 2003; Wills et al., 1997). One study in Canada
found about half the residents of a long-term care facility were taking a supplement (Viveky et
al., 2012). Vitamin D was the supplement used the most followed by calcium and multivitamins
(Viveky et al., 2012). The most commonly used supplement by residents in two assisted living
facilities in the United States were multiple vitamins (15.7 %) (Lam & Bradley, 2006). A study
conducted in Mexico found that vitamins and anti-anemic supplements were the most common
type of all drugs taken by nursing home residents (Pérez-Guillé et al., 2001). Twenty-eight
percent of men and 39 % of women were taking a vitamin or anti-anemic supplement (PérezGuillé et al., 2001).
Many people believe that VMNHS are regulated the same as prescription drugs, however
this is a common misconception. There is no requirement for the manufacturer to provide
evidence of product safety or effectiveness before marketing the product (United States
Congress, 2006). Safety is regulated through a post-market evaluation which tracks adverse
events (United States Congress, 2006). However, there are many problems with reporting and
tracking. One difficulty is that the voluntary reporting computer system is severely limited and
the FDA lacks sufficient staff and resources for tracking and reporting (U.S. General Accounting
Office, 2000). The General Accounting Office (GAO) found that “consumers face health risks
because current federal laws and agencies’ efforts do not effectively and consistently ensure that
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these products are safe” (2000, p.25). There is no regulation for the manufacturer to provide
safety related information such as dangerous drug interactions (U.S. General Accounting Office,
2000).
In 1994, the Dietary Supplement Health & Education Act (DSHEA) was passed giving
the Food and Drug Administration (FDA) regulatory authority to take actions against false or
misleading supplement claims, impure supplements, misbranded supplements, and safety issues
(United States Congress, 2006). The DSHEA requires a dietary supplement label to identify the
product as a supplement, list ingredients, and provide the net quantity and contact information of
the manufacturer. A disclaimer statement is also required stating that the FDA has not evaluated
the claims made on the label and stating that “… the product is not intended to diagnose, treat,
cure, or prevent any disease” (United States Congress, 2006). Yet supplements are being taken
to prevent, treat, and, cure health problems.
Background
The theory of physiologic homeostasis and the aging process is useful for understanding
the impact that supplements can have on the physical body. Physiologic homeostasis maintains
the body’s biological stability and balances metabolic activity and regenerative responses (Wang
et al., 2014). Aging disrupts homeostasis in several ways, including damage from oxidative
stress, dysregulation of cell number, and inadequate repair of damage (Boron, 2012; Wang et al.,
2014). People age at different rates with significant differences in physiological response and
homeostatic reserves. The physiological burdens placed on the body by VMNHS may impact
homeostasis.
The aging process causes a reduction in the function of organs along with a reduction in
repair ability (Navaratnarajah & Jackson, 2013). The kidneys and glomeruli decrease in mass
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and surface area with subsequent declines in the glomerular filtration rate (Navaratnarajah &
Jackson, 2013). There is also an increase in permeability of glomerular membrane associated
with proteinuria. Chronic diseases of the liver and kidney limit the ability of these organs to
metabolize and excrete VMNHS (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006).
Several age-related changes in skin and gastric secretions also impact status of vitamins
and minerals. Age related changes in skin result in decline in vitamin D production. This is
compounded by insufficient sun exposure due to reduced outdoor activity. The malabsorption of
nutrients in elderly persons is compounded by disease such as atrophic gastritis. Folic acid,
vitamin B-12, calcium, iron and beta-carotene absorption is affected by low acid conditions in
elderly persons’ stomach (Russell, 2001).
Polypharmacy and inappropriate prescribing, common in the elderly, contribute to the
potential for VMNHS to compromise homeostasis. Potentially inappropriate medications
include medication with significant risk of adverse drug event, high frequency of use, multiple
medicines with high rate of interactions, and under use of needed medicine (Gallagher et al.,
2007). VMNHS can interact with drugs which can increase or decrease the drugs activity
(Gardiner et al., 2008) and add to the potential for adverse responses. Qato et al. (2008) found
that 1 of 25 supplement users were at risk for a major drug-drug interaction.
Vitamin/Supplement Fundamentals
Vitamins are organic compounds that provide vital nutrients, which are required in
limited amounts. B vitamins are a class of water-soluble vitamins that have an important role in
cell metabolism (Medline Plus, National Institutes of Health, U.S. National Library of Medicine,
2015). There are eight different B vitamins and each has a unique function. Vitamin C is a
water-soluble vitamin and is required for essential metabolic reactions and may also act as
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antioxidant against oxidative stress (NIH, Office of Dietary Supplements, 2013b).
Vitamin D is fat soluble vitamin and may be considered a hormone as the synthesis and
activity occurs in different locations (NIH, Office of Dietary Supplements, 2016). Vitamin D
has a significant role in calcium homeostasis and metabolism and is needed for bone growth and
remodeling. Vitamin D may come from diet or be produced endogenously from ultraviolet rays
from sunlight. Vitamin D from sunlight and food is biologically inert and to become active must
undergo two hydroxylation reactions. The enzymatic conversions take place in the liver and
kidney. Due to concerns regarding the risk of cancer from sunlight there is no recommendation
for sunlight to meet the daily requirements and rather there is a Recommended Daily Allowance
(RDA) from dietary sources. Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) are
both forms of vitamin D which are manufactured for supplement use (NIH, Office of Dietary
Supplements, 2016). Vitamin E is a fat-soluble antioxidant and occurs naturally in 8 chemical
forms. The antioxidant effect of vitamin E protects cells from damage from free radicals
(molecules with an unshared electron) and is involved in immune function (NIH, Office of
Dietary Supplements, 2013c).
Calcium, iron, and potassium are minerals which are naturally occurring inorganic
substances. Calcium is the most abundant mineral in body and is required for muscle function,
nerve transmission, intracellular signaling, as well as vascular contraction and vasodilation (NIH,
Office of Dietary Supplements, 2013a). The balance between bone resorption and deposition
changes with age: in aging adults, bone breakdown exceeds formation resulting in bone loss.
Iron is a mineral that is an essential part of hemoglobin, myoglobin, and is required for growth,
development, cell functions and the synthesis of some hormones (NIH, Office of Dietary
Supplements, 2015b). Potassium, an electrolyte, plays a role in the transmission of nerve
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signals, muscle contractions, fluid balance and chemical reactions.
Dietary supplements are used for many purposes including supporting immune system,
supporting the healing process or reducing risk of age-related conditions. Dietary supplements
can include vitamins, minerals, fiber, fatty acids, amino acids, and natural food supplements.
Vitamin/Supplement Requirements and Side Effects
The Food and Nutrition Board at the Institute of Medicine of the National Academies
establish guidelines for dietary intake which included nutrient standards, dietary guidelines and
nutrition labeling. The Food and Nutrition Board also provides authoritative judgments on
relationships among nutrition and health. The Food and Nutrition Board publishes dietary
guidelines every 5 years using research to address issues of safety and quality. The Dietary
Guidelines Advisory Committee (2015) reported that more information is needed regarding
dietary intake of older adults, impact of polypharmacy on nutritional adequacy, and the rationale
for and the consequences of using high dose supplements (2015). Dietary Reference Intakes
(DRI) is the term for values to assess and plan nutrient needs: Recommended Daily Allowance
(RDA), Adequate Intake, and Tolerable Upper Intake Level. The RDA is the average daily level
of intake that is sufficient to meet the nutritional needs of nearly all healthy people.
While current evidence suggests that most adults, particularly those with limited sun
exposure, require a vitamin D supplement, there is controversy regarding recommended dosing
and the potential benefits of vitamin D (Hossein-nezhad & Holick, 2013). Different guidelines
are used to measure or report vitamin D deficiency or sufficiency levels (Hossein-nezhad &
Holick, 2013). The Endocrine Society recommends daily vitamin D supplement of 2,000 IU per
day to remain above 30 ng/ml, the Food and Nutrition Board recommends 600 IU/day to remain
above 20 mg/ml (Holick et al., 2011). The different ‘ideal’ vitamin D levels lends to controversy
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regarding dosage and use (Pludowski et al., 2017). Furthermore, there are different methods to
measure vitamin D levels and problems remain regarding accuracy of test results (Binkley et al.,
2004; Binkley & Sempos, 2014; Schleicher et al., 2016).
Though the side effects of VMNHS are understudied, evidence suggests that adults and
particularly the elderly are at risk for adverse events. Vitamin A toxicity is associated with liver
damage (Navaratnarajah & Jackson, 2013). Four percent of supplement uses reported an adverse
event they believe was related to the supplement and 13 % of adults using multivitamin,
multimineral reported adverse events (Timbo et al., 2006). Self-reported adverse event
symptoms from VMNHS include blood pressure problems, nausea, rash, vomiting, dizziness and
abdominal pain (Marra & Wellman, 2008; Timbo et al., 2006).
Methods
This report is a secondary analysis of data from a descriptive, correlational and crosssectional research study. Three not-for-profit nursing homes in the upper Midwest provided the
data and were chosen by convenience of proximity to the university. All the long term skilled
nursing home residents who had at least a one-month length of stay, except those specifically
admitted for short-term rehabilitation, were included and yielded a sample size of 247. The
Institutional Review Board (IRB) designated for each site approved the study. All the
information collected was de-identified and securely stored.
Four terms are used to categorize supplements: vitamin, mineral, nutrition, and herbal
supplements. Vitamin use included multiple forms of vitamin B, vitamin C, multiple forms of
vitamin D, and vitamin E. Minerals include calcium, iron, and potassium. Nutrition
supplements were products containing protein, amino acids, vitamins and minerals, or calories.
The term herbal is used, for ease of reading, to describe both herbal and other nonvitamin,
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nonmineral supplements that are botanical or do not fall into other categories. Herbal
supplements included cranberry, coenzyme Q-10, arginine, melatonin, probiotics and fish oil
supplements. There are VMNHS that were not represented in the medical records such as
vitamin A and are thus not reported by this study. Differences in the use of VMNHS based on
gender, BMI and length of stay are explored. Because of the recent emphasis on vitamin D and
controversy over dosage we specifically looked at dosage of vitamin D prescribed within and
outside of USDA guidelines.
Measurement
Data for the original study were collected from the health care records by two nurse
researchers and de- identified over one month in 2014. Standardized abstraction forms were
used and abstractor monitoring was performed by a senior researcher. For the secondary
analysis, data were abstracted and coded by one trained nurse researcher supervised by a senior
nurse researcher. Interrater reliability was .85 to 1.0 with an average of .96 for 10 forms.
Categorizations found in the literature, common guidelines and the medication
administration records (MARs) were used to code the specific VMNHS into SPSS. Data were
first broadly categorized as vitamin, mineral, nutrition, and herbal supplements. Since vitamin
and mineral products are often produced in a wide variety of combinations there was a category
for combinations of vitamin and minerals. Vitamins included the following: B vitamins, vitamin
C, vitamin D (vitamin D, vitamin D2, vitamin D3 and D Complex), and vitamin E. Nominal
coding was used to indicate whether a specific category of vitamin was taken or not. All eight
types of B vitamins (thiamin, riboflavin, niacin, Pantothenic acid, pyridoxine, biotin, folic acid
and cobalamins) while chemically distinct were categorized as vitamin B. Due to interest in
vitamin D, the different prescriptive forms of vitamin D and dosages were coded categorically
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per RDA with normal being considered as within 10% above and below RDA. The 3 levels
differentiated for vitamin D for adults over the age of 51 years was: below RDA < 540 IU,
within RDA 540 - 880 IUs and above RDA > 880 IUs. The 10 % was an arbitrary amount
chosen to help differentiate dosages and prescriptions to fit into the categories.
Minerals include the following; calcium, iron and potassium. Nominal coding was used
to indicate whether a specific category of mineral was taken or not. Calcium and vitamin D
combinations were coded under each category if specific dosages were given for calcium and
vitamin D respectively. This is the only combination of a vitamin and mineral in which one
prescription had the potential to be coded in two categories (calcium and vitamin D).
Nutritional supplements include the following house supplements, three name brand
products (referred to as Purchased Dietary Supplements), and calorie snacks (produced by each
nursing home kitchen). Each facility developed house supplements and caloric snacks. No
information was gathered to compare differences between facilities regarding house supplements
or snacks. Herbal supplements which are prescribed for health benefit and do not fall in other
categories, include cranberry, coenzyme Q-10, arginine, melatonin, probiotics, and fish oil.
Nominal coding was used to indicate whether a specific category of dietary supplement was
taken or not. Also for all categories if a product had multiple prescriptions and different
formulations it was noted as yes/ no, did not capture frequency. Only vitamin D captured
dosages.
The most recent Body Mass Index (BMI), hemoglobin (hGb), and hematocrit (hct), and
demographic data were also abstracted. BMI was calculated by dividing the person’s weight in
kilograms by the square of the height in meters (kg/m²). The Centers for Medicare & Medicaid
Services recommend for adults 65 years and older the normal parameter for BMI is ≥ 23 and <
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30 (Center for Medicaid and Medicare Services, 2015).
Analysis and Results
The sample and use of vitamin, minerals, nutrition and herbal supplements are described
using frequencies, percentages, means and standard deviations. Differences in the prescriptive
practices based on other variables were examined using Chi Square and t-tests. Since the
variable length of stay was skewed, comparisons using this variable were examined with the
non-parametric Mann-Whitney U test.
Residents were primarily female and the length of stay ranged from 1 month to 11.5 years
(M = 28.0, SD = 27.2). See Table 1 for characteristics of residents. VMNHS did not differ
based on gender (p = .148) or length of stay (p = .277). There was a statistically significant
difference in the number of vitamins prescribed between the three facilities (χ² = 10.269, p =
.006; range 71% to 92%). Of all the types of vitamin D prescribed, only D2 varied significantly
between facilities (χ² = 15.081, p = .001). Vitamin D2 use ranged from .05% (3 out of 63) to 29
% (32 out of 110).
Table 1. Characteristics of Residents (N=247)
Characteristics
M (SD)
Differences Between
the Three Facilities
χ²
Age
87.7 (7.6)
110.277
Minimum=54
Maximum=103
Gender
LOS*

Hgb
Hct
Average BMI **

Males n = 65
Females n = 182
28.0 (27.2)
Minimum=1
Maximum=140
11.9 (2.5)
36.6 (5.2)
26 (5.9)
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p

.004

.232

.891

161.820

.317

162.300
71.032

.003
.255

Low BMI <23

n=79 (32%)

Normal BMI 23-29.9

n=119 (48%)

High BMI

n=49 (20%)

≥30

*Length of Stay in Months
**Centers for Medicare & Medicaid Services recommended BMI for age > 65
Ninety-four percent (n = 233) of residents were taking a VMNHS (see Table 2). Eightyone percent (n = 201) were taking some type of vitamin, 77% (n = 192) were taking a mineral,
25% (n = 62) were taking an herbal supplement and 43% (n = 106) were taking a nutrition
supplement.
As seen in Table 2, the most commonly prescribed vitamin was vitamin D with multiple
residents being prescribed more than one form of vitamin D. More females took vitamin D (n =
120 of 182, 66% of females) than males (n = 40 of 65, 62% of males, χ² = .406, p = .524), though
there were no gender differences in the use of vitamin D, D2, D3 or D complex.
Table 2. Frequency and Percentage of Residents Taking Specific Vitamin, Minerals, Combination,
Nonvitamin nonmineral and Dietary supplements (N=247)
Total of
Frequency n (%)*
Vitamin
n (%)*
Nonvitamin
n (%)*
Residents Who
Nonmineral
are Prescribed
Vitamin
201 (81.4)
B
65 (26.3)
Acidophilus/
34 (13.8)
Probiotics
Any Vitamin D 178 (72.1)
C
18 (7.3)
Arginine
1 (0.4)
(D, D2, D3, D
complex)
Mineral
192 (77.7)
D
160 (64.8)
Coenzyme Q-10 4 (1.6)
Herbal
62 (25.1)
D2
49 (19.8)
Cranberry
11 (4.5)
Nutritional
106 (42.9)
D3
100 (40.4)
Fish Oil
8 (3.2)
VMNHS
233 (94.3)
D
1 (.4)
Melatonin
13 (5.3)
complex
Mineral
n (%)
E
3 (1.2)
Nutritional
n (%)
Calcium
117 (47.4)
Combinat n (%)
House
91 (36.8)
ions
Supplement
Iron
58 (23.1)
Combinat 100 (40.4)
Purchased
22 (8.9)
ion
Dietary
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Potassium

74 (29.9)

vitamin/
mineral
Combinat 17 (6.9)
ion
vitamins

Supplement
Snack

10 (4.0)

* n (%)* = n (n/N %)
Those taking vitamin D had a longer length of stay (M = 30.7, SD = 26.9) than those not
taking vitamin D (M = 23.2, SD = 7.1; p = .002). Of the entire study sample, 62% (n = 154)
were prescribed dosages of vitamin D above the RDA, 1 % (n = 3) were within RDA, 9 % (n =
21) were below RDA, and 28% (n = 69) were not prescribed any vitamin D (see Table 3). The
percentage of residents taking vitamin D at each facility was statistically significantly different
and ranged from 46 % to 78 % (χ² = 15.82, p < .001).
Table 3. Characteristics of Vitamin D Dosages (N=247)
Individual Dose of Vitamin D, D2, D3 and D Complex
Vitamin

Below RDA n (%)*

Vitamin D
Vitamin D2
Vitamin D3
Vitamin D
Complex

Within RDA n (%)*

70 (28.3)
0 (0)
3 (1.2)
0

8 (3.2)
0 (0)
1 (.4)
1 (.4)

Above RDA n (%)*
4 (1.6)
55 (22.3)
102 (41.3)
0

Total Dosage per Day Vitamin D: Combination of Vitamin D, D2, D3 and D Complex
0 Vitamin D

Below RDA n (%)*

Total Dosage 68 (28%)
21 (9%)
Vitamin D
* n (%)* = Frequency n (n/N %)

Within RDA n (%)*

Above RDA n (%)*

3 (1%)

154 (62%)

The most commonly prescribed mineral was calcium followed by prescription for
combination vitamins and minerals (see Table 2). Prescribed calcium did differ by gender (χ² =
3.236406, p = .036 one sided), with 66% of women on a calcium supplement as compared to
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62% of men. Potassium and iron supplements were also commonly prescribed. Residents taking
iron supplements had lower Hgb (M = 11.0, SD = 1.8) scores than residents not taking an iron
supplement (M = 12.2, SD = 2.6, t (224) = 3.038, p = .003).
The most commonly prescribed herbal supplements were acidophilus/probiotics (13.8%)
followed by melatonin and cranberry (see Table 2). There were no differences between genders
in herbal supplement use (χ² = 3.236.596, p = .440).
The most common nutrition supplement used was the house supplement (n = 91, 36.8 %),
while the use of the other four nutrition supplements (house snack and 3 Purchased Dietary
Supplements) ranged from 2.4% to 4 %. The residents on a nutrition supplement had a
significantly lower BMI (M = 24.2, SD = 5.3) than those not on a nutrition supplement (M =
27.3, SD = 6.0; t(238) = 4.233, p < .001). Thirty-two percent of sample (n = 79) had low BMI,
48% (n = 119) had normal BMI and 20% (n = 49) of the sample had high BMI.
Supplements infrequently used were: ginger supplement (n = 1), turmeric supplement (n
= 1), zinc sulfate (n = 3), magnesium supplement, (n = 3), and omega 3 (n = 1).
Discussion
Our finding that 94% of residents were taking a VMNHS is higher than results from both
long-term care residents with dementia (48.7% use) in Canada (Viveky et al., 2012) and
community dwelling older adults (82.5 %) in the U.S (Nahin et al., 2009). We also found
differences in use of supplements between the three facilities. Both the higher results and
differences between nursing homes may be due to varied prescription practices or sample
profiles.
The current study found fewer gender differences in supplement use than found in
NHANES trend monitoring reports (Gahche et al., 2011). Our findings suggest that gender
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differences in supplement use may show fewer differences once supplements are prescribed
within a long-term care setting. The finding that calcium and vitamin D use was significantly
higher for women may reflect the increased use of calcium in community dwelling U. S. women
from 28% to 61 % from 1988 to 2006 (Gahche et al., 2011)..
Estimates of dietary supplement use results vary depending on when the survey was
completed, lack of standardized definitions and categories for VMNHS, the population studied,
and the study design. In regard to study design results are impacted by difference in timing,
methods of report, and sampling methods. The third NHANES asked residents if they had used
supplements over the last month while the 2002 Health and Diet Survey was a national phone
survey based on self-report over the last 12 months (Timbo et al., 2006). The NHANES and the
2002 Health and Diet Survey are both self-report, another used pharmacy records (Viveky et al.,
2012) and this study used the MAR. The accuracy of reporting will vary depending on study
design and controls. Regarding population and sampling the NHANES does not include
institutionalized U.S. residents.
Among this sample, the most commonly prescribed products were vitamin D, calcium,
and combination products that contained both vitamins and minerals. Vitamin D doses were
often above the RDA and may be explained by a population at risk for vitamin D deficiency.
Risk factors for vitamin D deficiency include obesity, limited access to sun exposure, wearing
more clothing when outside, decrease in ability of skin to produce vitamin D due to age, and the
high prevalence of atrophic gastritis decreasing ability of older adults to absorb vitamin D
(Holick et al., 2011; Joshi, 2015). Also, the Endocrine Society Clinical Practice Guideline
suggests the Tolerable Upper Intake Level of 4000 IU/day vitamin D for maintenance for older
adults and for adults with vitamin D deficiency 10,000 IU/day (Holick et al., 2011). Recent
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studies have suggested that deficiency of vitamin D is associated with functional impairment and
fall risk in older adults (Centeno Peláez, Ausín, Ruiz Mambrilla, Gonzalez-Sagrado, & Pérez
Castrillón, 2014) as well as an accelerated cognitive decline (Miller et al, 2015). Joshi (2015)
suggested that the evidence is not sufficient to use vitamin D to promote health or prevent aging.
This study found that a wide variety of VMNHS are being used nursing homes. Five of
the 15 most prevalent dietary supplements taken by ambulatory elderly in the Ginkgo Evaluation
of Memory Study were not represented in our sample: glucosamine and chondroitin (17.9%),
garlic (4%), ginkgo biloba (3.8%), saw palmetto (3.6%), and Echinacea (2.3%) (Nahin et al.,
2009). While coenzyme Q-10, cranberry, arginine, melatonin, probiotics and fish oil were
reported in this study, these supplements did not make the list of the most prevalent in the
Ginkgo Evaluation of Memory Study (Nahin et al., 2009). The low rate of vitamin E use in this
sample,1%, was surprising as compared to ambulatory elderly rate of 59.4% (Nahin et al., 2009).
Our findings suggest there may be substantial differences in patterns of use between ambulatory
community dwelling elderly and long-term care residents. Many residents of long-term care are
prescribed a wide variety of supplements.
Limitation
Lack of standardized definitions and categorizations of multivitamins, multi-minerals and
herbals makes it difficult to compare results across surveys and time. Total dosages for vitamin
D only included the specific prescriptions of vitamin D and did not include vitamin D present in
food, combination vitamin/ mineral products, house supplements, snacks, or Purchased Dietary
Products. The results of total vitamin D for sample thus are expected to be lower than actual
intake. This study did not have data to compare blood levels of vitamin D to dosages prescribed.
The sample represents residents of three nursing homes were from one geographical area in the
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U.S which may impact generalizability of findings.
Recommendations for Future Research
There appear to be differences in supplement use between findings reported in the
literature regarding community dwelling adults and our findings from long term care.
Examination of patterns of supplement use by institutionalized adults in a variety of settings is
needed. There is a need to more clearly understand how nutritional needs and supplement use
change over illness trajectories and transitions from community dwelling to acute and long-term
care settings. Questions remain regarding benefits and safety of most products. There is a need
to examine dosages that are suitable for specific uses and patient profiles.
The motivations for prescribing supplements and for older adult’s decision to take
supplements may provide important explanations for the costly and potentially unsafe use of
many products. It would also be interesting to examine how patterns of use change based on
marketing and advertising campaigns. Understanding more clearly the role of physicians, health
care practitioners, and marketing campaigns in guiding choices could inform the development of
interventions and guidelines.
Conclusion
A significant proportion of older adults in three long term care facilities took a wide
variety of dietary supplements. Vitamin D, calcium, and vitamin/ mineral combination products
accounted for much of the supplement use. The most common products categorized with the
herbals were probiotics followed by melatonin and cranberry. Health care professionals and
food and nutritional professionals should be aware all sources of dietary supplement intake in
regard to RDA and drug interactions due to increased patterns of supplement use. Based on
prevalence of use, cited safety and cost concerns, greater consideration of the need for
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supplements and the factors that motivate the prescribing of these products is recommended as a
research and public health priority.
Chapter Summary
This chapter presented more detail regarding the HPM and the first manuscript. The
HPM theoretical constructs and variables were elucidated. The first manuscript, Supplement Use
by Frail Elderly in Nursing Homes, described the prevalence of vitamin, mineral, nutrition or
herbal supplement use in three nursing homes. Most the residents were taking a supplement of
some type and vitamin D was the most commonly taken supplement. The manuscript explored
part of the first research question: what supplements are older adults currently taking in an
institutional setting.
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Chapter 3
Summary of Methodology for Study
This chapter will review the methodology of the research study. The research design and
questions, study variables, instrumentation, survey development, settings, sample, protection of
human subjects, procedures for data collection, and the data analysis are discussed. Testing of
several variables for potential inclusion as covariates was presented. Variables of age, education,
and comorbidity that show statistically significant differences will be included as covariates in
the regression models.
Research Design
The research design was a descriptive cross-sectional design. Descriptive research is
nonexperimental with the purpose to observe, describe, and document in the natural setting (Polit
& Beck, 2012). A prevalence study has a cross-sectional design that describes patterns at a
specific point in time (Hulley, Cummings, Browner, Grady, & Newman, 2013; Polit & Beck,
2012). The research questions and hypothesis which guided this study were developed from the
HPM and literature review. Following are the conceptual model, research questions, and the
hypothesis that guided this study.
Conceptual Model
Using the HPM to study supplement use (See Figure 1), it is postulated that prior
supplement use, age, comorbidity and education level influence expectations of aging and selfefficacy which influences VMS use.
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Figure 1. HPM to Illuminate Supplement Use

Individual
Characteristics and
Experiences
Prior Related
Behavior
IV- Frequency of
supplement use in
past.

Personal Factors
(potential control
variables)

Behavior-Specific
Cognitions and
Affect
Perceived Benefit
of Action
IV- Expectations
regarding aging

Behavioral
Outcomes

Specific Behavioral
Outcome
DV-Supplement Use

IV- Self-efficacy
IV= Independent
Variable

•Age
•Educational level
•Comorbidity Status

DV=Dependent
Variable

Research Questions
1. What is the prevalence of VMS use among older adults?
2. What are older women’s levels of general self-efficacy and expectations of aging?
3. Is higher age associated with increased number of supplements taken?
4. Is there a difference in supplement use between women with higher and lower levels of
education?
5. Is there a difference in supplement use between women with high, medium and low levels of
comorbid conditions?
6.

What percentage of older women are taking vitamin D over the Tolerable Upper Intake
Level?
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7. Are older women cognizant of their vitamin D dosage?
Research Hypothesis
1. Expectations of aging will predict high VMS use.
Controlling for age, comorbidity, and education level; prior supplement use, high expectations of
aging and high general self-efficacy will predict VMS use by older women.
Study Variables
The main variables were prior supplement use, expectations of aging, general selfefficacy, and current supplement use. A summary of the study variables is found in Table 4.
Independent variables were identified by literature review and use of the HPM as a framework.
Independent variables were use of supplements in the past, expectations of aging (3 subscales:
physical, mental and cognitive function), and general self-efficacy (GSE). The dependent
variable is supplement use. The HPM suggests personal factors (age, level of education, and
comorbidity) might have influenced the outcome measure. Personal factors which related to
outcome measure were used as control variables.
Table 4. Summary of Study Variables
Variables
Independent Variables
Use of supplements in the past (Categorical Variable)
Expectations Regarding Aging (Interval Variable, Total 0-100 range score)
Expectations regarding physical health (Interval Variable, Total 0-100
range score)
Expectations regarding mental health (Interval Variable, Total 0-100 range
score)
Expectations regarding cognitive function (Interval Variable, Total 0-100
range score)
General Self-Efficacy (Interval Variable, Total Range 10-40)
Dependent Variable
Current Supplement Use (Interval Variable, Range 0- total number)
Control Variables: Personal Factors
Age (Interval Level, 65 years plus)
Education Level (Ordinal Variable)
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Comorbidity (Interval Variable, Range 0-45 Total)
Demographic Variables
Marital Status (Categorical Variable)
Ethnicity (Categorical Variable)
Race (Categorical Variable)
Level of Education (Ordinal Variable)
State of Health (Ordinal Variable)
Osteoporosis (Dichotomous variable Yes/No)
Annual Income (Ordinal Variable)
Rate Finances (Ordinal Variable)
Instrumentation
Instruments to measure comorbidity, expectations of aging and general self-efficacy were
used in this study. All instruments were in questionnaire form. Evidence regarding the
reliability and validity of each instrument is provided. Demographic information and current
supplement use questions were included. The current supplement use questions have been
developed using the NHANES Dietary Supplement and Medication Questionnaire as a guide.
The following is a list of the instruments used in this study and permission for use.
1) Self-Administered Comorbidity Questionnaire (SCQ) – measured the potential
covariate comorbidity. Dr. Katz gave permission via email (Appendix C) for the use
of The Self-Administered Comorbidity Questionnaire and requested the article
developed the SCQ be cited (Sangha, Stucki, Liang, Fossel, & Katz, 2003).
2) Expectations Regarding Aging Survey (ERA-12) – measured the independent
variable, expectations of aging. The Expectations Regarding Aging Survey (ERA-12)
was available at no cost. The authors requested the article regarding the development
of the survey be cited in the work (Sarkisian et al., 2005b).
3) General Self-Efficacy Scale (GSE) measured the general sense of perceived selfefficacy. The GSE was available at no cost and explicit permission is not needed to
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utilize the scale in research studies (Schwarzer & Jerusalem, 1995). The GSE may be
used if recognition was specified and additional items may be written and added to
scale to individualize the scale if desired.
Self-Administered Comorbidity Questionnaire
Comorbidity was expected in the sample population due to the age of the participants.
Comorbidity can have a confounding influence in studies (de Groot et al., 2003). There were
many instruments to measure comorbidity developed for a variety of purposes (de Groot et al.,
2003; Hall, Ramachandran, Narayan, Jani, & Vijayakumar, 2004). The study required a
comorbidity instrument the participants could fill out. The scale chosen for the study is the SelfAdministered Comorbidity Questionnaire (SCQ) (Sangha et al., 2003).
A simple list of chronic health problems is one method to quantify an individual’s
comorbidity. A list would provide an understanding of the complexity of the health issues but it
may not demonstrate the severity of the conditions or the burden of the conditions (Charlson,
Pompei, Ales, & MacKenzie, 1987). If the total number of comorbid diseases approach was
used there is an assumption that a patient with cancer would have the same illness severity as a
patient with hypertension (Charlson et al., 1987). A list of comorbid conditions does not reflect
the impact of the conditions on function.
The SCQ was developed to provide a self-administered questionnaire to measure
comorbidity. A panel of physicians selected medical conditions per their expert practice and
inclusion in comorbidity indexes: Charlson Comorbidity Index, the Cumulative Illness Rating
Scale and the Index of Co-Existent Disease (Sangha et al., 2003). The SCQ also allowed for
three additional comorbid conditions to be written in by the participant. Each medical condition
had 3 points possible: 1 for presence of condition, 1 if received treatment, and 1 if the condition
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limited activities. The question on treatment considered disease severity. The question on
activities considered the impact of the medical condition on functional limitations. The purpose
for questions on treatment and activity was to quantify the impact of the medical conditions.
Some comorbid conditions do not limit function, such as hypertension, while others severely
limit function (Sangha et al., 2003).
The SCQ had a possible total of 45 points with a range of scores from 0 to 45. The SCQ
was easy to administer, self-report and allowed for additional comorbid illnesses to be added
(Katz, Chang, Sangha, Fossel, & Bates, 1996; Sangha et al., 2003). It has been tested with the
elderly and has terms the elderly are familiar with (Katz et al., 1996; Sangha et al., 2003).
Reliability and validity.
The SCQ test-retest reliability was 0.94 (95% CI, 0.72, 0.99) measured with the intraclass
correlation coefficient (ICC) and was compared with test-retest reliability of the Charlson Index
of 0.92 (Sangha et al., 2003). The test retest reliability of specific items calculated with kappa
statistic and ranged from moderate (back pain = 0.40) to high (> 0.90 for heart disease,
hypertension, lung disease, kidney disease, diabetes, anemia and depression) (Sangha et al.,
2003).
The spearman's correlation coefficient of 0.55 was between the SCQ and the Charlson
Index. The SCQ has moderate association with Charlson Index (Sangha et al., 2003). The SCQ
was chosen as it captured the comorbid medical conditions and allowed for additional comorbid
conditions. It also included the severity and functional limitations (Sangha et al., 2003). The
SCQ medical terms have been simplified making the SCQ easy to read and understand (Sangha
et al., 2003).
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Expectations Regarding Aging Survey - 12
The Expectations Regarding Aging (ERA-12) was a 12-item instrument to measure
expectations regarding aging among older adults (Sarkisian et al., 2005b). The ERA-12 was
developed to provide a shorter scale that would be useful in surveys and would take less time to
complete. The ERA-12 was developed from the ERA-38.
All ten scales on the ERA-38, other than pain with a Cronbach’s alpha of 0.58, had good
internal consistency reliability with Cronbach alpha ≥ 0.73 and item discrimination ≥ 0.80
(Sarkisian, Hays, Berry, & Mangione, 2002b). Correlations with age, activities of daily living,
the Geriatric Depression Scale, and the physical and mental component cores of the Medical
Outcomes Study Short Form-12 supported construct validity. Almost 70 % of community
dwelling older adults who participants responded during the cognitive debriefing that all or
almost of the ERA-38 addressed important things (Sarkisian et al., 2002b).
Reliability and validity.
In the development of ERA-12, factor analysis was used to identify the dominant factors,
principal components with promax rotation (Sarkisian et al., 2005b). The three factors were
physical health, mental health, and cognitive function. For each of the three factors the authors
identified 2, 3, 4 or 5 item subsets that would explain maximum variation in overall factor score.
Based on previous work four items were selected for each of the three factors to form the 12item scale. The final scale was determined using: variance and internal consistency reliability,
focus group findings, redundant items removed, and completed by older adult in 5 minutes
(Sarkisian et al., 2005b). The Cronbach’s alpha, internal consistency reliability, for the three
scales ranged from 0.73 to 0.81. The test-retest reliability was measured on a 2-week retest with
intraclass correlation coefficient (a measure of the reliability of measurements) of 0.94.
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General Self-Efficacy Scale (GSE)
Perceived self-efficacy was related to subsequent behavior and was relevant to explore
behavior, behavior change, and for clinical practice (Schwarzer & Jerusalem, 1995). General
self-efficacy was the self-perceived belief in one’s self competence to tackle tasks and handle
adversity in a broad range of encounters (Luszczynska, Gutiérrez‐Doña, & Schwarzer, 2005;
Scholz, Gutiérrez Doña, Sud, & Schwarzer, 2002). Generic self-efficacy skills related to
different higher-order self-regulatory skills which were used in a variety of activities (Bandura,
2006). Specific self-efficacy was constrained to a specific task (Luszczynska et al., 2005). The
GSE scale measured general self-efficacy and allowed for additional items to be included for a
specific task (Schwarzer & Jerusalem, 1995). The perceived self-efficacy of the participants was
measured with the GSE. Additional questions were added for supplement use as detailed below.
Self-efficacy was conceptualized as the individual’s perceived “optimistic self-belief”
(Schwarzer, 1992). The GSE was created to assess the general sense of perceived self-efficacy
and was designed for the general adult population. The scale was self-administered. Responses
to the 10 questions were made on a 4-part scale: 1 = not at all true. 2 = hardly true, 3 =
moderately true, and 4 = exactly true. The GSE allows for additional items to be added as
desired to encompass a specific behavior. The GSE instrument was scored by summing up the
responses to all 10 items. The total score for the GSE ranged from 10 to 40.
Reliability and validity.
The GSE has been used widely in over 23 nations. The Cronbach’s alphas ranged from
.76 to .90 (Schwarzer & Jerusalem, 1995). Criterion-related validity was documented with
correlational studies. Positive coefficients were found with dispositional optimism and favorable
emotions. Negative coefficients were found with health complaints, depression and anxiety
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(Schwarzer & Jerusalem, 1995).
Additional items to GSE.
Bandura suggested that perceived self-efficacy scales be tailored to the concept of interest
and reflect the construct (2006). Perceived self-efficacy was different from locus of control, selfesteem, and outcome expectancies and the perceived self-efficacy items should reflect this
difference in phenomena (Bandura, 2006). As there were no self-efficacy scales specific for
VMS use, this author developed additional items for VMS use as prescribed by Schwarzer and
Fuchs (1995).
Schwarzer and Fuchs (Schwarzer & Fuchs, 1995) suggested phrasing for self-efficacy
items which include a barrier is “I am confident that I can (perform something), even if (barrier)”
(p. 180). Development of the additional questions followed Schwarzer and Fuchs’ processes
(1995). The subjects for each item were derived from the literature, feedback from health care
professionals, general discussions with older adults, and review of similar self-efficacy scales of
nutrition and medication adherence (Fernandez, Chaplin, Schoenthaler, & Ogedegbe, 2008;
Schwarzer & Renner, 2014). The additional questions went through two reviews and revisions.
Table 5 contains the survey questions for self-efficacy of VMS use.
Table 5. Additional Questions for Self-Efficacy for VMS Use
Subject of Item
Question for Survey
Routine
I am confident that I can make taking my supplements part of my routine.
Memory
I am confident that I can always remember to take my supplements.
Change in Day
I am confident that I will take my supplements when there is a change in
my usual day (unexpected things happen).
Schedule
I am confident I can take several supplements on different schedules.
Information
I am confident that I can find information I need to help manage my
supplements (for example: to get information, learn more about, avoid side
effects).
No Help
I am confident I can manage my supplements without help.
List all
I am confident I can list my supplements, including the doses and
schedule.
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Maintain supply

I am confident I can remember to get refills of my supplements before I
run out.

Descriptive and Potential Covariate Variables
Descriptive data were collected to describe the sample. Data were self-identified. The
following descriptive variables were gathered: marital status, ethnicity, race, level of education,
state of health, osteoporosis diagnosis, annual income, and how rate finances. State of health
was a good indicator of overall health. Potential confounding variables identified from the
literature review were age, education level, and comorbidity. Education level was used to
identify the highest level of schooling. Comorbidity was self-identified using the SCQ.
Current Supplement Use
Operational definition for VMS users were those who reported taking a VMS within the
past 30 days. Non-users were those who did not report taking a VMS in the past 30 days. Using
a time frame to identify VMS users captures users who take VMS on different schedules and the
30-day time frame commonly used (Bailey, Fulgoni, Keast, & Dwyer, 2012). Participants were
also asked to bring their supplements on the day of the survey. If a participant brought in their
supplements, the inventory (check list) and 24-hour recall were confirmed with participant
against the supplements brought in.
The first question on VMS use, requested that participants check off the inventory any
VMS they have taken in the past 30 days. The list was formulated using the classification
system (Appendix A) and space was provided to write in any additional supplements not on the
inventory. Participants were asked to identify what they took, the name of the product, and how
long they have taken this or a similar product. The second question asking about VMS use was a
24-hour recall of all VMS taken. Total for current supplement use was the sum of each VMS
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reported taken in the last 30 days. For example, is a calcium is taken three times a day, it is
counted as one VMS towards the total. If a VMS is taken once a week it is counted as one VMS
towards the total. The total is not a pill count per day, but a reflection of total number of
different VMS taken in the past 30 days.
It is a challenge to collect accurate data regarding supplement use (Neuhouser, 2003;
Thompson & Nichter, 2007)). The methods to obtain supplement data include using a
classification system, defining supplement use, providing supplement inventory, including a 24hour recall, and specifying how to measure VMS usage, have been described in other studies
(Foote et al., 2003; Patterson, Levy, Tinker, & Kristal, 1999; Viveky et al., 2012; Wold, Wayne,
Waters, & Baumgartner, 2007). A detailed supplement inventory approach or check list has
been found to correlate well with nutrient intake estimates (Park, Harnack, & Jacobs, 2009). The
method of asking participants to show the supplement products has been described to improve
reliability (Lam & Bradley, 2006; Patterson, Levy, Tinker, & Kristal, 1999; Wold, et al., 2007).
Reliability and validity.
Recruitment material informed participants to bring their VMS. This allowed the
participants to show the researcher what they are currently taking. This also allowed the
researcher to compare what they brought with what was written on survey. This allowed for
validation to confirm what was reported on the survey to what participants brought. The
expectation was that the physical supplement bottles would increase the reliability of VMS
reported.
Survey Development
The data was gathered on current supplement use by means of a survey compiled by this
researcher. The individual questions to gather the data needed for the research questions,
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separate from the instruments used, were first constructed and then combined to make a
questionnaire (Peterson, 2000). Close ended questions and open ended questions were employed
by the survey (Fink, 2013; Fowler, 2009; Peterson, 2000). Close ended questions were: past use
VMS, current VMS use, vitamin D prescription, and the demographic questions. Open ended
questions were; reasons to use vitamin D and list all VMS taken in past 24 hours. Informative
instructions were provided and for list all VMS taken in past 24 hours a definition of VMS was
given for clarity. Guidelines used to develop questions included: one thought per question;
question should be meaningful, concrete, clear; answer choices were mutually exclusive and
exhaustive (Fink, 2013; Peterson, 2000). Dr. Julie Ellis provided the annual income and rating
of finance questions.
Two methods were used to gather information on VMS usage; a checklist of VMS taken
in last 30 days and a 24-hour recall of what VMS taken. Using two methods captured a larger
fraction of VMS use (Nicastro, Bailey, & Dodd, 2015). The NHANES Dietary Supplement and
Medication Questionnaire has been tested and found to be successful in gathering information
and can be easily modified. The NHANES Dietary Supplement and Medication Questionnaire
demonstrated the importance of clarity, clarify understanding of questions, explain definitions,
and asking in several different ways to elicit correct information. However, the NHANES
questionnaire was extensive (over 30 pages long) and has many items that do not apply to the
research questions and hypothesis of this dissertation. Several questions on VMS use were
developed for this study using the NHANES Dietary Supplement and Medication Questionnaire
as a guide (Division of Health and Nutrition Examination Surveys, 2016). The questions,
regarding vitamin D use and the other VMS use followed the NHANES Dietary Supplement and
Medication Questionnaire. The question for vitamin D asked strength, dose, how much per day,
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name of supplement, how much is last 30 days and length the time the product had been taken.
The question regarding other VMS was an inventory checklist, the types of products were listed,
and asked to check if product was taken in last 30 days, name or type of product, and length of
time the product had been used. The order of the VMS in question on what VMS used was
guided by the classification system of VMS used for this study (Appendix A; Bailey et al.,
2013).
The questionnaire was constructed to make it easy to read, enough space for answers,
informative instructions, and definitions and explanations where needed (Peterson, 2000). The
information instructions included on the first page that dietary supplements included the use of
vitamin, mineral, herbal dietary supplements including antacids and any prescription
supplements. When asked to list all VMS taken in last 24-hours, a definition was provided.
Dietary supplements include vitamins, minerals, antacid/calcium supplements, fiber supplement,
amino acids, performance enhancers, herbs, herbal medicine products, and plant extracts. The
term dietary supplements does not include meal replacement beverages, weight loss or
performance booster drinks, food bars or tea.
The questions were also listed in order of most important to less important information
(Fink, 2013). This allowed the older participant to have the most attention and energy given to
the most important questions (Peterson, 2000). The first two questions were screening questions
that were designed to start the participants to think of the questionnaire topic but also be easy to
answer (Peterson, 2000). The substantive questions followed the screening questions, including
use of VMS and all the instruments. The survey ended with the comorbidity and demographic
questions (Fink, 2013; Peterson, 2000).
The questions in the survey were listed in order of lest sensitive to more sensitive
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information to establish baseline comfort in providing information and moving to more sensitive.
The sensitive questions regarding finances and education were at the end of the survey. The
questions regarding use of supplements were first and demographic questions were last. The
demographic questions are typically placed at the end of questionnaires (Peterson, 2000).
Demographic questions were factual and easier to answer which helps to avoid problems with
fatigue (Peterson, 2000). Easy to answer and clear questions are less likely to impede an older
individual from answering (Peterson, 2000).
To minimize response bias in the survey as suggested by Bandura, the self-efficacy scales
were identified by a nondescript title rather than self-efficacy (Bandura, 2006). Early survey
development feedback was provided by several individuals to refine the questions, change the
order of questions, and confirm amount of time to complete survey. Assistance with layout and
spacing was provided by UWM CON professional staff. Feedback for the readability and
feasibility of the survey was conducted with nine individuals. Four changes were suggested and
implemented in the survey; increased font size, one question was moved to different page, past
use question the length of time was clarified, and numbering system with larger fonts was added.
The question asking the participant to list the VMS they had taken in the past 24 hours was
moved from bottom of page 3 to top of page 4, and additional space was provided. Several
individuals mentioned they had missed the question and several required more room to write.
Setting
The study participants were recruited from independent living community settings:
senior dining sites, a church, and local Continuing Care Retirement Community facilities which
have independent living as part of the continuum of care. Participants were recruited from sites
in Southeastern Wisconsin.
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Sample
Sample/Participants
The target population for this study were independent living women. Criterion sample
allows for selection of cases that meet predetermined important criteria (Polit & Beck, 2012).
Important criteria for the study were 1) 65 years of age or older, 2) female, 3) able to speak and
read English, 4) in an independent living setting, 5) no memory problems, 6) all consent
requirements are met and willing to participate in the study.
Potential participants were excluded if they were unwilling to give their age, reported
memory problems, or did not complete a minimum of 95% of the survey. Potential participants
were enrolled only from independent living apartments in a Continuing Care Retirement
Community or the community settings which had given prior approval for the study.
Sample Size
Regression analysis allowed for predicting the outcome variable from one or more
predictor variables (Field, 2009). Field (2009) suggested the number of cases per predictor does
not address the strength of relationship measured or the power required to detect effects. Munro
suggested specification of the assumptions for statistical power, significance level, and effect
size desired for the study using Cohen’s formula (2005). Expert advice and a priori power
analysis for hierarchal regression were used to determine the necessary sample size for the study.
A prior power analysis was used to determine lowest threshold of sample size. Too few subjects
may result in a lack of statistical power to detect a difference (type II error). An adequate sample
size helps avoid type 1 error (Hulley et al., 2013).
The conventional proposed statistical power level was 0.80, a value less than 0.80 incurs
a risk of Type II error the failure to reject a false null hypothesis (Cohen, 1992). A value higher
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than 0.80 would require a sample size that exceeds available resources (Cohen, 1992). The
significance criterion (alpha) was set at 0.05, to avoid committing a Type 1 error the risk of
mistakenly rejecting the null hypothesis (Cohen, 1992). Across various studies using HPM, the
variance explained by the HPM variables tested ranged from 19% to 59% (Pender, 1996). A
moderate effect size (R2) of 0.15 was assumed as this was the first time HPM has been studied
with VMS. The 3 possible control variables (age, education, comorbidity) were included in step
A of the calculator and the 3 independent variables (prior use of supplements, expectations of
aging, and general self-efficacy) were included in step B of the calculator (Soper, 2016). Using
the parameters described above, Soper’s priori sample size calculator for hierarchical multiple
regression result was 79 (Soper, 2016). The expert adviser suggested increasing the sample size
to 110.
Control strategies such as a variety of sites and an adequate sample size helped minimize
bias and preserve validity in the study (Polit & Beck, 2012). Sample imbalance may cause bias,
to prevent this a variety of different sites were sought. While this does not ensure ability to fully
reflect the population of the United States it does seek to avoid sample imbalance found if only
one facility was utilized for data collection. Flawed implementation could cause biases if the
survey was not carefully implemented (Polit & Beck, 2012).
Protection of Human Subjects
Approval for this study was granted from this researcher’s dissertation committee and the
University of Wisconsin-Milwaukee Institutional Review Board (IRB). Letters of support were
granted from each site before any recruitment of participants took place. The primary
investigator was a licensed registered nurse and had received training from Collaborative
Institutional Training Initiative Program, including IRB- Biomedical and Social & Behavioral
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Combined Researchers.
Consent Procedure
Older adults were considered a vulnerable population due to age. Steps were taken to
ensure participants’ understanding of the consent procedure. Direct recruitment was utilized at
senior dining centers and the church (see Appendix D). No direct recruitment was used in the
three Continuing Care Retirement Communities (CCRC). The Health Insurance Protection
Accountability Act (HIPAA) protects individuals who are in nursing home settings.
Informational sessions regarding the potential survey were provided or IRB approved handouts
were posted for potential participants from CCRC’s.
Fully informed consent was obtained from each subject. Key points in the consent form
(See Appendix E) included: study goals, type of data collected, procedure for collecting data,
time commitment, , risks and benefits, no compensation, confidentiality pledge, voluntary
consent, right to withdraw and researchers contact information (Fink, 2013; Polit & Beck, 2012).
The University of Wisconsin-Milwaukee IRB approved a Waiver to Document Informed
Consent. After consent information was read and any questions answered, the consent was
implied by the completion of the survey.
Risks vs Benefits
Participation in the study posed no apparent risk, harm, or hazards to the participants.
The Expectations Regarding Aging Survey (ERA-12) contains questions regarding aches and
pains, energy levels, less time with friends, being lonely, worry, normal to be depressed,
forgetfulness, and mental slowness (Sarkisian et al., 2005b). The participant rated the question
on a scale of definitely true, somewhat true, somewhat false, and definitely false. The ERA-12
had been used in self-administered studies by mail (Sarkisian et al., 2005b). The ERA-12 survey
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posed no apparent risk for harm. The major potential risks were loss of time and fatigue or
boredom. This research project had minimal risks to subjects. This research project had modest
benefits. The major potential benefits include: being able to talk with a friendly person, escape
from normal routine, excitement of being part of a study, contributing to a worthwhile project,
and satisfaction that the information they provide was valuable (Fowler, 2009; Polit & Beck,
2012).
IRB approval was granted to allow the primary researcher to provide a 20-minute general
education talk for a Continuing Care Retirement Center which requested a general education talk
as a service for residents prior to the survey. The title of the topic was “Your New Year’s
Resolution: General Fitness, Wellness and Health Aging”. The 20-minute general education talk
was provided at the facility on two days for any resident of the facility.
Recruitment Techniques
There was one data collector for recruitment, consent, and data collection. Key contact
people were identified at each site. Set days were planned with key contact person to recruit
participants at the sites contingent on accessibility. The primary researcher and each key contact
person planned the information dates, reminder announcement dates, where to post flyer, and the
survey dates. The amount of time spent at each site was dependent on number of potential
participants, other competing activities, and as determined with key contact person. Recruitment
began after IRB approval and letter of support was received from each facility.
To ensure consistency during the recruitment phase the recruitment materials were
prepared in advance, all materials were approved by IRB, and the same materials were used at
each site. Recruitment materials included a flyer for sites, a reminder announcement, an
informational session outline, and a handout for use in place of the informational session (See
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Appendix D). The key contact person made the reminder announcements and assisted in
distribution of flyers. The key contact person also helped identify the best time to start and end
data collection, identified private areas for participants to fill out the survey, and identified an
area to use if the survey needed to be read to a participant. The key contact person also assisted
to ensure data collection did not disrupt participants planned activities such as the bingo time or
during the meal time at senior dining sites.
All sites distributed the flyers per their organizational process. Reminder announcements
were made at all senior dining sites, at the church, and one Continuing Care Retirement
Community. The timing of the information session differed depending on site needs. At senior
dining sites and one Continuing Care Retirement Community the informational session
immediately proceeded the survey. At the church and one Continuing Care Retirement
Community the informational session was a week preceding survey. And at the third Continuing
Care Retirement Community the handout of the informational session was distributed by the
facility per organizational guidelines the week before survey collection. The primary researcher
also gave an informational session regarding the survey preceding all survey recruitment at each
site.
Age was assessed by self-report. Prospective participants’ ability to speak and read
English were assessed by ability to understand and process instructions, responses to researcher,
and ability to read the consent form. Participants with visual impairment were assisted by the
primary researcher by reading the consent in a private setting (or where the participant requested)
and answering any questions. If the participant with visual impairment wished to do the survey
after hearing the consent read, the primary researcher then read the survey questions and filled
out the survey form with responses as directed by the participant.
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A key ingredient to successful recruitment of older women was to address barriers to
recruitment such as mistrust, fear of lack of confidentiality, and burdens (McHenry et al., 2015;
Mody et al., 2008). Maintaining a respectful partnership with the institutions and participants
also engendered trust with the participants (Mody et al., 2008). The key contact person was
invaluable for introduction of primary researcher to participants. The primary investigator was
respectful and expressed gratitude for participation in the survey, these are means to engender
trust (McHenry et al., 2015; Mody et al., 2008). At each site to protect confidentiality the key
contact person and primary investigator gave attention to the provision of adequate space and
privacy to complete the survey and answer all questions (Mody et al., 2008). While designated
private areas were provided at each site, participants choose where they wanted to sit.
Participant concerns or questions were addressed as they arose. If the participant chose
to withdraw from the study the data collected was not utilized in the study. Concerns regarding
confidentiality were addressed by reviewing consent with the potential participant. Requests to
take the survey home and return another day were refused, and explained importance of primary
researcher being present during the survey completion.
De-identification and Protection of Data
Each survey form was identified by a unique number assigned after data collection. No
identifiable information such as name, social security number, address, or phone number were
collected. All the research records were kept in a locked file cabinet by the primary investigator.
De-identified data was collected and entered into SPSS and kept on a password protected
computer. Backup files were kept on an external hard drive. De-identified data were shared for
consulting on the dissertation process with Dr. Kovach, members of research committee, and
statistician. Original surveys will be destroyed within five years of the end of the study. As
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stated in the consent de-identified data on SPSS may be kept indefinitely and used in the future
for research or educational instruction purposes.
Data Management Plan
Effort was taken to ensure no missing survey data at time of collection. At the time of
collection, the primary investigator checked for completeness and any outliers before the
participant left when circumstances allowed. All participants were aided with survey completion
as needed. Survey forms were collected at the site, placed in a folder and then conveyed that day
directly to the primary researcher’s office. The surveys were kept in locked file cabinet that is
used only by the researcher (Fink, 2013).
A codebook was maintained during data collection and data analysis. The codebook
contained decisions with data entry, summary of study variables, variable names, variable label
definition, coding descriptions, notes, and identified the question on survey each variable
corresponds with. For the data analysis, the codebook contained a worksheet for research
questions, variable and level of measurement, and planned statistical test (Hulley et al., 2013).
Decisions regarding data analysis were also noted in the codebook as they occurred.
The Statistical Package for the Social Science (SPSS) data was kept on the primary
investigator’s personal computer that is password protected. The primary investigator is the only
person who uses the computer. A two-person method was used to enter the data, one person
reading the data and one person typing into SPSS. The data was hand-entered and double
checked for accuracy. As the data was gathered it was entered into SPSS, generally within 24
hours. The data was visually checked and analyzed for outliers, illogical or missing data.
Missing data was coded as missing and given a label missing. Decision on data entry were noted
in the code book as they occurred.
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Data Analysis
The data analysis was conducted using IBM SPSS Statistic 23 student version. Prior to
analysis, the data was screened by checking that all variables values fell within the range of
possible values for the specific variable. Any irregularity in the SPSS data file was checked with
survey and any errors were corrected and noted in codebook. All variables were examined using
range, minimum and maximum values, mean and skew prior to analysis. Assumptions for
analysis and frequency distributions of all variables were checked before proceeding with the
analysis. Sufficient variability in the dependent measure of supplement was confirmed with a
range of 0-16 VMS taken per day. A conventional alpha level of .05 was chosen as standard for
all significance testing. Skew, missing values, and transformation of variables was discussed in
following section regarding assumptions of the parametric data for analysis.
Assumptions of Parametric Data
The data was analyzed to ensure the necessary assumptions for the planned statistical
analysis were met. Parametric tests were based on a normal distribution and the following
assumptions were tested: variables were quantitative or categorical, non-zero variance, normal
distribution including skew, linearity of data, multicollinearity, and homoscedasticity (Field,
2009; Pallant, 2016). Scatterplots of variables were confirmed for linearity. Two outliers were
identified with stem and leaf plot for VMS use in the past, data was confirmed against the
surveys. The data were not altered as the responses were categorical, the participants who had
never used VMS in the past. Multicollinearity was not a problem, an initial linear regression
analysis found Variance Inflation Factor (VIF) was close to 1. Scatterplot with multiple
regression was checked and found homoscedasticity.
Tests for skewness in distributions were performed and the following variables were
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skewed in the data set: use of VMS in past, SCQ, ERA mental health subscale, VMSSE, and the
dependent variable supplement use. The use of VMS in the past was a categorical variable
which the raw data showed was negatively skewed. There were a small disproportion number of
individuals who never used VMS (3%) or hardly used VMS in the past (11 %). The decision
was made not to transform or merge the categories of VMS use in the past.
SCQ, the variable for comorbidity, raw data showed positive skew demonstrating that a
larger proportion of the individuals had no (12 %) or fewer comorbidities. As the SCQ has true
zero responses a square root transformation was completed lowering the skew from 4.16 to 2.66
and the histogram displayed a clustering of zero responses with an approximately normal curve.
The SCQ was a control variable and did not relate significantly to the dependent variable (p =
.95) and did not correlate to dependent variable (.018) and was not used in the final multiple
regression. Non-parametric was used where necessary to answer the research questions due to
skew.
The ERA mental health subscale was negatively skewed as a large proportion (53% in the
top 25% percent of total score) of the individuals responded that the mental health responses
were ‘definitely false’ and 21% scored all responses as ‘definitely false’. When the ERA mental
health scale was transformed with logarithm or square root the skew went from 3.14 to 10.8 and
6.13 respectively. Decision was made to not transform the data and use non-parametric tests as
needed. The ERA mental health subscale was not used in the multiple regression as the
subscales were highly correlated with the total ERA.
The raw data showed a negative skew (-8.6) for VMSSE, a large proportion of the sample
chose exactly true for most responses. The individuals reported they were very confident in their
ability with VMS. Thirty-seven percent of responses were clustered at right of the histogram.
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VMSSE was not transformed as both log and square root transformation increased the skew and
did not convert VMSSE into a normal distribution. VMSSE did not relate significantly to the
dependent variable (p = .94) and did not correlate to dependent variable (-.007) and was not used
in the multiple regression. Non-parametric was used where necessary due to skew to answer the
research questions.
The dependent variable supplement use was negatively skewed with 50% of individuals
taking 4 or less VMS per day. The dependent variable VMS use was transformed using square
root as variable had true zero scores. The skew was transformed into normal parametric
distribution from -4.43 to 1.54, with normal appearing histogram.
All missing data on the dataset were verified against original surveys. The ExpectationMaximization (EM) method was chosen to replace missing values. The EM method was
reasonable to replace missing data values when regression analysis is the method selected to
examine the variables. EM method was useful for multiple regression as it retained relationships
with other variables. The EM method is suitable if there is less than 5% missing data: all
variables had 5% or less missing variables. The EM method used other variables to impute a
value and checked until it reached the most likely value. The EM method was used to impute
single missing values for variables VMSSE, GSE, SCQ, and ERA for use in the first multiple
regression.
Descriptive questions
Descriptive statistics (marital status, race, ethnicity, range of income, financial situation,
state of health, and presence of osteoporosis) and the potential control variables (age, education,
and comorbidity levels) were used to summarize demographic information and sample
characteristics. Continuous variable such as age were described using the mean, range, and
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standard deviation. Categorical variables such as race, state of health, marital status and use of
VMS currently and in the past, were described using frequency, frequency distribution and
percentage. The SCQ was skewed and was described with the median, the most suitable
measure of central tendency (Polit & Beck, 2012).
Question 1, regarding prevalence of current VMS use, was described using means,
standard deviations, ranges, and frequencies of VMS use. Classification system was applied to
report dietary supplement categories.
Question 2 regarding the results of the instruments used; GSE, and ERA total and ERA
subscales physical health and cognitive function, were reported using means, standard
deviations, and ranges. As GSE median was often used to divide the sample, the median was
reported. The VMSSE and ERA subscale mental health were skewed and the median was used
to reflect the measure of central tendency. The reliability of each scale for use in this study was
given.
Question 3 examined the association, measured by Pearson correlation coefficients or
Spearman’s rho, between age and amount of VMS use. The relationship between age and
amount of use of supplements was also examined between young-old (65 to 74 years) and those
75 years and older by means of chi-square.
Question 4 described the difference in VMS use between women with different levels of
education. The non-parametric Mann-Whitney U Test was used due to skew of variables. The
dependent variable was use of VMS (interval scale) and the independent variable is education
with 2 discrete levels. Also, reported the frequency and percentage of the untransformed
education levels and use of VMS.
Question 5 identified if there was a difference in supplement use between women with
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high, medium and low levels of comorbid conditions. As the assumptions for parametric
statistical analysis were not meet, the non-parametric Kruskal-Wallis Test was used.
Question 6 considered if older women were aware of their vitamin D dosage. The
frequency and mean were reported. A chi-square was used to compare those who could report
their dose to the response on VMSSE question regarding confidence of dosage knowledge.
Question 8 reported on the frequency and percentages of women in the sample are taking
vitamin D over the Tolerable Upper Intake Level.
Theoretical Question
Hierarchical multiple regression was the statistical test used for the research hypothesis.
There was an interest in the relationship between the dependent variable of VMS use and the
independent variables of past use, self-efficacy, and expectations of aging. Multivariate
regression has the advantage to adjust for several control variables in the analysis phase and
allowed the researcher to control the order of entry based on theoretical considerations and
current literature (Field, 2009).
Multicollinearity is the presence of a strong correlation between two or more predictors
in a multiple regression model (Field, 2009; Polit & Beck, 2012). Multicollinearity is a concern
as the unique estimate of the regression coefficients cannot be determined and it becomes
difficult to judge which variables are important (Field, 2009; Polit & Beck, 2012). A correlation
matrix of all the control and predictor variables was examined for correlations above .80 (Field,
2009). The ERA total score had high correlations (.84, .82, and .85) respectively with ERA
physical health, ERA mental health and ERA cognitive function. The decision was made to use
the ERA total in the multiple regression. ERA total score is a combination of ERA physical
health, ERA mental health and ERA cognitive function. There were no other variables with
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correlations ≥ 80 (Field, 2009). The variables VMS use in the past and education level were
ordinal variables but were treated as interval for hierarchal regression.
Following Fields strategy for multiple regression, a two-step process was followed. First
a regression analysis with all the control variables and predictors were entered to observe the
variables which contribute significantly. Once the control variables and independent variables
were determined significant and are important, a regression analysis was run to define the model.
For the first regression, step 1 contained the control variables: age, education level and
comorbidity. Step 2 contained the independent variables prior supplement use, general selfefficacy, VMSSE, and expectations of aging. The second multiple regression was run with the
control variables, the independent variables that were found to be significant and important.
Limitations and Ethical issues
The design of the study was non-experimental and strategies such as specification and
matching to reduce confounders was limited (Hulley et al., 2013). Descriptive cross-sectional
research was to describe relationships among variables, was inherently weaker than experimental
study, and did not support inferences of causality (Hulley et al., 2013; Polit & Beck, 2012).
However this research design did have the advantage of avoiding dropout problems and lower
time and expense (Hulley et al., 2013; Polit & Beck, 2012). A convenience sample had the
advantage in cost and logistics is chosen as participants are easily accessible and meet the
inclusion criteria (Hulley et al., 2013). Random sampling would increase expense and require an
increased number of facilities for an adequate sample size. Convenience sampling is the weakest
form of sampling and has the highest sampling bias (Polit & Beck, 2012). The convenience
sample may not represent the population (Hulley et al., 2013). The limitation of using a
convenience sample is this type of sample is not highly rigorous, limits the ability to have a
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representative sample and does not meet scientific standards for generalizing findings of the
sample to the general population (Polit & Beck, 2012). The statistical testing was centered on a
logical theory-based hypothesis to avoid using large amounts of random variables which can lead
to type I error (false positive).
The data for the study was self-report which is efficient and participants are aware of
their own supplement use, and thoughts and beliefs regarding expectations of aging and
perceived general self-efficacy. Two of the variables can only be gathered by self-report from
the participants, expectations of aging and perceived general self-efficacy. The three instruments
used in the study were developed for self-report. The validity and accuracy of the self-report
data is a concern and may be a limitation (Polit & Beck, 2012). There is also the effect that the
participant may want to report what they think the researcher wants to hear and this can bias the
data. Participants sometimes respond in order to make a favorable impression (Polit & Beck,
2012). Having the subjects show the actual supplements is one method to improve accuracy and
validity of the study.
Measurement error is inherent in all studies. Missing data can threaten the validity of the
conclusions. Measurement attrition is the failure to complete the outcome measurement, for this
study ensuring the survey questions were completed helped avoid this (Shadish, Cook &
Campbell, 2002). There may have been a difference between participants who enter the study
and those who do not participate in the survey. There was no way to measure this difference.
Ethical Issues
One of the most important ethical issues was protection of study participants. Two of the
ethical issues of concern were informed consent and confidentiality for all participants (Fink,
2013; Polit & Beck, 2012). Informed consent and confidentiality were taken into consideration
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during the planning phase. Participants needed to aware of enough information that they can
make an informed decision on participation. The flyer, announcement, informational session and
consent documents were prepared to provide sufficient information for informed choice and
consent. Confidentiality was protected, no names or identifying information were gathered.
Privacy at each site was available to participants, and they had the option of sitting where they
desired. Participants were assured that their participation was strictly voluntary and they could
stop at any time. Protecting confidentiality continued beyond the data gathering phase.
Procedures to ensure data is de-identified and secured were followed during analysis and after.
Chapter Summary
This chapter presented the methodology for the research survey. The design of the
research study included the targeted research questions, study variables, instrumentation, and
survey development. The settings, sample, and steps taken for the protection of human subjects
were discussed. The data collection and the steps of the data analysis were detailed. The steps
taken for the variables which did not meet the assumptions for parametric data were explained.
Limitations of the cross-sectional study were presented. The key ethical issues of confidentiality
and informed consent were considered throughout the research study.
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Chapter 4
Introduction
This chapter will describe the sample and present the statistical results for the research
questions and research hypothesis. The research questions are divided into two manuscripts, the
second and third manuscripts of the dissertation. References for both manuscripts in chapter 4
are located at the end of the dissertation. The second manuscript reports the results of the nontheoretical research questions and third manuscript reports the results of the theoretical research
questions and research hypothesis. The research questions reported in the second manuscript
comprise: prevalence of VMS use including the complexity of herbal use; the relationship
between age, education, comorbidity with VMS use, and the questions related to supplement of
interest, vitamin D. The second manuscript also describes the sample. The third manuscript
reports the levels of general self-efficacy and expectations of aging and describes the results of
the hypothesis regarding whether expectations of aging and self-efficacy are predictors of VMS
use by older women. Results that do not apply to either manuscript, such as the comparisons in
supplement use between older adults living in the community and in nursing homes, are reported
after the third manuscript.
Vitamin D and Supplement Use by Older Women in Independent Living Settings
Abstract
Dietary supplements, such as vitamins, minerals and herbal products, are commonly used
by older women. It is vital that health care professionals have information regarding current use
patterns due to new products and safety concerns. Additionally, as vitamin D use surges there is
a need for current information regarding presence of use over Tolerable Upper Intake Level. A
self-report survey was collected from 110 women 65 years or older from community or
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Continuing Care Retirement Centers in the upper mid-west of the United States. The majority of
the sample (n = 73, 67%) report frequent use of vitamin, mineral and herbal supplements over
the course of their life. Ninety-two percent were using a vitamin, mineral or herbal supplement
(Md = 4.5, SD = 3.6, range 0 to 16) at the time of the survey. About a third of the sample used
herbal products (n = 34, 30.9%). Vitamin D (n = 82, 74.5%) was the most frequently reported
used supplement. From major category, the most frequently used was multi-vitamin, multimineral. Calcium (n = 55, 50.5%) was the most frequently reported from minor category. The
most frequently used herbal was coenzyme Q-10 (n = 14, 12.7%). The most frequently cited
reason for using vitamin D was lack of sunlight and to supplement diet. Seven percent who took
vitamin D were at the Tolerable Upper Intake Level or above for dosage. In this study, there was
not a significant association between VMS use and age or comorbidity, however education was
significantly associated with VMS use. In conclusion, a majority of older women are using a
wide variety of vitamin, mineral and herbal products. Many reasons were given for use of
vitamin D and a small number of older women were taking doses of vitamin D over the
Tolerable Upper Intake Level. Health care professionals should educate themselves and their
patients about issues regarding dosage and use of VMS.
Introduction
Dietary supplements are essential for health. Too little or too much is detrimental for
overall wellness. The U.S. population, 65 years and older, is larger now than in any previous
census (United States Census Bureau, 2014). In 2014, there were 46.2 million people over 65
years old and by 2030 they will make up 20% of the U.S. population (Ortman, Velkoff, &
Hogan, 2014; United States Census Bureau, 2014). There has been mounting use of VMS in the
United States over the past several decades (Bailey et al., 2011; Briefel & Johnson, 2004; Millen,
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Dodd, & Subar, 2004; Radimer et al., 2004). The use of VMS in the United States increased
from 14% in 1998 (Kaufman, Kelly, Rosenberg, Anderson, & Mitchell, 2002) to 63% in 2010
(Qato, Wilder, Schumm, Gillet, & Alexander, 2016). Older adults use VMS more than younger
adults (Radimer et al., 2004; Timbo et al., 2006). One study found 84% of US adults over age 54
used a multivitamin, multimineral supplement and 34% used an herbal or other dietary
supplement in the previous year (Timbo et al., 2006) Older women use more VMS than men and
white women are more likely to take supplements than other racial groups (Bailey et al., 2011;
Sebastian et al., 2007). One study found that older women increased their use of vitamins,
minerals, and herbal products over time (Wold et al., 2005). Vitamin D is the supplement of
interest in the study. There is a concern regarding use of vitamin D in dosages above Tolerable
Upper Intake Level. To avoid gender differences this study was conducted to describe VMS use
by older women in independent living settings. Continuing care retirement centers were
included as women in this setting are excluded from national surveys such as the NHANES.
This study is intended to inform health care professionals of current VMS use by older women
with a focus on vitamin D.
There are potential risks and harm from the use of VMS by older adults. Supplements
are regulated differently than medication, supplements do not require premarket testing (Cohen,
2014). Supplements have been found to be adulterated with adulterated with hazardous
contaminants including banned weight loss medications, steroids, stimulants, lead, arsenic,
mercury, cadmium, and pesticides (Cohen, 2014; Kutz, 2010). About 23,000 emergency
department visits occur each year due to adverse events from VMS use (Geller et al., 2015).
Drug interactions result from VMS use and polypharmacy (Cassileth, Heitzer, & Wesa,
2009). Almost three-fourths of community dwelling older adults were found to combine one
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dietary supplement with a prescription drug and one third used three or more supplements with
three or more prescription drugs (Nahin et al., 2009). VMS have been found to interact with
prescription drugs and chemotherapy in ways that are potentially harmful (Cassileth et al., 2009;
Wold et al., 2005). Herbal products are biologically active and may interfere with other VMS or
prescriptions medications (Cassileth et al., 2009). Older adults are at risk of drug interactions
due to polypharmacy and increasing VMS use. Health care providers need current information
on VMS use by older women.
Age related changes in physiology impacts vitamin and mineral needs of the elderly.
There is a decline in renal and hepatic function with age (Rowe, Andres, Tobin, Norris, & Shock,
1976; Tan, Eastment, Poudel, & Hubbard, 2015). Decreased renal function may affect vitamin D
metabolism and result in lower vitamin D levels (Wells & Dumbrell, 2006). Increasing age
causes changes in the absorption, distribution, metabolism and excretion of VMS. Dietary
supplements are essential for good health but there are health and safety concerns especially for
older adults (Timbo et al., 2006).
Patterns of supplement use in adults change over time and it is important that health care
professionals are cognizant of current trends of VMS use. There are more VMS available on the
market than ever before. Over the last 20 years the number of VMS available in the U.S. has
exploded from an estimated 4,000 to over 55,000 (Cohen, 2012). It is estimated that between
$20 and $30 billion is spent on dietary supplements yearly (Cassileth et al., 2009). Growth in
supplement use may be due to new products availability, perception of benefits, published
research, marketing, and public media (Cassileth et al., 2009). Older adults are consuming a
wider variety of VMS than ever before (Archer, 2005; Timbo et al., 2006; Wold et al., 2005).
Health care professionals need to be aware of what VMS are being taken, why VMS are being
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taken, potential drug interactions, and appropriateness of use.
Purpose
Because of the increased use of available products on the market, safety concerns, and the
historical factors, this study is timely and needed. The purposes of this study were to: a) describe
the prevalence of VMS use among older women; b) describe vitamin D use including dose, use
at or above the Tolerable Upper Intake Level, and reasons for use; and c) compare differences in
VMS use based on age, education, and comorbid conditions.
Methods
Study Design, Setting, and Sample
This report is a descriptive, cross-sectional study conducted at three Continuing Care
Retirement Centers, one church, and senior dining program sites in the Midwest. Soper’s priori
sample size calculator for hierarchical multiple regression was used with statistical power set at
0.80, an alpha of 0.05, and a moderate effect size of 0.15 based on previous literature review
(Pender, 1996). Power analysis yielded the need for a sample size of 79. To provide increased
ability to detect smaller effects, the target sample size was set at 110.
Convenience sampling was used. Inclusion criteria were: female, age 65 or older, able to
speak and read English, in an independent living setting, with no memory problems as
determined by self-report. Recruitment included the use of flyers, announcements and
informational sessions. Consent was demonstrated by return of completed surveys and no
identifying information was collected. Participants with vision impairment who wished to
participate were read the consent and survey, and responses were marked as directed. A total
sample of 110 women completed a survey over a three-month period. The University of
Wisconsin-Milwaukee Institutional Review Board (IRB) and researcher’s dissertation committee
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granted approval for this study.
Data Collection
Data was collected by means of self-report survey. Information regarding the research
study was provided at each site per sites organizational process prior to survey. At each CCRC a
private area was provided where interested individuals could go to participate. The church and
senior dining sites had the consents and surveys handed out at a designated table. At each site
after participants read consent those who chose to participate were given a survey to fill out.
Each site had a private area designated to fill out the survey, however participants could choose
to sit where they desired. For participants with visual impairment the private setting was utilized
for confidentiality and privacy. The flyers suggested participants bring VMS on day of survey.
If a participant brought in their personal VMS, the researcher and participant compared the VMS
bottles with the 24-hour recall and check list questions on the survey. If there was a discrepancy
between survey data and VMS brought in by participant, the researcher clarified and corrected
any incongruities on the survey working with the participant. The surveys were completed at the
site with researcher present.
Measurement
The survey contained various demographic, lifestyle and health items to describe the
sample; marital status, race, ethnicity, range of income and financial situation, state of health,
and presence of osteoporosis. Age, education, and comorbidity were collected for comparison to
VMS use. Age was based on self-report of number of years old. Education level was
categorized and asked for the highest level of school completed; less than high school, high
school degree or equivalent, some college credit, associate degree, bachelor’s degree or graduate
degree. Assessment of knowledge of osteoporosis diagnosis was bimodal response of yes or no.
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Comorbidity was assessed by response to the Self-Administered Comorbidity Questionnaire
(Sangha et al., 2003). The Self-Administered Comorbidity Questionnaire (SCQ) includes 12
medical conditions with 3 additional comorbid conditions to be written in by the participant as
needed. Each medical condition had 3 questions: presence of condition, if received treatment,
and if the condition limited activities. The SCQ has a possible total of 45 points with a range of
scores from 0 to 45 and has been used with older adults (Katz et al., 1996; Sangha et al., 2003).
The SCQ test-retest reliability was 0.94 (95% CI, 0.72, 0.99) and has moderate association with
Charlson Index (Sangha et al., 2003). The SCQ had good reliability with Cronbach α = .81 in
the current study.
There were questions regarding past VMS use, questions specific to vitamin D, and
questions on prevalence of VMS use. There were two questions concerning past and recent
VMS use, the first asking how much VMS use over the course of their life, and the second
asking if VMS were used in past month. For vitamin D, participants were asked to list any form
of vitamin D taken in last 30 days, this included vitamin D, vitamin D2, vitamin D3 and calcium
and vitamin D. Participants were asked for each vitamin D they listed, the dose/strength, how
much did they take on a single day, supplement name, how many days taken in past 30 days, and
length of time supplement taken. An open-ended question was used to enquire about reasons for
vitamin D use. A question regarding prescription of vitamin D by health care professional had
bimodal response of yes/no. And a question regarding osteoporosis status had bimodal response
of yes/no. A question asking if the participants were confident they could list their supplements
including doses and schedule had 4 item Likert scale responses (not at all true, hardly true,
moderately true, and exactly true). The question on confidence followed all other VMS use
questions.
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Included in the survey were two separate methods to gather VMS prevalence information
as this has been found to capture larger number of VMS users (Nicastro, Bailey, & Dodd, 2015).
The two methods were a check list of common vitamins, mineral and herbal supplements and a
24-hour recall. Both the checklist and the 24-hour recall questions were developed using current
literature, the NHANES Dietary Supplement and Medication Questionnaire, and a classification
system for VMS (Bailey et al., 2013; Division of Health and Nutrition Examination Surveys,
2016). There are no standardized categories or classification system for supplements
(Comerford, 2013). For this study, the classification system (see Appendix A) used was
originally developed to report NHANES VMS data (Bailey et al., 2013).
The classification system divides VMS into 3 categories and provides definitions and
examples for each category (Bailey et al., 2013). The category groupings are major, minor, and
other. Major VMS categories included; multi-vitamin, multi-mineral (MVMM), multi-vitamin
(MV), multi-mineral (MM), and herbals. Minor categories included: fatty acids, calcium
containing, joint supplements, protein and sport, and fiber and colon health. The other category
contained single nutrient supplements, these were stand-alone single nutrient supplements not
otherwise categorized such as vitamin D or iron. The check list for each of the categories were
asked in a nominal coding format (yes/no) to indicate whether a specific VMS was taken or not.
Two pages of the survey were devoted to the checklist asking about VMS use in the last
30 days. For each of the items the participants were asked to check if they had taken the
supplement in the past 30 days. If the answer was affirmative the participant was asked to
provide the name/ brand name of product and length of time they have taken product. The
checklist items were multi vitamin; multi-vitamin, multi-mineral; vitamin A, vitamin B, vitamin
C, vitamin E, calcium, chromium, iron, selenium, zinc, magnesium, potassium, multi-mineral,
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botanicals and herbals, fatty acids, joint supplements, protein and sport supplements, fiber and
colon health, and other. Examples were given for categories. There was also space provide to
write in anything not on the checklist.
The 24-hour recall response was a question asking participants to list all the vitamin,
mineral and herbal supplements they have taken in the past 24 hours. The following additional
information was provided for clarification for participants, “Dietary supplements include
vitamins, minerals, antacid/calcium supplements, fiber supplement, amino acids, performance
enhancers, herbs, herbal medicine products, and plant extracts. Dietary supplements do not
include meal replacement beverages, weight loss or performance booster drinks, food bars or
tea.” The question as at the top of a page and the participants had the entire page to write in.
The total VMS use included the vitamin D reported, checklist of last 30 days and the 24hour recall. For data entry, the vitamin D was entered followed by VMS on the checklist. Any
additional VMS from the 24-hour recall were entered into SPSS. A two-person method was used
for data entry. The responses from all questions were categorized according to the classification
system definitions. Herbal supplements with multiple ingredients were organized by major
ingredient. Example of this is an herbal sleep aid which was categorized by major ingredient
under bromelain but also contained melatonin, lemon balm, chamomile, lavender and an
unknown proprietary blend. Due to the interest in vitamin D, calcium with vitamin D was coded
into 2 categories: vitamin D and calcium containing. This was the only VMS that was coded in
two categories. All types of B vitamins are chemically distinct and were reported separately. All
nutrient supplements which contained 2 or more vitamins without minerals were coded as MV
except for B complex. B-complex was coded separately, however for MV’s total the B-complex
was combined with the MV’s for the total MV category. Replies for reason the participants use
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vitamin D were coded per theme. The reply of not enough sunshine, not enough sun in the
winter, and not enough in my diet to make up for lack of sunshine were coded under lack of
sunshine/supplement diet.
Data Analysis
All data analysis was conducted using SPSS 23 student version. Prior to analysis the data
was checked to ensure the necessary assumptions for the planned statistical analysis were met.
The SCQ and VMS total were right-skewed (positive skewness) which was to be expected as
both measurements have true zero or low number responses. For SCQ and VMS total a square
root transformation was completed lowering the skew to acceptable scores and both histograms
displayed a clustering of zero responses with approximately normal curves. Non-parametric
tests were used where necessary and are detailed below. Descriptive statistics (frequency,
percent, SD, range) were used to describe participant characteristics; actual vitamin, mineral and
herbal use; dosage levels of vitamin D; vitamin D use over the Tolerable Upper Intake Level;
and reasons to use vitamin D. The Tolerable Upper Intake Level, maximum daily intake that is
not likely to cause adverse health effects, for vitamin D is 4,000 IU for adults over the age of 51
years.
Chi-square tests were conducted to assess differences between participants living in the
community or CCRC’s. To differentiate meaningful groups for age those between 65 to 74 years
old were designated young-old as compared to those 75 years and older (Neugarten, 1975;
Youmans, 1977). Chi-square analysis were used to examine differences in age. To compare low
use to high use of VMS, the low use group was defined as taking 0-4 VMS and the high use
group taking 5-16 VMS, the median (4.5) was used to determine groups. A chi-square test was
used to compare participants who could or could not report their vitamin D dose in relation to
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their confidence of dosage knowledge. Fisher’s exact test was reported if cell was less than
expected for Chi-square tests. The question regarding vitamin D dosage was asked before the
question regarding confidence of knowledge of the dosage.
A focus of the study was the relationship of VMS use to age, education and comorbidity.
As total VMS use was positively skewed the Spearman rank order correlation was reported to
describe the strength and direction of relationship of VMS total and age. The Mann-Whitney U
Test was used to examine the difference in VMS use between women with different levels of
education and different comorbidities. An independent samples t-test was conducted, as sample
size was adequate, to compare total amount of VMS use (interval level) and education levels.
The Kruskal-Wallis was used to report difference in supplement use between women with high,
medium and low levels of comorbid conditions. A conventional alpha level of .05 was used for
all statistical tests.
Results
Sample
There were 110 participants with an average age of 78 (SD = 7.6, range 65 to 93). The
majority described themselves as white (91%, n=100), and 38% had a bachelor degree or higher.
Only 22% (n = 24) were married/partnered, with 46% (n = 51) widowed and 32% (n = 35)
single.
Of the 72% (n = 79) who reported income level, 13% were under 100% Federal Poverty
level, 64% were between $12,000 to $50,000, and 23% were over $50,000. Fifty-three percent
(n = 55 of 103), had more than enough money at the end of the month. Forty percent had just
enough money at the end of the month, and 7% did not have enough money at the end of the
month. At all income levels, there were respondents who indicated that they had more than
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enough finances at the end of the month.
About half (49%, n = 54) reported very good health, followed by 27% (n = 30) with good
health, and the same number reported excellent or fair health (12%, n = 13). There were no
reports of poor health. Thirty nine percent (n = 43) were aware they had an osteoporosis
diagnosis. The SCQ median was 7 (SD = 4.8) with an actual range of 0-25 out of a possible 0-45
total. The higher the score the higher the comorbidity level (combination of diagnosis, treatment
and impact on function). The SCQ found thirteen participants (12%) reported no comorbidity.
The three most common diagnosis’ reported for the SCQ were arthritis (64%, n = 70), high blood
pressure (57%, n = 63), and back pain (36%, n = 40). On the three open-ended sections for
additional diagnosis on the SCQ instrument, 21% (n = 23) had 1 additional diagnosis, 5% (n = 5)
had 2, and 1% (1 person) had 3 additional diseases. These diseases included thyroid (n = 8),
high cholesterol (n = 5), fibromyalgia (n = 3), glaucoma (n = 3), irritable bowl (n = 3), atrial
fibrillation (n = 2), chronic pain (n = 2), gout (n = 1), Scleroderma (n = 1), hypoglycemic without
diabetes (n = 1), lupus (n = 1), postural orthostatic tachycardia syndrome (n = 1), sciatic (n = 1),
Sjogren’s syndrome (n = 1), sleep apnea (n = 1) torticollis (n = 1), and Raynaud’s disease (n =
1).
There were 78 (71%) older women recruited from community sites and 32 (29%) from
the CCRC’s. There were no statistically significant differences in ethnicity, race, marital status,
age, state of health, osteoporosis diagnosis, report on end of month finances or comorbid
conditions between those living in community or CCRC’s. Eighty-four percent of women living
in CCRC’s had a college education or higher as compared to 61% of women living in the
community, χ2 (1) = 5.647, p = .024. A larger percent of women living in CCRC (39% CCRC vs
16% community) reported their income over $50,000, Fishers exact test p = .01. The women
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living in the CCRC’s did take more VMS than those in community, 5-16 VMS per day (66%
CCRC vs 44 % community), and fewer women in CCRC took 0-4 VMS than those in
community (35% CCRC vs 56% community), χ2 (1) = 4.407, p = .04.
Prevalence of VMS
Only 3 participants had never used a VMS over the course of their life, but the majority
of the sample (n = 73, 67%) frequently used VMS. At the time of the survey 92% (n = 101)
were using a VMS and the median number of VMS used were 4.5 (SD = 4, range 0 to 16; See
Figure 2). Ten participants (9%) were taking 10 or more VMS.

Number of Older Women

Figure 2. Total Number of Vitamins, Minerals, and Herbal Supplements Taken
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Vitamin D was the most frequently used supplement from all categories. The most
frequently used supplement from the major category was MVMM and calcium from the minor
category (see Table 6). Fatty acids, in the minor category, included; fish oil (22%, n = 24),
flaxseed (9%, n = 10), and omega 3 (8%, n = 9). Nineteen percent of the sample were using
fiber and colon health products with psyllium products (9%, n = 10) and probiotics (11 %, n =
12) being most commonly used. The joint supplements were products with glucosamine or
chondroitin with the majority taking a combination glucosamine and chondroitin (87.5%, n = 14
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of 16). Few women were using protein supplements, protein powder (2.7 %, n=3), lysine (2.7 %,
n=3), and 1 Cysteplus (sulfur containing amino acid, .9%).
Table 6. Vitamin, Mineral, and Herbal Supplements [VMS] Used Most Frequently by
Older Women (N=110)
Single Nutrient
Major categories
%* (n)
Vitamin
%* (n)
Supplements
MVMM
50.0 (55)
Vitamin A
3.6 (4)
MV
34.5 (38)
Vitamin B1
.9 (1)
Herbals
30.9 (34)
Vitamin B2
.9 (1)
MM
2.7 (3)
Vitamin B7
5.5 (6)
Total for All VMS
%* (n)
Vitamin B12
15.5 (17)
VMS
91.8 (101) Folate
1.8 (2)
Minor categories
%* (n)
Vitamin B Complex
19.1 (21)
Vitamin B not
Calcium containing
50.0 (55)
3.6 (4)
identified
Fatty acids
33.4 (37)
Vitamin C
25.5 (28)
Fiber and colon health
19.1 (21)
Vitamin D
74.5 (82)
Joint supplements
14.5 (16)
Vitamin E
14.5 (16)
Lutein
5.5 (6)
Protein and sport
6.4 (7)
Single Nutrient Other
Supplements

%* (n)

Magnesium

18.2 (20)

Potassium
Zinc
Selenium
Iron
Chromium

9.1 (10)
5.5 (6)
3.6 (4)
2.7 (3)
1.8 (2)

Most Frequently Used
Herbals
Coenzyme Q-10

%* (n)
12.7 (14)

Melatonin

8.2 (9)

Cranberry
Garlic
Turmeric
Cinnamon

5.5 (6)
4.5 (5)
4.5 (5)
3.6 (4)

* % = n/N
A third of the sample used herbal products (see Table 6). The use of herbals was not
significantly different between young old (65-74 years) and those 75 years and older, χ2 (1) =
.342, p = .56. Of those taking herbals, 68 % (n = 23 of 34) were above 75 years old. There were
31 separate herbals products reported. The herbals products reported were (products reported
once have a [1] following the name): alfalfa, herbal appetite suppressant (1), alpha lipoic acid
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(1), arnica (1), bilberry (1), broccoli extract (1), bromelain (1), candida cleanse (1), charco caps
(1), coenzyme Q-10, Chinese herbals (1), cinnamon, cranberry, cumin (1), D-mannose (1),
Echinacea (1), gingko (1), garlic, ginger (1), green tea extract (1), hawthorn (1), melatonin, milk
thistle (1), oil of peppermint (1), red rice yeast, resveratrol (1), Pau D’Arco (1), rosemary (1),
turmeric/ curcumin, mineral oil (1), and tart cherry herbals extract (1). All herbals products were
taken orally and were supplement products.
As seen in Table 7, the participants who used herbals products, most used only one.
Sixteen participants (15%) took more than one herbal. The participants who took the most
herbals are listed in Table 7 with the products taken. The participants who took the most herbals
also took other vitamin and mineral supplements.
Table 7. Most Frequent Users of Herbals with Types of Herbals Taken (N=110)
Herbals Taken

Total VMS
(n)

State of
Health

SCQ
Score
0-45

.9 (1)

Coenzyme Q-10, Cranberry, Garlic Oil, Green tea
extract, Cinnamon extract, melatonin, Milk
thistle, Mineral oil, Bromelain

16

Good

2

User taking 7

.9 (1)

Alfalfa tablets, Arnica, B-Mannose, Candida
cleansev, Charco caps, Pau d’Arco (Tabebuia
impetiginosa), Turmeric

15

Fair

24

Users taking 4

2.7 (3)

1)Garlic Oil, Melatonin, Hawthorn, Bilberry

9

Excellent

1

2) Garlic, CoQ10, Resveratrol, Alpha lipoic acid

13

Very Good

11

3) Broccoli extract, Ginger, Turmeric, Cumin

13

Good

8

1) Curcumin (compound in Turmeric), Chinese
herbal, CoQ10

12

Very Good

2

10

Very Good

0

Herbals
usage

% (n)

User taking 9

Users taking 3

1.8(2)

2) CoQ10, Garlic, Melatonin
Users taking 2

8.2 (9)

Users taking 1

16.4 (18)

Users taking 0

69.1(76)
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Use of Vitamin D
Seventy-five percent of the participants took vitamin D (n = 82). The most frequently
cited reason for vitamin D, see Table 8, was lack of sunlight/supplement diet. Sixty-one percent
(n = 67) report the vitamin D was prescribed. There was a significant association between the
knowledge of osteoporosis diagnosis and use of vitamin D (p = 0.002, Fisher's exact test).
Thirty-nine percent (n = 43) of the participants reported they had a diagnosis of osteoporosis. Of
those 43 with a diagnosis of osteoporosis, 91 % (n = 39) were taking vitamin D. Nine percent
(4) of the participants aware of an osteoporosis diagnosis choose not to use vitamin D.
Table 8. Reasons to Use Vitamin D (N=110)
%ª (n)
Lack of sunlight/supplement
diet
Physician suggested
Bones/Osteoporosis
Low blood levels
Desire to be heathy
Help with immune system
Do not know why take it
Depression
Seasonal affective disorder
Advised by friend or family
Heart
Polymyalgia rheumatic
Do not use or answer
missing
ª % = n/N

18.2 (20)
16.4 (18)
15.5 (17)
10.9 (12)
3.6 (4)
1.8 (2)
1.8 (2)
.9 (1)
.9 (1)
.9 (1)
.9 (1)
.9 (1)
27.3 (30)

Of the 82 participants who took vitamin D, 28% (n = 23) of them did not know the dose
they were taking. The response to the question regarding confidence to list their supplements
including the doses and schedule, 92% of those taking vitamin D (n = 75 of 82) felt confident. In
the question on vitamin D use, 18 of the 23 (78%) who did not know their dose of vitamin D
reported on the confidence question that they felt confident that they could list their supplements,
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including the doses and schedule and only 4 reported they were not confident, χ2 (1) = .45, p =
.50.
Of the entire sample, 6% (n = 6) took a dose below RDA, 4 % (n = 4) took within the
RDA, and 39% (n = 43) took more than RDA but less than UL (Tolerable Upper Intake Level).
There were 7 % who were at UL or above. Of the 4 % (n = 4) who were above the UL, two were
taking 5,000 IU daily (one prescribed for low blood level, second not prescribed and taking for
bone health), one took 25,000 IU twice a week (did not answer prescription question or reasons
for use), and one took 50,000 IU twice a week (prescribed for low blood level). The most
frequently reported dosage level of vitamin D were 1,000 IU per day (16.4%, n=18 of the 110)
and 2,000 IU per day (10.9%, n=12 of the 110).
Key Variables and VMS Use
The literature has shown that age, education and comorbidity are associated with VMS
use; this study examined the relationship of age, education level and comorbidity with VMS use
by older women. Spearman rank order correlation (rs = -.07, p = .49) did not show a significant
relationship between age and number of VMS taken. Nor was there a significant difference
between the young old (65-74 years) and those 75 years and older in regard to low (0-4 VMS) or
high use (5-16 VMS) of VMS used, χ2 (1) = 0.63, p = .43. The participants with high school
education took less VMS (M = 3, SD = 3) than those with a college (M = 6, SD = 4) education;
t(107) = -3.53, p = 0.001.
The SCQ (Md = 7.0, SD = 4.84) had a range from 0 to 25 out of a possible 45 points.
There was no difference in levels of supplement use between women with low, medium and high
levels of comorbid conditions, Kruskal-Wallis test (H, p = 0.979). Participants had significant
differences in amount of VMS use for 2 comorbidities. The total VMS use was less for those
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with heart disease (M = 3.6 VMS, SD = 3.0) than for those without heart disease (M = 5.2 VMS,
SD = 3.7), Mann Whitney test (U = 825.5, p =.039); and total VMS use was less for those with
high blood pressure (M = 4.0 VMS, SD = 3.0) than those without high blood pressure (M = 5.9
VMS total, SD = 4.0), Mann Whitney test (U = 1044.0, p= .008).
Discussion
There were few differences between the older women living in the community setting
and living in the CCRC’s, this may be different in other regions of the country. Women living in
the CCRC’s reported higher educational and income levels and also had higher use of VMS.
Consistent with other studies those with a higher education and income did take more VMS
(Archer et al., 2005; Bailey et al., 2011; Dickinson & MacKay, 2014; Foote et al., 2003; Gray,
Paganini-Hill, & Ross, 1983; Kennedy, 2005; Lee & Kim, 2009; Radimer et al., 2004; SatiaAbouta et al., 2003).
Use of VMS
In this study, participants reported a high rate of current VMS use and most participants
had used VMS during their life. Only a small percentage of participants reported that they had
never used VMS, this is in alignment with another study were 6% had never tried a supplement
(Gray & Rutledge, 2013). As seen in Table 9, the high current use of VMS is consistent with
other studies (Bailey et al., 2011; Bailey et al., 2013; Elder & Nisly, 2011; Gray et al., 1983;
Radimer et al., 2004). The high use of VMS highlights the popularity of VMS with older
women. Health care professionals need to be aware of high use by older women and the impact
VMS may have on the plan of care.
Surprisingly demographic factors, such as age, state of health, income level, and
comorbidity, were less predictive of VMS use. Many studies have found that VMS use increases
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with age (Bailey et al., 2011; Bailey et al., 2013; Foote et al., 2003; Miller et al., 2008; Radimer
et al., 2004; Satia-Abouta et al., 2003). One study found the use of VMS did not increase for
women when participant characteristics were controlled (age, education, race/ethnicity, and
BMI; Satia-Abouta et al., 2003). The studies that did find the increase of VMS use with age also
had wider range in age, adults from 18 years and older (Kennedy, 2005; Miller et al., 2008), or
45 years and older (Foote et al., 2003). In this study, older women (75 and above) were not
taking significantly more than the young-old women (65 to 74 years). Table 9 provides
prevalence rates of VMS use for women over the age of 50 reported in the literature. The
prevalence rates for women alone are higher than when men are included. One possible reason
for higher use of VMS in older women may be attributed to the increased use of vitamin D and
calcium to prevent osteoporosis and maintain bone health. The higher use in this study may also
result from the location of the study, less sunlight during winter months, and women’s awareness
of the need for vitamin D in winter months.
Table 9. Prevalence of Older Women Using Supplements by Age, Year and Study
Women’s
Primary Authors
Prevalence Typeª
Year b
Study
Age
Name
> 58
75%
VMS
1982
Part of cohort study
Gray
≥ 55

66 %
85 %

VMS

1986
2004

Iowa Women’s Health
Study 1986 cohort

Park

> 45

72%

8 VM

19931996

Multiethnic Cohort

Foote

>51

47%

VM

19941996

Continuing Survey of
Food Intakes by
Individuals, Diet and
Health Knowledge Survey

Sebastian

60-99

14%
20 %
20 %

NVNM
NVNM
NVNM

1994
1995
1996

New Mexico Aging
Process Study

Wold

96

27 %
42%
46%

NVNM
NVNM
NVNM

1997
1998
1999

50-59

56%

VMS

19971999

INTERMAP

Archer

> 50

75%

VMS

20002002

VITAL study

Satia-Abouta

>54

75 %

VMS

2002

2002 Health and Diet
Survey

Timbo

51 to 70
> 70

72 %
75 %

VMS

20032006

NHANES

Bailey

≥ 65

92%

VMS

20162017

Present Study

Hekel

ª VMS = vitamin, mineral or herbal supplement, NVNM = Nonvitamin, nonmineral supplement, VM = Vitamin and
mineral supplements
b
Year data gathered

Some studies have reported supplement use is more common among those who report
themselves as healthy versus those who report poor health (Archer et al., 2005; Kennedy, 2005).
The ‘inverse supplement hypothesis’ has been described as adults who use VMS but need the
supplements the least (Conner et al., 2003). Studies which support the inverse supplement
hypothesis report VMS users to have higher dietary nutrient intakes, report themselves as
healthy, higher incomes, and higher education than VMS non-users (Braun & Venter, 2008; Kirk
et al., 1999; Kofoed et al., 2015; Sebastian et al., 2007). There was no significant difference
between income or state of health and VMS found in this study. As no participants in the current
study reported poor health this limits the ability to compare with studies who had participants
with poor health. Higher education level is often associated with higher income level (Johnson
et al., 2000), this was not reflected in the sample where the educational level and range of
income were not significantly correlated.
97

Individual medical diagnosis has been found to influence supplement use. Cancer
patients are using increasing amounts of VMS (Cassileth et al., 2009). One study suggested that
cancer survivors had higher supplement use as a preventative measure (Miller et al., 2008).
While this was not supported by the study, 24% (n = 26) of the sample reported cancer, and all
but one of those were using VMS, there was not a significant difference in VMS usage found
between those with cancer and those without. Regarding specific health problems only high
blood pressure and heart disease had significant relationships with VMS total use, participants
with the conditions used less VMS. Other studies have found that supplement use increased with
the number of chronic conditions (Miller et al., 2008). In this study, where the comorbidity score
considered treatment and impact on function, there were no differences in supplement use
between women with low and high levels of comorbid conditions. The difference in findings of
comorbidity and VMS use may be due to differences in comorbidity tools, difference in goals of
the studies as some studies are examining one specific comorbidity, and differences in samples.
There is variation found between studies on what VMS are most commonly used.
Vitamin D, MVMM, and calcium were the vitamins and minerals most frequently taken in the
current study. Many studies have found that MVMM is the most commonly used VMS (Bailey
et al., 2011; Foote et al., 2003; Satia-Abouta et al., 2003; Sebastian et al., 2007). The most
commonly taken VMS reported in a 1980’s study were vitamin C, vitamin E, and thiamine (Gray
et al., 1983), in the late 1990’s United Kingdom study fish oil, multivitamins, garlic tables and
vitamin C were reported (Johnson et al., 2000), and in a 2000’s study MV, vitamin C and
vitamin E were reported (Foote et al., 2003). A small study of 49 seniors found the most
common VMS were calcium, MV, fish oil, and vitamin B (Elder & Nisly, 2011). There was a
wide difference in most common VMS taken, this may be from the different years the studies
98

took place, the different regions of the country, different measurement of VMS, and changes in
popularity of VMS. This highlights the necessity for continuing research on VMS use.
Use of Herbals
About a third of the participants from this study took herbals. This in similar to results
from other studies where rates of herbal use range from around 20% (Kennedy, 2005; Marinac et
al., 2007; Wold et al., 2005) to 46% (Gray & Rutledge, 2013; Wold et al., 2005). Wold et al.
(2005) found the use of nonvitamin nonmineral products increased over time, as seen in Table 9.
The individuals who took the largest number of herbals (Table 7) demonstrate the wide variety in
use. The current study had over 31 separate herbal categories represented for 110 participants.
The number of products used does not represent the total number of different herbals ingested as
many products had multiple ingredients. The high number of herbals was consistent with other
studies (Archer et al., 2005; Marinac et al., 2007; Timbo et al., 2006; Wold et al., 2005).
The use of herbal products was not significantly associated with age in the current study.
Kennedy (2005) found that herbal use was highest for adults aged 45 to 64. While not a
significant finding in this study, the use of herbals was higher for those over 75 years old. This
may reflect differences in use of herbals such as self-treatment, greater acceptance of herbals
over time, or different presence of health conditions (Wheaton, Blanck, Gizlice, & Reyes, 2005).
The popularity and use of herbals changes over time (Cassileth et al., 2009; Wold et al.,
2005). The most frequently used herbals this study found were Coenzyme Q-10, melatonin, and
cranberry. Other commonly reported herbals include glucosamine, Echinacea, ginkgo biloba and
garlic (Kennedy, 2005; Marinac et al., 2007; Wold et al., 2005).
There are several things that may impact the difference in findings regarding the most
popular herbals. The lack of a uniform classification system causes differences in reporting. For
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example, the classification system for the current study has glucosamine and chondroitin as joint
supplements under the minor category, thus they are not included into the herbal category. Other
studies included joint supplements in the herbal category (Marinac et al., 2007; Wold et al.,
2005). How the data was gathered may cause differences in findings. This study used 30 days
as a time frame and a 24-hour recall, these time periods may miss periodic or seasonal use of
VMS. The change in popularity of VMS over time is impacted by media reports of research and
may also reflect the differences between regions, availability, or marketing (Cassileth et al.,
2009).
Use of Vitamin D
There was a small number of older women who were taking vitamin D dosages at or
above the Tolerable Upper Intake Level. This number is lower than actuality as other sources of
vitamin D were not included; vitamin D in diet and vitamin D in VMS such as MVMM’s.
Several authors have found that vitamin and mineral supplements can contribute to excessive
intake (Archer et al., 2005; Bailey et al., 2010; Bailey et al., 2012; Murphy, White, Park, &
Sharma, 2007). Excessive intakes of folic acid, iron, magnesium, zinc, vitamin A, vitamin C and
niacin have been found in supplement users (Archer et al., 2005; Bailey et al., 2010; Murphy et
al., 2007). Older adults have been found to take excessive amounts above the Tolerable Upper
Intake Level (UL) for folic acid, vitamin A, vitamin B-6, vitamin C, vitamin D and vitamin E
(Bailey et al., 2010; Bailey et al., 2012). Excessive intakes are often found when a MVMM is
taken with additional vitamins and minerals. To reduce excessive intakes while providing
enough to provide for adequate intake, Murphy et al. (2007) has suggested a change in the
formulation of multivitamin products.
Most women with osteoporosis were taking vitamin D and followed their health
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providers’ recommendations. Common vitamin D doses were 1,000 IU and 2,000 IU per day.
Both doses are above the RDA but well below the UL of 4,000 IU’s per day. There are a wide
variety of vitamin D dosages that are available over the counter and vitamin D is being added to
more products. The combination of more products containing vitamin D in wide ranges of doses
increases the risk for dose above the UL. One third of women taking vitamin D did not know the
dose of the vitamin D supplement that they were taking daily. This highlights the importance for
the health care professional to communicate and educate about the use of VMS.
It was interesting to note that in the survey the participants listed their VMS taken and
dosages of vitamin D before they completed the measurements for self-efficacy. Of those who
were unable to list their dose of vitamin D, 18 reported they felt confident that they could list
their supplements even though they had been unable to answer the question earlier in the survey.
This brings up an interesting phenomenon which is helpful for health care professionals to take
into consideration. Self-perception of awareness and use may not reflect actual practice or
knowledge. This highlights the importance of older adults bringing all the VMS used into the
health care appointments.
There was high use of vitamin D in this study. The high use of vitamin D in this report
may be partially explained by location and time of year, northern state and in the winter months.
Women reported lack of sunlight, use of blood tests to determine vitamin D status, and treatment
recommendations by health professional if vitamin D level is low. Older women living in the
northern parts of the United States get less sun light in the winter months and may be a
population at risk for vitamin D deficiency. A fifth of women taking vitamin D were aware of
the lack of sunlight and need for vitamin D. Of those who took vitamin D, 11 % were cognizant
they had low blood levels and 16 % took vitamin D due to recommendations by their health care
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professional.
The survey did not ask about screening for low blood levels so the percentage of older
women who reported they had a vitamin D screening (11%) may be lower than the actual
number. Currently the USPSTF does not recommended screening for vitamin D deficiency in
asymptomatic adults over the age of 18 years as the current evidence is insufficient to balance
benefit and risks of harm (Moyer & U.S. Preventive Services Task Force, 2013). The USPSTF
has recommended use of vitamin D to prevent falls for women over the age of 65 years who are
at high risk for falls (Moyer & U.S. Preventive Services Task Force, 2013). The USPSTF is
currently in the process of updating this recommendation. The USPSTF recommendation does
not apply to treating people with vitamin D deficiency or osteoporosis. The high use of vitamin
D and the small number taking doses above the UL have important implications for health of
older women.
Limitations
This study lacked the ability to determine total vitamin D levels as dietary intake of
vitamin D was not gathered and vitamin D in MV, MVMM and other supplements were not
included in the total. The last participant of the survey brought in a glucosamine which had
4,000 IU of vitamin D listed under ingredients, other participants which used glucosamine may
also be taking vitamin D doses that were not reported. The actual number of participants taking
vitamin D above the UL may be higher than reported in this study.
This descriptive study describes frequency and types of supplements by self-report and
many participants did not have their actual supplements with them to confirm ingredients. Some
supplements had multiple ingredients and were categorized under the major ingredient thus some
ingredients in herbals was not represented in the results. The use of VMS is difficult to compare
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across studies due to the lack of a standardized definitions and categorizations. The sample was
primarily white which limits generalizability of findings. The sample represents participants
from various senior dining sites, a church, and three Continuing Care Retirement Centers from
Wisconsin which also limits generalizability of findings.
Recommendations for Future Research
An area for future research is awareness of dosage of vitamin D and the discrepancy
between perception and knowledge. Twenty-eight percent of the older women did not know
how much vitamin D they were taking. The majority of those who did not know the dose
reported they perceived themselves as being confident (78%, 18 of the 23). There was
incongruity between confidence (regarding dosage and schedule of supplement use) and ability
to report dosage of vitamin D. Future research exploring dosage taken to dosage prescribed as
well as the inconsistency between perception of confidence and knowledge would be valuable to
inform practice.
Several participants used vitamin D at the UL or above. Additional studies are needed to
examine amount of use above tolerable upper intake limit for vitamin D. Questions remain
regarding what influences older adults to use VMS and what influences older adults to use
vitamin D at or above the Tolerable Upper Intake Level. Future studies are needed to investigate
the decision to use vitamin D at or above the Tolerable Upper Intake Level and physiological
impact of use at higher than recommended daily amount. There is a need to more clearly
understand the effects of overuse of VMS. Research that would monitor the effectiveness,
toxicity, side effects, and impact on the health systems is needed (Cassileth et al., 2009). With
the rising costs of health care, the fiscal impact of improper VMS use is also warranted.
Research on potential public health policies regarding VMS safety are needed to protect the
103

health of older adults.
Conclusion
Supplements are an important source of vitamins and minerals for many older adults.
Older women who use VMS tend to have a higher educational level. In this study, the majority
of women used VMS. Vitamin D, MVMM, and calcium were the VMS most frequently used.
There were many reasons for taking vitamin D and a small percentage were taking vitamin D
dosages at or above the tolerable upper intake limit. The majority of older women with
osteoporosis were following their health professional’s recommendations for taking vitamin D.
Health care professionals need to be aware of the VMS older adults are taking to monitor use
over recommended amount. Greater communication, consultation, and education is needed
regarding VMS use. Future studies are needed to examine the influences to use VMS in the
older population. Public health policies and VMS safety regulations are needed to protect the
health of older adults regarding VMS use.
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Influence of Expectations of Aging on Supplement Use by Older Women
Abstract
The use of vitamins, minerals, and herbal supplements (VMS) is changing and
increasing. This study examined the relationship of independent living older women’s individual
characteristics and behavior-specific cognitions, from the Health Promotion Model, to the use of
vitamins, minerals, and herbal supplements. A proposed model was used to extrapolate potential
influences of vitamin, mineral and herbal supplement use by older women. Variables of interest
are expectations of aging and perceived self-efficacy. The research design is a descriptive crosssectional design. Data were abstracted from the surveys of 110 community dwelling
participants. As predicted by the theory, prior health behavior, education, and expectations of
aging were associated with vitamin, mineral and herbal supplement use. The three predictors
explained 27 % of the variance. Unexpectedly self-efficacy, age, and comorbidity did not impact
vitamin, mineral and herbal supplement use for older women in this study. Findings from this
study suggest that expectations of aging may be an important consideration to understand health
behavior of older women. Findings also support the association that past health behaviors may
have on current behavior. The current study supports the relevancy of the Health Promotion
Model to examine older women’s use of supplements and a revised model is presented.
Introduction
The use of VMS by older women is increasing and VMS are being used for a wide
variety of reasons (Bailey et al., 2011; Bailey et al., 2013; Radimer et al., 2004). There are
concerns regarding safety, side effects, drug interactions, and use above recommended amounts.
As the population of older women continues to increase, health maintenance is extremely
important. Older adults have taken VMS to improve their diet, provide essential nutrients,
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prevent disease, treat illness and manage chronic disease. Understanding the factors that
influence VMS use is essential to designing interventions and providing counselling.
The health promotion model (HPM) provides a framework to explore the variables that
encourage vitamin, mineral and supplement use to enhance health. The HPM has been used to
explain health-promoting behaviors. The theoretical underpinnings of the HPM are social
cognitive theory and expectancy-values theory (Pender et al., 2011). Determinants of health
promoting behaviors are categorized as individual characteristics and experiences, which
influence behavior indirectly, and behavior-specific cognitions and affect which influence the
behavior directly (Pender, 2006; Pender et al., 2015). As seen in Figure 3, individual
characteristics and experiences included in the model are prior related behavior and personal
factors (age, education, and comorbidity). Two behavior-specific cognitions were selected for
the proposed model, perceived benefits of action (expectations of aging) and self-efficacy. Both
are considered to be modifiable and significant motivators. There is evidence to support the
validity of each as correlates of health behaviors (Pender, 2002; Pender et al., 2015).
Prior related behavior is the occurrence of a similar or same behavior in the past (Pender
et al., 2015). Empirical evidence support the importance of prior behavior; prior behavior is
often one of the best predictors of subsequent behavior (Pender, 2002; Pender et al., 2015). Prior
related behavior is the use of VMS in the past. The regular habit of taking a supplement in the
past influences the possibility of VMS use.
The nature of the targeted health behavior studied influence which personal factors are
relevant (Pender, 2006; Pender et al., 2011). In the literature, personal factors which are
associated with supplement use include age, comorbidity, and education level (de Groot et al.,
2003; Johnson et al., 2000; Kim, 2009; Levy et al., 2002; Meisner & Baker, 2013; Sebastian et
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al., 2007; Valderas et al., 2009). Supplement use increases with age and is a personal factor that
may impact VMS use (Bailey et al., 2011; Dickinson & MacKay, 2014; Gahche et al., 2011;
Radimer et al., 2004). Older adults have a greater chance of having multiple chronic disease and
comorbidity has been found to have a confounding influence (de Groot et al., 2003; Egger, 2012;
Marengoni et al., 2011; Valderas et al., 2009). Educational level is a representation of income
and has been associated with supplement use (Dickinson & MacKay, 2014; Johnson et al., 2000;
Meisner & Baker, 2013). The personal factors that are associated with VMS use will be used as
control variables.
Perceived benefits of actions are expectations of positive outcomes that ensue from
engaging in a health behavior. Perceived benefits of action have been associated with improving
eating behaviors such as increasing fruits and vegetables and physical activity (Conn, Tripp‐
Reimer, & Maas, 2003; Walker, Pullen, Hertzog, Boeckner, & Hageman, 2006) . Older adults
with positive views of their aging were found to practice more preventative health behaviors over
time (Levy & Myers, 2004).
Expectations Regarding Aging (ERA) are an older adult’s perceptions of their aging and
had been used to examine relationships between perceptions of aging, health behaviors and
outcomes (Sarkisian et al., 2005a; Sarkisian et al., 2005b). ERA measures the expectations one
has of future health and cognitive function in conjunction with aging (Joshi, Malhotra, Lim,
Østbye, & Wong, 2010). ERA vary and have been documented to influence health behaviors
both current and future (Goodwin et al., 1999; Leventhal & Prohaska, 1986; Levy et al., 2002;
Rakowski & Hickey, 1992; Sarkisian et al., 2003; Sarkisian et al., 2005a). Older adults with
higher ERA expected to maintain their functioning and performance and were more likely to
continue health behaviors over time (Levy et al., 2002; Meisner & Baker, 2013; Sarkisian et al.,
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2002a). This study hypothesized that ERA would influence the current health behavior of
supplement use. ERA represent the perceived benefits of action, as seen in the proposed model
in Figure 3.
Perceived self-efficacy is the individual’s belief or conviction that one has the
competence and skill to execute the behavior for the desired outcome (Pender et al., 2015;
Schwarzer, 1992). Self-efficacy beliefs are important determinants of motivation, thought and
action (Bandura, 1992; Bandura, 2006). In several studies, self-efficacy has been a consistent
predictor of success in various health behaviors including healthy eating and physical activity
(Conn, 1997; Pender, 1996; Wu & Pender, 2002). A higher level of self-efficacy increases the
possibility that the individual will engage in a health behavior (Pender et al., 2015). It is
proposed that individuals with positive self-efficacy are more likely to engage in supplement use.
Figure 3. Proposed Model to Study Factors that Influence the Use of Vitamins, Minerals, and
Herbal Supplements
Individual
Characteristics and
Experiences
Prior Related
Behavior
IV- Use of
supplements in past.

Personal Factors
(potential control
variables)

•Age
•Educational level
•Comorbidity

Behavior-Specific
Cognitions and
Affect
Perceived Benefit
of Action
IV- Expectations
regarding aging

Self-Efficacy
IV- General selfefficacy
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Specific Behavioral
Outcome

DV- Supplement
Use

The HPM, the framework for the study, has not been used to investigate modifiable
factors that influence the use of VMS. The research hypothesis for the study is: Controlling for
age, comorbidity and education level, expectations of aging, self-efficacy, and prior related
behavior will predict VMS use. The study describes the ERA, general self-efficacy, prior related
behavior and personal factors (age, education level and comorbidity). Personal factors which
relate to VMS use will be used as control variables for the multiple regression. A multiple
regression model will be used to determine predictors of VMS use.
Methods
A descriptive cross-sectional design was used to study the factors that influence the use
of VMS. The University of Wisconsin’s Human Research Protection Program Institute Review
Board approved the project and provided waiver to document informed consent. Sample size of
79 was determined by a priori sample size estimation for multiple regression. The statistical
power level was 0.80, the significance criterion (alpha) was set at 0.05, and a moderate effect
size (R2) of 0.15 was assumed from previous studies of HPM variables (Pender, 1996). The
sample size was set at 110 to provide improved capability to detect smaller effects.
Data were collected by self-report survey from older independent living women in the
upper Midwest. Data was collected at two County senior nutritional programs, one church, and
three Continuing Care Retirement Communities (CCRC). A key contact person at each site
made announcements and posted flyers asking women 65 years and older to participate in a
survey regarding VMS which took up to 45 minutes to complete. An informational session prior
to survey was provided depending on organization protocol. Informed consent was obtained,
after reading the consent form and consent was given by completion of survey. An area at each
site was provided for confidentiality and privacy, however participants choose where they
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wished to fill out the survey in the different settings. Participants were excluded if they were
younger than 65 years, could not speak or read English, self-reported a memory problem, male,
or not in an independent living setting. Vision impaired women who desired to do the survey
could participate, the primary researcher read the consent and survey and marked indicated
answers.
Measurement of Variables
Control Variables
Age was measured by self-report of current number of years old. Education level had 6
categories: less than high school; high school degree or the equivalent (for example: GED); some
college credit, no degree; associate degree; bachelor’s degree and graduate degree. Comorbidity
was measured using the Self-Administered Comorbidity Questionnaire (SCQ). The SCQ has
been tested with elderly, contains familiar terms, is self-report, easy to administer, and includes
treatment and function impact (Katz et al., 1996; Sangha et al., 2003). The SCQ has 15 possible
medical conditions, 12 listed and 3 fill in the blank. Each condition has 3 yes/no questions and
each yes is scored for a point; presence of condition, receive treatment, and does this limit
activity (Sangha et al., 2003). Range of possible scores is 0 to 45. The SCQ has moderate
association with Charlson comorbidity index and the test-retest reliability intraclass correlation
coefficient was 0.94 (95% CI, 0.72, 0.99) (Sangha et al., 2003).
Predictor Variables: Expectations of Aging, Self-efficacy, and Prior Related Behavior
Aging expectations were measured with the Expectations Regarding Aging -12 (ERA)
(Sarkisian et al., 2005b). The ERA-12 is comprised of 12 questions with 4-point scale: definitely
true, somewhat true, somewhat false, and definitely false. There are 3 subscales (physical health,
mental health, and cognitive function) and a global scale, each scale has measurement has a
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range of 0 to 100. A lower score indicated the participant’s expectation of decline with aging,
the higher score indicated the expectation of preservation and attainment of high physical and
mental function with aging (Sarkisian et al., 2005b). The Cronbach’s alpha for the three scales
were ranged from 0.73 to 0.81 and for the global alpha was 0.88 (Sarkisian et al., 2005b). The
test-retest reliability on a 2-week retest with intraclass correlation coefficient of 0.94 (Sarkisian
et al., 2005b).
General Self-Efficacy Scale (GSE) measured the general sense of perceived self-efficacy.
It is self-administered and the responses to the 10 questions are: 1 = not at all true. 2 = hardly
true, 3 = moderately true, and 4 = exactly true. Scoring is by summing up the responses to the 10
questions, range from 10 to 40 possible. The GSE has been widely used and alphas ranged from
.76 to .90 (Schwarzer & Jerusalem, 1995). Criterion-related validity was documented with
correlational studies, positive correlation with optimism and favorable emotions and negative
correlation with health complaints, depression and anxiety (Schwarzer & Jerusalem, 1995).
The median has been used to divide a sample into low or high self-efficacy and this was used to
divide sample for the current study (Schwarzer, 2009).
The GSE allows for additional items which relate to the concept of interest (Schwarzer &
Fuchs, 1995). The subject for the additional items were derived from the literature, feedback
from health care professionals, general discussions with older adults, and review of similar selfefficacy scales of nutrition and medication adherence (Fernandez et al., 2008; Schwarzer &
Renner, 2014). VMS self-efficacy (VMSSE) items were developed following Schwarzer and
Fuchs guidelines (1995). The additional items are seen in Table 10. The response range for each
of the VMSEE items was 1 to 4: 1 = not at all true. 2 = hardly true, 3 = moderately true, and 4 =
exactly true. The possible range of scores for VMSSE was 8 to 32.
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Table 10. Eight Items for VMS Self-Efficacy
Item Subject
Question for Survey
Routine
I am confident that I can make taking my supplements part of my
routine.
Memory
I am confident that I can always remember to take my supplements.
Change in Day
I am confident that I will take my supplements when there is a change in
my usual day (unexpected things happen).
Schedule
I am confident I can take several supplements on different schedules.
Information
I am confident that I can find information I need to help manage my
supplements (for example: to get information, learn more about, avoid
side effects).
No Help
I am confident I can manage my supplements without help.
List all
I am confident I can list my supplements, including the doses and
schedule.
Maintain supply
I am confident I can remember to get refills of my supplements before I
run out.
Past use of VMS was a close ended question, “Over the course of your life how much
have you used or taken any VMS?” A Likert-type scale was used for responses. The four
available response choices were; never used, hardly have used, occasionally have used, and
frequently used.
Vitamin, Mineral, and Herbal Total Use
Prior use of supplements was measured by two questions, use over the course of life and
over the last 30 days. Participants were asked over their life how much have they used or taken
any VMS, the choices were never, hardly, occasionally or frequently. Participants were also
asked if they had taken VMS over the last 30 days. Non-users were those who did not report
taking a VMS. Using a time frame to identify VMS users captures users who take VMS on
different schedules and the 30-day time frame commonly used (Bailey et al., 2012).
The operational definition for current VMS use were those who reported taking a VMS
from a 24-hour recall or a check list asking about VMS use within the past 30 days. The 24-hour
recall question asked participants to list all the vitamin, mineral and herbal supplement they have
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taken in the past 24 hours. There was a definition of VMS to provide clarification. The question
on VMS use in past 30 days was a checklist with additional space to write any VMS not on
check list. The check list was formulated using a classification system that Bailey et al. (2013)
developed to examine the 2007 to 2010 NHANES data. The categories are major category
(multi-vitamin, multi-mineral; multi-vitamin, multi-mineral and herbals), minor category (fatty
acids, calcium-containing, joint supplements, protein, fiber and color health), and other single
nutrient supplements (single nutrient supplement not in any other category such as vitamin D).
A prior manuscript reported older women’s VMS prevalence, complexity of vitamin, mineral
and herbal use, relationship with demographic characteristics and described reasons for and
amount of vitamin D use. The total VMS count is not a pill count per day, but a reflection of
total number of different VMS taken in the past 30 days from the checklist and 24-hour recall.
Each point represents a VMS taken. This method of reporting and measuring VMS usage has
been described in the literature (Viveky et al., 2012).
Analysis
Statistical analysis was conducted with SPSS Statistic 23 student version. The sample
characteristics, SCQ, GSE, VMSSE and ERA total and ERA subscales and VMS totals were
reported using mean, median and percentages of the non-transformed data. Normality was
assessed and linearity between variables assured. SCQ, ERA mental health subscale, VMSSE,
and VMS total were skewed and non-parametric analyses were used. The median was reported
for the measure of central tendency for skewed variables. Spearmen’s correlations analysis was
used to identify variables having significant relationships with VMS use due to skew and ordinal
level of data. An independent sample t-test was conducted to determine if there was a difference
between the VMS total used between those with low versus high GSE scores (2 groups divided
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by mean).
Multiple regression was used to test the null hypothesis of no difference in VMS use
from prior supplement use, ERA, GSE, VMSSE and control variables. A square root
transformation for SCQ and VMS total normalized each distribution. Transformation of VMSSE
and ERA mental health increased the skew and transformation was not utilized. The
Expectation-Maximization (EM) method was reasonable for regression analysis to replace
missing data values as it retained relationships with other variables. All missing data on the
dataset were verified against original surveys. Missing values were imputed using the EM
algorithm in the Missing Values Analysis modules of SPSS. The EM method replaced missing
variables; VMSSE (6 missing), SCQ (3 missing), and ERA total (5 missing), ERA physical
health (1 missing), ERA mental health (2 missing), and ERA cognitive function (3 missing).
Each variable had 5.5 % or less missing data following guidelines for the EM method. The
Little’s missing completely at random (MCAR) test χ2 = 32.080 (df = 31, p = .413), reflects the
missing data was missing completely at random. Assumptions of regression model, such as
linearity of variables with VMS total were confirmed after transformations and EM method.
To examine the results of the hypothesis a two-step process followed Field’s strategy for
multiple regression (Field, 2009). For the first regression variables were entered to observe
which contribute significantly, step 1 contained the control variables (age, education level and
SCQ) and step 2 contained the independent variables (prior supplement use, GSE, VMSSE, and
ERA). ERA was entered last as the variable of interest following Field’s design (Field, 2009).
The second multiple regression contained the control variable and independent variables found to
be significant and important.
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Results
Description of Sample and Control Variables
As seen in Table 11, the participants were predominately widowed or single (78%) and
white (91%) and had at some college or higher (67%). The majority were over the poverty level
(87%) and reported they had just enough or more than enough money at the end of the month
(93%). The reported state of health was good or better (88%). Sixty-eight percent had used
VMS frequently over the course of their life and 92% were using VMS currently. Age was not
significantly associated with VMS use and education had a weak positive relationship to total
VMS use. The median score of the SCQ which includes treatment and function was 7 (SD =
4.8). The median comorbid diagnosis for the participants was 3 problems (SD = 2). The most
common diagnosis’ were arthritis (n = 70), high blood pressure (n = 63), and back pain (n = 40).
SCQ has a weak, non-significant relationship with VMS use. The SCQ had acceptable Cronbach
alpha of .810 (Tavakol & Dennick, 2011).
Table 11. Characteristics of Study Participants (N= 110)
Participant Characteristics
n (%)

rs Total

p

VMS
Marital Status (N = 110)
Married
Partnered
Single
Widowed

23 (21)
1 (1)
35 (32)
51 (46)

Ethnicity (N = 110)
Hispanic or Latino
Not Hispanic or Latino
Prefer not to answer

3 (3)
99 (90)
8 (7)

Race (N = 110)
White
American Indian
Black or African American
Prefer not to answer

100 (91)
6 (5)
2 (2)
2 (2)

Range of income (N = 79)
Less than $12,000

10 (13)

.05
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.66

$12,000 - $15,000
$15,000-$18,000
$18,000-$25,000
$25,000-$50,000
Over $50,000
Rate Finances (N = 103)
Have more than enough money
at the end of the month
Have just enough money at the
end of the month
Do not have enough money at
the end of the month

12 (15)
11 (14)
8 (10)
20 (25)
18 (23)
.06

.56

.19

.05*

.03

.72

.40

.01**

55 (53)
41 (40)
7 (7)

Education Level (N = 109)
Less than high school
High school degree or equivalent
Some college
Associate degree
Bachelor degree
Graduate degree

1 (1)
34 (32)
19 (17)
13 (12)
22 (20)
20 (18)

State of health (N = 109)
Poor
Fair
Good
Very good
Excellent

0 (0)
13 (12)
30 (28)
53 (48)
13 (12)

Osteoporosis Diagnosis (N = 110)
Yes
No
Do not know

43 (39)
62 (56)
5 (5)

Supplement use over life course (N = 108)
Never used
Hardly used
Occasionally used
Frequently used

3 (3)
12 (11)
20 (18)
73 (68)

Current supplement use (N = 110)
Yes
No

99 (90)
11 (10)

Age M (SD), range (N = 110)

77.7 (7.6), 65 to 93

- .07

.49

SCQ Md (SD), range (N = 110)

Md 7.0 (4.8), 0 to 25

.011

.91

rs is the Spearman’s Rho statistical analysis, control variables are italicized.
*Correlation is significant at the 0.05 level
** Correlation is significant at the 0.01 level

116

Description of Predictor Variables: Expectations of Aging, Self-efficacy, and Prior Related
Behavior
The average ERA subscale scores, from low to high, were 46 (SD = 22) for physical
health, 50 (SD = 22) for cognitive function, and a median of 75 (SD = 23) for mental health. The
average global ERA score was 57 (SD = 18). There was a negative skew for ERA mental health
as the participants tended to expect a high level of function in aging. ERA total had a
nonsignificant weak relationship with VMS use. The ERA total and subscales had acceptable
Cronbach alpha’s ranging from .72 to .86 as seen in Table 12 (Tavakol & Dennick, 2011).
The average for GSE was 33 (SD = 4.6) with actual range of 19 to 40. The participants
with low GSE took on average 4.8 VMS per day while those with higher GSE took on average
4.9 VMS a day, there was no significant differences between the two groups t(108) = -.25, p =
.804. GSE had significant moderate relationships with ERA total (rs = .39. p < .01). The GSE
had acceptable Cronbach alpha of .89 as seen in Table 12 (Tavakol & Dennick, 2011).
The median score for VMSEE was 29 (SD = 4). There was negative skew for VMSSE as
participants tended to report that they were very confident in the use of VMS. This was reflected
as the median for all eight questions was 4 out of the possible range of 1-4. VMSSE had a weak
relationship with GSE (Spearman’s rho rs = .33, p < .01). VMSSE had a weak negative nonsignificant relationship with total VMS use as seen in Table 12. The VMSSE had acceptable
Cronbach alpha’s ranging from .72 to .86 as seen in Table 12 (Tavakol & Dennick, 2011).
The majority of the participants frequently used supplement (66%, n = 73). There were
13.6 % (n = 15) of participants who reported never or hardly have used VMS. And 18 % (n =
20) who occasionally used VMS. Supplement use over life course had a positive moderate
relationship with VMS use as seen in Table 11. The median number of supplements taken a day
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was 5 (SD= 4) with a range of 0-16 VMS taken. Positive skew was found for VMS total as there
were high numbers who used 5 or less supplements.
Table 12. Results of Expectations Regarding Aging, General Self-efficacy and Vitamin, Mineral
and Herbal Supplement Self-Efficacy Measurements
Scales
M (SD)
Range of
Cronbach’s
Correlation p
Scores
coefficient
to VMS
alpha
total
Global ERA
57.0 (18.4)
11 to 97
.862
-.148
.13
ERA physical health

46.4 (22.2)

0 to 100

.715

-.086

.38

ERA mental health

Md 75.0 (22.6)

8.3 to 100

.744

-.183

.06

ERA cognitive
function

50.2 (21.7)

0 to 100

.790

-.026

.79

General Self-Efficacy
(Possible Range 1040)

33.1 (4.6)

19 to 40

.893

.005

.96

VMS self-efficacy
(Possible range 8-32)

Md 28.5 (4.0)

8 to 32

.841

-.014

.89

Research Hypothesis - Variables Which Influence VMS Use
The first regression analysis was completed with all the control variables and predictors
entered to observe which contribute significantly. The step 1 variables age and SCQ were not
used in final regression due to weak correlation, as seen in Table 11, and non-significant low
(age, β = -.04, p = .673; SCQ, β = .048, p =.620) standardized beta-coefficients. Step 2 variables
GSE and VMSSE were removed as neither were significant nor correlated with VMS use in
older women and did not add to the model (GSE, β = -.02, p = .869; VMSSE, β = -.01, p =.939).
Age, SCQ, GSE, and VMSSE were not included in the final regression.
As shown in Table 13, in Step 1of the second multiple regression, education level
accounted for 2.3 % of the variance in VMS use. At Step 2 with the addition of past use of VMS
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and ERA there was a significant increase of 23.3 % variance in the model. The results of the
hierarchal regression indicated that education level, prior use of VMS, and ERA explained 27 %
of the variance.
Education level, prior use of VMS, and ERA were significant predictors of VMS use in
the model. For past use of VMS, the standardized beta-coefficient was .469. This means that
controlling for education and ERA, when prior use of VMS increases by one unit, it is predicted
that VMS use will increase by .469. For ERA, the standardized beta-coefficient was -.197. This
means that controlling for past use of VMS and education level, when ERA increases by one
unit, it is predicted that VMS use will decrease by .197. Past use of VMS was the strongest
predictor of current VMS use followed by ERA.
Table 13. Final Regression for Determinants of Vitamin, Mineral, and Herbal Supplement Use in Older Women
(N=110)
Step and Predictor
R²
Adjusted R²
Δ R²
Standardized ß
t
p
Variable

Step 1
Education Level
Step 2
Education Level
Use VMS in Past
ERA Total

.033

.023

.033

.180

1.888

.062

.265

.244

.233**

.182
.469
-.197

2.216
5.523
-2.285

.036
<.001
.024

F(3, 104) = 12.53, p <.001
* p < .05, ** p < .001

Discussion
The primary objective of this study was to identify factors associated with supplement
use. The expectations of future mental health, physical health and cognitive function on the use
of VMS were a significant predictor. Expectations of aging negatively predicted VMS use. The
older women who expect declines of physical, cognitive and mental functioning with aging had
higher VMS use. While older women who had higher ERA, expect to preserve high physical
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and mental function with aging, had lower VMS use. This is contrary to other studies where
older adults with higher scores or positive self-perceptions or expectations of aging generally
practiced more preventative health behaviors.(Sarkisian et al., 2003; Sarkisian, Liu, Ensrud,
Stone, & Mangione, 2001).
The health behavior VMS supplement use may not be equivalent to other health
behaviors such as exercise or nutrition. There may be influences that motivate VMS use for
older women that are distinctive from motivations for other behaviors. Supplement use does not
require the same level of behavior change or lifestyle change that exercise and nutrition require.
The cognitions influencing those with lower expectations of aging to use more VMS could be
examined using qualitative methods to further explore this finding. Expectations of aging is a
modifiable factor. It would be valuable for primary care professionals to be aware of how ERA
influences different health behaviors.
This study also did not examine the appropriateness of the VMS use by older women.
Are women who need the VMS the ones taking the supplements? The literature often shows that
women who exercise more, eat healthier diets, higher education level and higher incomes tend to
take VMS. This is a very interesting finding that ERA has a significant negative relationship
with VMS use. Is there a difference in appropriateness in VMS use between those with lower or
higher ERA? Are women with lower expectations of aging taking more VMS to buffer or
protect their future health. These are questions that have clinical implications for health care
practitioners and further study is warranted.
While other studies of other health behaviors have found self-efficacy to be a predictor,
GSE and VMSSE were not found to be significantly associated with VMS use in this study
(Gray & Rutledge, 2013; Pender, 2002; Walker et al., 2006). The construct of self-efficacy has
120

frequently had empirical support in the health promotion model. In 86% of studies using the
health promotion model, self-efficacy was found to be significant and was retained in the model
(Pender, 2002). A study, also using the GSE to measure self-efficacy, found Polish athletes (20
to 30 years old) with lower GSE scores more likely to use vitamin supplements (76% low GSE
vs 56% higher GSE) than those with higher GSE scores (Gacek, 2016). A significant difference
in use was not found between those with low and high GSE scores in the current sample. While
there are many differences between the two studies, this does highlight the importance of selfefficacy in the study of health behaviors and in future studies.
Self-efficacy has a role in adopting a health behavior and has been found to help maintain
health behaviors such as physical exercise (Conn, 1997; Schwarzer & Fuchs, 1995). Selfefficacy has a major role in the intention to change a behavior (Schwarzer & Fuchs, 1995). In
the current study, self-efficacy does not appear to be a determinant for maintenance of VMS use.
The majority of the sample had used VMS frequently over the course of their life. Self-efficacy
may have an impact on intention to use supplements and early adoption or use of VMS. This
does not rule out that self-efficacy may have been predictive for the intention to use the VMS
early in life, but this was not explored in the current study. Supplement use is complex and a
combination of social, economic, psychological, and economic factors may influence older
women (Conner, Kirk, Cade, & Barrett, 2001). Factors other than self-efficacy may be the
motivators for current use. The challenge is to identify the behavior-specific cognitions and
affect that impact older adults.
In studies using the health promotion model about 60% of demographic characteristics
were found significant and were retained (Pender, 2002). Education level, age and comorbidity
were measured in this study because these variables affect numerous elements of older women’s
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lives and have been found in previous studies of VMS use. As found in the current study,
education level has been found to be a significant predictor for supplement by older adults
(Johnson et al., 2000; Kim, 2009; Sebastian et al., 2007). While studies have found that VMS
use increases with age (Bailey et al., 2011; Bailey et al., 2013; Foote et al., 2003; Miller et al.,
2008; Radimer et al., 2004; Satia-Abouta et al., 2003), the current study did not find differences
between older women in the sample. While comorbidity was not found to be associated with
VMS in this study, having heart disease and high blood pressure was related to VMS use. It may
be helpful to continue to examine individual diseases and VMS use. It is also important for
clinicians to be aware that there are supplements that are hazardous with certain health states and
to discuss VMS use with patients.
This study was predominately white women, this is a group who have been found to be
more likely to take supplements than other racial groups (Sebastian et al., 2007). In the literature
ethnicity has been found to be a factor but inadequate representation in the participants in this
study suggests further research is needed. The high proportion of white women decreases the
generalization of the findings. Other studies have found that while VMS use was high across
ethnic groups there are differences in type and length of use for VMS (Albright et al., 2012;
Foote et al., 2003; Murphy et al., 2011). To study ethnicity additional research with probability
samples in other geographic regions would be informative. This information would also be
valuable for health care professionals in providing care, prescribing and avoiding drug
interactions.
Prior use has been found to be a significant determinant and retained in 75% of studies
testing the construct with the health promotion model (Pender, 2002). Prior use has been found
to have both a direct effect and indirect effect on current health behavior. The direct effect may
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be due to habit formation. The HPM suggests indirect influence includes relations to perceptions
of past self-efficacy, past benefits, and activity-related effect of prior use. It is important to be
aware of prior use in older adults as prior use can alert health care professionals to discuss
current and future use of VMS with older women. The findings of this study support the
importance of future research to examine predictors of VMS use.
Research Hypothesis Revised
The variance explained by the model indicates the existence of additional predictor
variables. Determinants that were found to be significant were retained in the model and the
determinants which were poorly correlated and not significant were removed from the model.
The health promotion model and participant responses on the survey offer additional variables
which could be examined to identify predictors of VMS use. The personal factor of the HPM
associated with supplement use was education and is retained in the revised model, while
comorbidity and age were not significant and were not retained. Behavior-specific cognitions
and affect that could be explored include interpersonal influences. Interpersonal influences are
the cognitions regarding the beliefs, behaviors or attitudes of others. Interpersonal influences
incorporated are; influence of family, friends and health care professionals; and media.
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Figure 4. Revised Model to Identify Factors that Influence Supplement Use

Individual
Characteristics and
Experiences
Prior Related
Behavior
IV- Use of
supplements in past.

Personal Factors
(potential control
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Affect
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Action
IV- Expectations
regarding aging

DV- Supplement
Use

Interpersonal
Influences*
IV- Family, Friends,
and Health Care
Professional*
IV-Media portrayal of
benefits of use*

*Added to Model
Limitations
The study’s findings should be interpreted with the following limitations in mind. First,
the amount of variance explained in the variables was small to moderate and indicate the
existence of additional predictor variables. Second, there are additional variables for study
suggested by the theoretical model which were not within the scope of this study. The crosssectional design of the study prohibits the ability for definite conclusions regarding cause and
effect in the relationship between education, prior use, and ERA with older women’s VMS use.
Finally, additional research and measurement development is needed for measure of VMS selfefficacy and measurement of Tolerable Upper Intake Level use of VMS. Identification of
behavior-specific cognitions and affect is also of key importance in future research as these are
the constructs which are modifiable and may be used to develop interventions.
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Conclusion
In summary, the health promotion model was useful to begin an exploratory study of
predictors of VMS use in older women. Variables found to have an impact on VMS use include
educational level, past prior use, and expectations regarding aging. This study suggests that
further research examine additional potential predictors of VMS use. Future studies focusing on
predictors of VMS use by older adults may allow interventions to improve or protect the health
of older adults.
Comparison of Supplement Use Results from Nursing Home Residents and Independent
Living Older Women
While all the independent living adults were women, 26% of the residents in the nursing
home were men. There was a wider range of age in the nursing home residents, 54 to 103, than
in independent living sample, 65 to 93 years. There is no data for comparison for most of the
demographics, comorbidity, ERA and GSE as the data from nursing home was a secondary
analysis.
At the time of the survey 92% of the independent living women (ILW) were using a
VMS, while in the nursing home 94 % were taking a VMS and/or nutritional supplement.
Vitamin D was the most frequently used supplement from all categories for both groups followed
by calcium and MVMM. Both groups are from the same geographical area though the results
were gathered 2 years earlier for nursing home residents.
Very similar amounts of use were found between the ILW and nursing home residents for
vitamin D, 75% for ILW and 72% for nursing home residents. In the nursing home, more
females took the basic form of Vitamin D (n = 68, 37%) than males (n = 14, 22%) (χ² = .406, p =
.524). For the ILW 39 % (n = 43) had a diagnosis of osteoporosis. No diagnosis’ were available
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from the secondary analysis of the nursing home.
There are similarities regarding dosage of vitamin D between the two groups. Low
numbers were using dosages below or within RDA for both groups. Of the ILW, six percent (n
= 6) took a dose below RDA and 4 % (n = 4) took within the RDA, for the nursing home
residents, 9 % (n = 21) were below RDA, 1 % (n = 3) were within RDA. Both groups were
taking dosages above the RDA for vitamin D. For ILW 39% (n = 43) took more than RDA but
less than UL (Tolerable Upper Intake Level), and 7 % who were at UL or above. For the nursing
home group 62% (n = 154) were prescribed dosages of Vitamin D above the RDA, and 28% (n =
69) were not prescribed any vitamin D.
There were wide differences in the herbals used between nursing home residents and
ILW, twenty percent higher use of herbal in the ILW. In the nursing home setting, 11.3 % (n =
28) were taking an herbal supplement (with Acidophilus removed from herbal category and
added to colon health category) and 43% (n = 106) were taking a nutrition supplement. Both
nursing home residents and IWF had melatonin and cranberry as frequently used herbals and
coenzyme Q-10 use was higher in ILW, see Table 14. For nursing home residents, the most
commonly prescribed herbal supplement was melatonin and for ILW it was coenzyme Q-10.
There were no differences between genders in herbal supplement use (χ² = 3.236.596, p = .440)
in the nursing home setting. The ILW also took a much wider variety of herbal supplements 31
versus 5 reported from the nursing home secondary analysis. In the nursing homes, there were 2
herbals reported as infrequently used: ginger supplement (n = 1) and turmeric supplement (n =
1).
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Table 14. Comparison between Independent Living Women (N = 110) and Nursing Home
Residents (N = 247)
Major categories
ILW
Nursing
Single Nutrient
Nursing
ILW
Home
Vitamin
Home
%* (n)
%* (n)
%* (n)
Supplements
%* (n)
MVMM
MV
Herbals
MM

VMS

50.0 (55)
34.5 (38)
30.9 (34)
2.7 (3)
Total for All VMS
91.8
(101)

40.4 (100)
6.9 (17)
11.3 (28)
0
94.3 (233) ª

Vitamin A
Vitamin B1
Vitamin B2
Vitamin B7
Vitamin B12

Calcium containing

50.0 (55)

47.4 (117)

Fatty acids
Joint supplements
Fiber and colon
health

33.4 (37)
14.5 (16)

4.5 (11)
0

10.0 (11)

13.8 (34)

Vitamin E

Protein and sport

6.4 (7)

0

Single Nutrient Other Supplements
1.2 (3)
Magnesium
18.2 (20)
Potassium
Zinc
Selenium
Iron
Chromium

9.1 (10)
5.5 (6)
3.6 (4)
2.7 (3)
1.8 (2)

0

Total for B
Vitamins

Total for B
Vitamins

36.4 (40)

26.3 (65)

25.5 (28)
74.5 (82)

7.3 (18)
72.1 (178)

14.5 (16)

1.2 (3)

5.5 (6)

0

Folate
Vitamin B
Complex
Vitamin B not
identified
Vitamin C
Vitamin D

Minor categories

3.6 (4)

Lutein

Most Frequently Used Herbals
CoenzymeQ10
12.7 (14)
1.6 (4)

29.9 (74)

Melatonin

8.2 (9)

5.3 (13)

1.2 (3)
0
23.1 (58)
0

Cranberry
Garlic
Turmeric
Cinnamon

5.5 (6)
4.5 (5)
4.5 (5)
3.6 (4)

4.5 (11)
0
0.4 (1)
0

Note ILW are Independent living women (N= 110), Nursing Home are individuals in long term care facility (N=247)
* % = n/N
ªAlso includes House Nutritional Supplements given to nursing home residents

Chapter Summary
This chapter presented the results in two manuscripts; the first manuscript reported the
results of the research questions focused on VMS prevalence, vitamin D and variables of interest
and the second presented the results of the research hypothesis. The comparison of VMS use
between long term care residents and community dwelling residents was described and will be
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discussed in Chapter 5.
A higher number of older women are taking VMS than has been reported previously.
Vitamin D is the most common VMS taken and there is a small percentage who are taking
vitamin D over the Tolerable Upper Intake Level. A wide variety of reasons were given for use
of vitamin D. Three variables were found to have an impact on VMS use: educational level, past
prior use, and expectations regarding aging. Surprisingly age, comorbidity and self-efficacy
were not found to be well correlated or significant in relation to VMS use. Further research is
suggested that will examine additional potential predictors of VMS use and further theoretical
development of the model.
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Chapter 5
Overview
This chapter presents a summary of the studies major findings and a discussion of the
differences in VMS use between nursing home residents and independent living older women.
Proposed implications for VMS use are offered. Potential goals for public health policies are
presented. Strengths and limitations of the study are reviewed followed by recommendations for
future research.
Background
There are a host of historical factors which corroborate the need for continued VMS
research. VMS are not regulated as prescription medications. Contents of supplement products
are not uniform regarding dosage or ingredients and have been found to be adulterated. The
FDA has vast enforcement challenges. The side effects of VMS are not thoroughly studied nor
are VMS tested before marketed and sold. The potential actions and burdens of VMS on organs
are not clearly understood. Liver injury from VMS use is increasing and is more severe with
outcomes such as liver transplantation and death (Navarro et al., 2014). Dietary supplements are
used for many purposes, proven and unproven. The use of VMS among older adults has been
steadily increasing over the last 40 years (Bailey et al., 2011). The elderly adults are taking more
VMS than in the past (Timbo et al., 2006).
Vitamin D is the supplement of interest in this research study. Vitamin D deficiency is
thought to be prevalent due to inadequate sun exposure, inadequate dietary sources,
malabsorption and chronic disease. Vitamin D receptors are found in almost every cell in the
body. Immune function, cell growth, neuromuscular function and inflammation reduction are
impacted by vitamin D. Currently there are many studies regarding the role vitamin D has with
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diseases, infections, disorders, cancers and fracture. The concern regarding vitamin D deficiency
as well as underconsumption and overconsumption highlights the importance to gather current
information regarding use.
The theoretical underpinnings of this study were aging with physiological homeostasis
and the HPM (Pender et al., 2015). Each theory complements the premise of the study. First,
the physiological changes of aging and aging’s impact on physiological homeostasis puts older
adults at higher risk for complications or risk from under or overconsumption of VMS. Second,
factors not related to medical need may influence VMS use and the HPM helps to explore the
use of VMS by older women.
Due to the changes in physiologic homeostasis from aging, older adults are at higher risk
from vitamin dosages above the UL. Physiologic homeostasis maintains the body’s biological
order by balancing metabolic activity and regenerative responses (Wang, Karpac, & Jasper,
2014). Aging causes a widespread loss of homeostasis which can result in damage, inadequate
repair of damage or dysregulation of cell number (Boron & Boulpaep). The aging body
potentially has difficulty maintaining homeostasis when substances outside the body, such as
VMS, are introduced (Wang et al., 2014). Age related changes may alter the pharmacokinetic
and pharmacodynamics which increases the risk of adverse events (Castelino, Hilmer, Bajorek,
Nishtala, & Chen, 2010; Hamilton, Gallagher, & O’Mahony, 2009).
The HPM provided the structure to explore the factors that predict VMS use. For the
current study variables from the HPM were chosen to construct a parsimonious model. This was
the first use of HPM focusing on VMS use by older women. Age, education, and comorbidity
were measured as control variables. Prior supplement use, ERA, GSE, VMSSE were measured
as potential predictors of VMS use. ERA, GSE, and VMSSE are modifiable factors and ERA
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has been reported to influence current and future health behaviors. Education level, prior use of
VMS, and ERA were found to be significant predictors of VMS use by older women.
Discussion of Research Questions from Survey Results
Research Question One: What is the Prevalence of VMS use Among Older Women?
A majority of older women were taking VMS’s. The findings from the survey suggest
that vitamin D was the most prevalent supplement taken. About a third were using herbals.
There is a vast field of research concerning prevalence of VMS that reaches back over 50 years.
Frequently MVMM were found to be the supplement most commonly used (Bailey et al., 2011;
Foote et al., 2003; Satia-Abouta et al., 2003; Sebastian et al., 2007). The results of the current
study support the literature regarding the expanding use of vitamin D, herbals, and other
supplements (Bailey et al., 2011; Gahche et al., 2011; Radimer et al., 2004). There was a small
number of women who took up to 16 VMS products. The use of multiple VMS in the older
population raises the risk of drug interactions. This study offers current prevalence use of VMS
by older women from the community and CCRC’s and the results demonstrate the reported use
does vary in type and amount of VMS reported from earlier studies.
Research Question Two: What are Older Women’s Levels of General Self-efficacy and
Expectations of Aging?
General self-efficacy influences how older adults think, feel and act (Scholz et al., 2002).
Low GSE has been associated with helplessness, pessimistic thoughts regarding
accomplishment, and depression. High GSE has been associated with decision making,
optimism and achievement (Scholz et al., 2002). The mean GSE of the sample (33.1, SD = 4.6)
was higher than means reported by Scholz et al. (2002) who sampled 19,120 persons from 25
different countries (M = 29.5, SD = 5.32). GSE has been studied in relation to many constructs
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but only one other study has tested GSE and supplement use. Gacek (2016) looked at GSE and
use of dietary supplements in Polish athletes (M = 31.3, SD = 3.2). Athletes with lower GSE
used MV supplements significantly more often (Gacek, 2016). In the current study, older
women with lower GSE did not take differing amounts of VMS. However, this study did not
look at individual VMS in relation to GSE as Gacek did in the study of athletes (2016). GSE
may be a valuable construct in the study of different populations than that represented by the
sample.
This may be the first study to measure ERA in regard to VMS use by older women. It is
important to understand older women’s perceptions of their aging because of the impact those
perceptions have on health care behaviors. Older women with lower expectations of aging used
more VMS. Older women’s expectations of aging may affect how they perceive their health
potential and impact health care prevention and promotion practices.
In this sample, there was a wide difference in the ERA subscales, lowest for physical
health and highest for mental health. The participants had very high mental health subscale score
which shows a majority did not feel it was true that: they would spend less time with friends and
family, being lonely was something that happens as you get old, that quality of life declines as
people age, and it is normal to be depressed when you are old. Similar patterns with physical
health subscale lowest and highest for mental health subscale was seen in other studies. Davis,
Bond, Howard and Sarkisian (2011) found the ERA subscales for primary care clinicians (age M
= 48.6, SD = 11.6, age range in years = 23-87) followed the same pattern. A study including
middle-aged and older adults also found the same pattern (Meisner & Baker, 2013). Weltzien
(2007) also found that expectations of young, middle-aged and older women were lower for
physical health than mental health also which is similar to the results of the current study.
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There has been a challenge to ageism over the past 30 years in the population (Palmore,
2005) and idea of successful aging may be changing people’s expectations of aging. Davis et al.
(2011) suggest there may be a cohort effect for ERA. Weltzien (2007) looked at aging
expectations and health behaviors and found older women had less positive future health
expectations and lower expectations for physical health than young and middle-aged women. A
generation’s exposure of life experience, media, new research on aging, and changes in image
and perception of aging may influence the levels of ERA. Expectations of aging may differ from
one generation to another.
Research Question Three: Is Higher Age Associated with Increased Number of
Supplements Taken?
In this study, a significant relationship between age and an increase in the number of
supplements taken was not found. In studies with a wider range of age an increase in VMS use
was found (Foote et al., 2003; Kennedy, 2005; Miller et al., 2008). While not significant, the
Spearman rank order correlation (rs = -.07, p = .49) reported a negative correlation between age
and VMS suggesting that for this sample as age increased there was a non-significant slight
decrease in VMS use. The current study may not be representative of the population. The
results of this study were different from the studies reported VMS use increasing with age (Foote
et al., 2003; Kennedy, 2005; Miller et al., 2008). There is limited research on VMS use by the
oldest segment of the population however it has been reported that as people enter hospice they
are taking a wide variety of VMS (Holmes, Kaiser, Jackson, & McPherson, 2010). Use of VMS
by the oldest adults in the study may differ by type of VMS used from the youngest in the
sample, this study did not examine patterns of use by ages. The current study only included
women living in CCRC’s or the community setting.
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Research Question Four: Do Women with Higher and Lower Levels of Education Differ in
Their Supplement Use?
The participants were asked to choose the highest level of schooling they completed from
6 levels of education. The answers were dichotomized into high school or less and greater than
high school education. The women with a high school or less education took fewer VMS than
the women with a college education. The findings from the study suggest that education does
contribute to VMS use in older women. The research on VMS has included education frequently
and the results are consistent with other studies. This is also one of the factors that is sometimes
included in the inverse supplement hypothesis, that VMS users tend to have higher dietary
nutrient intakes, report themselves as healthy, have higher incomes and higher education than
VMS non-users (Braun & Venter, 2008; Kirk et al., 1999; Kofoed et al., 2015; Sebastian et al.,
2007).
Research Question Five: Do Older Women with High, Medium and Low Levels of
Comorbid Conditions Differ in their Supplement Use?
There are a burgeoning number of studies regarding VMS and different disease
categories. To measure comorbidity the Self-Administered Comorbidity Questionnaire (SCQ)
was used which allowed for a total of 15 comorbid conditions. The problems the SCQ included
were heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach disease, kidney
disease, liver disease, anemia or other blood disease, cancer, depression, back pain, and arthritis
(osteoarthritis, degenerative arthritis or rheumatoid arthritis) with three additional medical
conditions that could be written in. In this study, there was no significant difference in the level
of supplement use between women with low medium or high levels of comorbid conditions.
When each comorbid condition was examined separately with VMS use two did differ in
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supplement use; high blood pressure and heart disease. The participants with high blood
pressure or heart disease took less VMS than those without the conditions. It was not the
purpose of this study to examine the types of supplements taken associated with each reported
comorbidity, and the participants were not asked why each supplement was being taken. There
is extensive and ongoing research on VMS use with heart disease and cancer.
Research Question Six: What Percentage of Older Women are Taking Vitamin D at and
Above the Tolerable Upper Intake Level?
At this time, there are 301 current clinical Trials ongoing and over 3,000 studies are
found for vitamin D on the registry and results database of clinical studies. Vitamin D is a topic
of interest to many adults. About three-fourths of the independent living older women in the
current study were taking vitamin D. There were 7 % of the participants who were taking
vitamin D at the UL or above, 3 % were at the UL and 4% were above the UL. Of the 4 % (n =
4) who were above the UL, two were following their health care professional’s advice for low
blood levels, one reported taking it for her bone health but her doctor did not prescribe it, and the
fourth women did not answer the questions. The results are in alignment with other research
regarding use of VMS over UL, that a small segment does take vitamin D in amounts over the
UL. The Office of Dietary Supplements leads and sponsors efforts which include assessment of
vitamin D status (Bailey et al., 2010). There are health risks from excessive vitamin D, the
calcium levels can increase in the blood leading to damage to heart, kidney and blood vessels
(NIH, Office of Dietary Supplements, 2016). There is emerging information that use of vitamin
D at high levels may over time cause adverse health effects. There is a need for research in the
use of vitamin D over UL and long-term use.
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Research Question Seven: Are Older Women Cognizant of Their Vitamin D Dosage?
About a third of the participants who were taking vitamin D were not able to list amount
of vitamin D dose and reported they did not know the dose they were taking. Even when
participants were unable to report their dose of vitamin D, two-third replied they felt confident
they could list their supplements including the doses and schedule. The question on confidence
came later in the survey. Perception of confidence did not align with knowledge of dosage
regarding vitamin D. Health care professionals should be aware that confidence in regarding
supplement use reported by a client may not equate to accurate knowledge.
The dosage of vitamin D was only for the vitamin D supplement alone and did not
include vitamin D found in other supplements or in the diet. Total dosage of vitamin D was not
accounted for by the survey. Bailey et al. (2010) estimated vitamin D intake from dietary
sources and dietary supplements, females and males over 70 years old had lowest prevalence of
meeting the adequate intake and dietary supplements helped to meet adequate intake of vitamin
D. With the increasing numbers of women taking VMS and the higher dosages available, an
estimate of total vitamin D intake from food, water, and VMS would aid in monitoring total
nutrient intake.
Discussion of Results Regarding Hypothesis and Proposed Model
Several of the variables were not well correlated with VMS use, did not add to the model
and were not included in the final multiple regression; age, SCQ, GSE, and VMSSE. The age
range may not have been great enough to show differences as most of the participants had used
or were currently using a supplement. The SCQ was chosen as the instrument included the
impact of treatment and function, however comorbidity was not found to impact amount of VMS
use. This may be that VMS are used for preventative reasons as well as treatment. Women with
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low comorbidity may have been taking VMS to maintain health, while those with higher
comorbidity levels may have been taking VMS to treat their illness. There is a growing number
of studies regarding VMS use for specific disease and chronic health issues. It may be helpful to
identify why each VMS is being taken and allowing for investigation regarding VMS use and
specific health issues. VMS use was not significantly correlated with GSE or VMSE. This may
be due in part as the majority of the sample had been using VMS frequently over the course of
their life and GSE may have greater impact on early adoption of the behavior and less on
maintenance of VMS use.
Education and prior use are significant predictors of VMS use. As the education level
increases the amount of VMS used also increases. Other studies have also found that education
level to be associated with supplement use. Prior use has direct and indirect effects on current
health behaviors and is frequently found to be significant variable for predicting health behaviors
with the health promotion model (Pender, 2002). A majority of the women who participated in
the survey had used VMS in the past and many of them were frequent users of VMS. Prior use
has the greatest impact on VMS use in the current study.
The expectations of aging on the use of VMS was a significant predictor. Expectations of
aging negatively predicted VMS use, the lower the expectations of aging the higher the VMS
use. A study found older adults with higher ERA scores practiced more preventative health
behaviors and those with lower ERA scores practiced less (Sarkisian et al., 2003). There may be
a practical difference in health behaviors studied. While studies have found for some health
behaviors that a higher ERA leads to higher behaviors this may not relate to other types of health
behaviors. Each health behavior needs to be studied to see the effect of ERA. Taking a
supplement may also be easier for an older adult to do than starting a lifestyle change such as
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exercise and healthy eating.
Discussion of Nursing Home and Community Older Women’s Use of VMS
The women living in the community or CCRC’s (independent living women) and adults
in the three nursing homes lived in the same geographic area. The data from the nursing homes
were gathered 2 years prior to the survey for the independent living women. The independent
living women and adults in the nursing homes have similar use of vitamin D, 75 % and 72 %
respectively; and similar VMS total use, 92 % and 94 % respectively.
Both nursing home residents and independent living women were taking dosages above
the RDA for vitamin D. Thirty-nine percent of independent living women took more than RDA
but less than UL (Tolerable Upper Intake Level), and 7 % who were at UL or above. For the
nursing home residents 62% (n = 154) were prescribed dosages of Vitamin D above the RDA.
The research suggests that nursing home residents may be at high risk for vitamin D deficiency
due to lack of sun exposure, age, obesity, and high number of chronic conditions and more may
be on a high dose of vitamin D for treatment. The secondary analysis did not have access to
diagnosis or laboratory results of vitamin D screening.
There was higher use of herbals in both variety and numbers by the independent living
women than in the nursing home setting. The medication reconciliation process used with
admission to nursing homes may be a screening point and may limit the types of supplements. In
this dissertation only 3 nursing homes were included in the secondary analysis and while there
were differences in amount of vitamin D prescribed between the nursing homes there were only
5 herbals on the Medication Administration Records from the 3 facilities. The five herbal
supplements nursing home residents were taking were coenzyme Q-10, melatonin, cranberry,
turmeric, and ginger. The residents may have been taking herbals that family brought in and that
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was not captured in the secondary analysis. The results of number and types of herbal prescribed
may reflect the attitudes and beliefs regarding VMS use of the prescriber. The prescriber
attitudes and beliefs regarding VMS use may differ across the United States. The prescription of
herbals may also be due to new research regarding specific supplements. Family members may
request the primary health care provider to prescribe herbal remedies.
The higher use of potassium and iron by nursing home residents may be a result of
treatment. Also, the probiotic use was higher in nursing home residents, this may be due to
possible nursing home prescribers ordering probiotics to be started with an antibiotic. The use of
VMS by nursing home residents demonstrates the impact others have on VMS use. With entry
into long term care the health care provider may have a significant impact on VMS use. The
current study did find differences between facilities with one supplement, there may differences
found in other regions and types of facilities in prescription of VMS.
Strengths of Study
This was an original study to examine how expectations of aging and other factors
influence the use of VMS by older women. The study also examined current vitamin D dosage
and reasons for use along with prevalence of VMS use. The results provided new and critically
needed information. Prevalence studies of VMS use are periodically needed to determine current
use patterns and inform health care professionals of contemporary trends. This is especially key
for health care professionals with older adult clients.
A theoretical framework such as the health promotion model plays an important role in
guiding the research study. The health promotion model has been shown in previous studies to
merit use for health behavior research with older adults and identification of modifiable factors
for intervention development (Pender et al., 2011; Pender et al., 2015). The literature review and
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the theoretical framework guided identification of pertinent variables and suggest relationships
between the variables to examine VMS use. Using the health promotion model relationships
between variables were explained and prediction of relationships was possible. Having a
theoretical framework provided a basis for hypothesis formulation and development of the
research questions for the current study.
Quantitative methods allowed for objective measurements and the statistical analysis of
data collected by survey. A priori power analysis is a best practice to determine sample size and
is an ethical consideration (Hayat, 2013). For this study, it was important to have enough
participants to ensure with a high degree of certainty that the statistical analyses results were
accurate. The a priori power analysis also has an ethical consideration to prevent additional
older adults being included needlessly.
The cross-sectional design is an economic and practical design. The cross-sectional
design limits effort needed to find and follow up with the older participants. Another strength
was incorporating older women from CCRC who are not included in national studies on VMS.
The methodology used to gather the data was a survey. The survey was an effective
means to collect self-report information for the variables of ERA, GSE, VMSSE, prior use, SCQ,
and current VMS use along with the demographic variables. The definitions of supplement use,
prior supplement use, age, and education are fully supported and the concepts are simple, clearly
and specifically defined and easily understood. The measurement tools ERA, GSE and SCQ are
well-established and have been used in studies.
It is difficult to gather accurate and reliable VMS data. The method to gather the data for
the outcome measure and provide the sum for total VMS use was reported in the literature and
similar methods have been used with other studies. This method uses more than one question to
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gather the data on VMS and reduces the chance that VMS would not be reported by the
participants. The outcome measure provides a sum of total VMS use that provides clear and
easily understood value of how many types of VMS are being used.
A codebook was part of the methodology for the study. The codebook was used to
document decisions regarding data and to collect or track unusual or unexpected data during the
study. Several participants wrote in comments on the survey, the codebook allowed for
documented of the unexpected data. The codebook allows for another researcher to be able to
replicate the results of the study. The codebook also assists the primary researcher to track
decision points and retain fidelity.
Limitations of Study
There were several limitations of the study. Convenience sampling was used in this
study which limits generalizability. The sample, women 65 years and older, for the study was
not representative of national ethnic, racial, or gender groups. The primary researcher explored
including the Spanish and Asian community sites however it was beyond the scope of the study.
The need for translators and translation of survey and instruments was a barrier for the current
study to include older ethnic minorities.
There were some limitations to design and timing of the study. A cross-sectional design
that collected data at one point in time for each participant was used in this study. The crosssectional design does not allow the identification of causal or predictive relationships. The data
collection took place over winter months in the north central United States. Data collection over
a longer period would potentially reflect additional VMS that are used seasonally. Future studies
would allow for examination of VMS use over time and in different regions of the country.
The settings where the study took place may also be problematic. The community
141

settings included senior dining sites. Older adults who attend senior dining sites may be more
aware of and interested in nutrition. Older women who attend senior dining sites may also take
different types or different amounts of VMS than women who do not attend senior dining sites.
Another factor regarding the setting is the women who filled out the survey were mobile enough
to come to the site where the survey was given. Women with barriers to mobility may have
different VMS use patterns.
The survey was limited to the length and number of questions to avoid fatigue and burden
on participant. The most pertinent variables were identified by literature review to provide a
parsimonious model. There are additional variables in the HPM that were not included in the
survey and the revised proposed model reflects the need for continued research.
The structured survey used for quantitative research methods has close ended questions.
The close ended questions limit the responses by the participants, there may be responses not
represented by the options. This was true for some of the participant as several wrote in
additional comments to some of the close ended questions. The results of close-ended questions
cannot represent the totality of possible participant responses.
There were five participants who wrote additional comments on the survey; three on
ERA and two on GSE. The comments on ERA were: “expectation of aging was not be a burden
on family” (at the top of the page), and the second response “having pain shouldn’t be an
expected part of aging”, and the third wrote in “some parts of the body wear out”. On GSE one
individual wrote in that her “faith helps” her and that she remains calm with “meditative
choices”. Another participant wrote in GSE that when someone opposes her she doesn’t “let this
bother me, I usually get what I want whether today or a month from now so why bother”. Open
ended questions and open space for feedback does provide richer response, however using
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established instruments with close ended questions does not allow for the richness of individual
feedback.
The study may have suffered from a “Hawthorne effect” simply by the researcher being
present. The Hawthorne effect suggests that individuals are aware of their participating in a
study and modify their behavior to their perception of what the researcher is seeking. Several
potential participants did ask if the survey was just for people who took supplements. This could
drastically impact the findings. While the researcher used a set introduction speech for all sites
and all were asked to participate the question still arose with a few potential participants.
The constructs of expectations of aging and self-efficacy were considered separate
constructs however there may have been some overlap. There was a significant weak
relationship (r = .38, p < .001) between the variables of interest GSE and ERA in this study.
This result suggests the possibility that the two instruments are measuring similar factors that are
present in expectations of aging and general self-efficacy.
The total types of VMS and amount of vitamin D taken per day were difficult to capture.
Many VMS had multiple ingredients which were not captured by the categories. The coding of
the VMS especially the herbals was by the major ingredient. Vitamin D was an ingredient in
many supplements not only for supplements labeled as vitamin D. This impacts the accuracy of
the total vitamin D dosage accuracy.
Recommendations
Implications for Practice
This study supports previous findings that the majority of older adults are using a wide
variety of VMS and taking differing amounts. Health care professionals play an important role
in supporting successful aging and primary, secondary and tertiary preventive health care.
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Health care professionals can assist older women in managing their VMS. Health care
professionals and food and nutritional professionals should be aware of VMS use by clients
regarding amount and type of VMS use, use in relation to RDA, and potential drug interactions.
Studies have shown a low disclosure rate of herbal supplements (Eisenberg et al., 1998; Gardiner
et al., 2006; Holmes et al., 2010). Improving disclosure of VMS to health care providers is an
important goal. A standardized procedure for health care providers regarding communication,
assessment, teaching, and documentation could help identify VMS use and encourage disclosure
of VMS use. Implications for practice include having; guidelines for communication and
documentation of all VMS use, guidelines for evidence based recommendations for use,
guidelines for screening of vitamin D, and evidence-based guidelines for treatment.
This study also supports previous findings of possible overconsumption, a small
percentage of older women are using vitamin D over the UL. If there is high VMS use, health
care professionals should be aware of the increased potential for drug-nutrient interactions and
potential for toxicity. Health care professionals and food and nutritional professionals should be
alerted to assess for overuse of specific nutrients. Vitamin disorders are usually masked by
current chronic disease (Joshi, 2015). Direct care health professionals need to be aware of
guidelines for assessment of vitamin deficiency and toxicity to distinguish if VMS use is
impacting current health.
An unexpected finding that is of interest to health care providers are the small percentage
of older women who are not taking the supplement their health care provider suggested.
Identification of nonadherence may be difficult but valuable. Many factors are involved in
nonadherence and intentional non-adherence (Hughes, 2004). Identification of nonadherence
allows an opportunity to identify barriers and engage in participatory decision making. Non144

adherence may result in poor outcomes which is a greater risk in the elderly (Hughes, 2004).
VMS should be examined for underconsumption and overconsumption. Up to date
knowledge of what the VMS the media and family are encouraging older adults to take would be
helpful. Current guidelines and evidence based information of the benefits or risks of VMS can
help guide practice. It is also important to communicate with clients and clarify if client’s
perception of benefits and risk align with health care providers.
Health care professionals need to understand older women’s expectations regarding aging
in relation to different health promoting behaviors. For VMS use, older women with lower ERA
may be taking more VMS. Expectations of aging is modifiable and interventions to improve
expectations of aging can be developed. Kim (2009) suggests that any interventions to improve
expectations regarding aging should be linked with the health promoting behavior desired to
change. There is a consideration regarding interventions to modify expectations of aging. If the
person’s expectation of aging is low but is realistic due to personal health history and current
diagnosis than an intervention to improve expectation of aging would not be desirable.
Suggestions for Policy Avenues
While this dissertation did not focus or study health care policy or regulation a majority
of older women were using vitamins, minerals and herbal supplements. This may suggest that
future policy and regulations focus on protecting the safety and health of older adults. Several
health policies are suggested to ensure and support the health of older adults. Policy changes
over time and modifications at the Federal level could improve monitoring for supplement
safety. Several suggestions are also provided for the health care professional such as acting as an
advocate and adopting evidence based practice when sufficient evidence is available.
The Dietary Supplement Health and Education Act of 1994 allows for supplements to be
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marketed and sold without premarketing approval and testing. Anything labeled as a supplement
is only removed after harm has been caused and the supplement identified. There have been
several tragic cases that have caused organ failure or death. Both the very old and very young
are being prescribed and taking probiotics. The Centers for Disease Control and Prevention
(CDC) put out a CDC Health Advisory in 2014 regarding an infant death from a supplement
(probiotic powder) used in the hospital (Vallabhaneni et al., 2015). The probiotic was
contaminated by a fungus and the infant died from a rare fungal infection to the entire bowel.
When an older adult is prescribed an antibiotic with an illness it is not unusual to also take or be
prescribed a probiotic. Regulation of VMS for purity, cleanliness, and adulteration needs to be
seriously considered. Health care professionals need to become aware of the issues surrounding
VMS use and advocate when and where health professionals can have an impact. Being willing
to speak to State and Federal representatives regarding issues surrounding VMS is one area to
advocate.
Health care professionals can remain informed on the current recommendations,
recommendations in progress and information for health professionals provided by the U.S.
Preventions Services Task Force and other literature. There is a need for consensus regarding
vitamin D guidelines. Different guidelines are used to report vitamin D deficiency or sufficiency
levels (Hossein-nezhad & Holick, 2013). The different ‘ideal’ vitamin D levels lends to
controversy regarding dosage, use and scope of vitamin D deficiency in the United States
(Holick, 2005; Holick & Chen, 2008; Pludowski et al., 2017; Shah & Gupta, 2015). Different
studies regarding vitamin D deficiency have used different cutoff levels for the definition of
deficiency resulting in different results (Shah & Gupta, 2015). Wijnen, Salemink, Roovers,
Taekema and de Boer (2015) suggest that some current guidelines for supplementation doses are
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too low for frail older adults with vitamin D deficiency. While current evidence suggests that
most adults, particularly those with limited sun exposure, require a vitamin D supplement,
controversy regarding recommended dosing and the potential benefits of vitamin D abound. The
U.S. Preventive Services Task Force Final Research Plan for vitamin D, calcium or combine
supplementation is seeking answers to some of these questions regarding dose response and
harm in relation to fractures (U.S. Preventive Services Task Force, 2016). Additional research is
needed to resolve the controversies.
A policy for the local level is to ensure that evidence based guidelines are in place for
care of older adults. The U.S. Preventive Services Task Force guidelines and the Endocrine
Society guidelines recommend routine screening only for those at risk of vitamin deficiency
(Chung, Lee, Terasawa, Lau, & Trikalinos, 2011; Holick, et al., 2011; Pfotenhauer & Shubrook,
2017). The U.S. Preventive Services Task Force and the Endocrine Society also provide
guidelines on screening, disease states and treatment recommendations (Chung, Lee, Terasawa,
Lau, & Trikalinos, 2011; Holick, et al., 2011). The Institute of Medicine recommends the RDA
for adults 51-70 years for vitamin D is 600 IU and for adults over 70 years the RDA is 800 IU
(NIH, Office of Dietary Supplements, 2016). Health care professionals are the gatekeepers of
medication reconciliation and follow up. Health care professionals can help older adults ensure
the dosages and type of VMS are appropriate.
Health care professionals should consider the overall physical health and potential side
effects when recommending VMS. The CDC recommendation, published after an infant died
from a contaminated probiotic, stated that physicians should consider that the FDA does not
regulate supplements as drugs when they consider the use of any dietary supplement
(Vallabhaneni et al., 2015). For vitamin D, further evidence is needed to establish the claims of
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benefit and before recommending for use that is not established (Pfotenhauer & Shubrook,
2017).
Implications for Future Research
There appear to be differences in supplement use between findings reported in the
literature and the findings from the secondary analysis of the long-term care residents. Future
research of supplement use by institutionalized adults in a variety of settings is needed and
research on differences between health care providers prescriptive practices is warranted. There
is a need to understand how supplement use changes over illness trajectories and transitions
between community dwelling, acute care, long-term care settings, and hospice. The secondary
analysis found differences in VMS use between nursing homes. The interaction between
primary care providers motivations, older adult’s perceptions and desires to take VMS and
influences from family and friends may provide important explanations for the costly and
potentially unsafe use of many products.
Future research is required to identify safety and benefits of VMS products and determine
suitable dosages for specific uses and patient profiles. A small percentage of adults are using
dosages of vitamin D over the Tolerable Upper Intake Level. Additional studies are needed to
examine self-medication of vitamin D above the Tolerable Upper Intake Level including what
influences older adults to use at or above the Tolerable Upper Intake Level. The Dietary
Guidelines Advisory Committee (2015) suggests more information is needed regarding
overconsumption of vitamin D and rationale for and consequences of using high dose
supplements. Research is needed to monitor the effectiveness, side effects, toxicity, and impact
on health (Cassileth et al., 2009). Qualitative research with older adults who take multiple VMS
may identify reasons for overuse that could be explored in subsequent quantitative research. The
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current study provided some initial information regarding vitamin D dosage in older women,
further research is needed.
Further longitudinal studies are indicated to demonstrate cause and effect relationships
between factors that influence and actual use of VMS. Future studies should explore constructs
that were not measured in this study that might explain variation in VMS use. Comorbidity
score did not have a significant impact on VMS use in this study, however the health conditions
heart disease and high blood pressure had significant impact on amount of VMS. Other health
conditions may be warranted for further study such as malnutrition or undernutrition. The lack
of proper nutrition or an undersupply of nutrients has been linked to decreased quality of life,
prolonged hospital stays, and increased morbidity and mortality (Kyle & Coss-Bu, 2010). Using
an instrument like the Mini Nutritional Assessment would help to indicate nutritional status
(DiMaria-Ghalili & Guenter, 2008). Nutritional status and other health conditions associated
with VMS use are indicated for further research.
A revised model is offered for further research regarding VMS use. It would be valuable
to continue research regarding use of VMS using the HPM as the theoretical framework. Further
longitudinal research to examine if ERA does decrease with age as has been suggested by some
studies (Kim, 2009, Sarkisian, Hays, & Mangione, 2002a; Sarkisian, Steers et al., 2005b). In
these studies, older participants had lower scores. Increasing age with the advent of health
difficulties and the experiences of loss of family and friends may cause a lower ERA (Sarkisian,
Hays, & Mangione, 2002a; Sarkisian, Steers et al., 2005b). A longitudinal study would allow
examination of the relationship between ERA and VMS, does a change in ERA cause a change
in VMS use. Davis et al. (2011) found a difference in ERA between men and women primary
care clinicians, with women having higher ERA than men while the women in the study tended
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to be younger on average.
Future research needs to examine how factors such as interpersonal influences such as
family, friends, health care professionals and the media may influence ERA and VMS use. The
current study had barriers which prevented the inclusion of non-English speaking ethnic
minorities. These ethnic groups use VMS and future research should include non-English
speaking minorities. Men should be included in future research.
Longitudinal data from larger and more diverse populations would enhance the ability to
understand the role of the variables and identify other variables that predict the use of VMS over
time. Research on potential public health policies regarding VMS safety and policy guidelines
for use are needed to protect the health of older adults. With soaring health care costs, research
of the fiscal impact of improper VMS use is also warranted.
Conclusion
The HPM is a theory that is suitable for research of VMS use and the development of
interventions (Pender et al., 2015). Prior use, expectations of aging, and education contribute to
VMS use by older women. A majority of older independent living women and nursing home
residents were taking a variety of VMS. Vitamin D was the most commonly taken supplement
by nursing home residents and independent living women. More independent living women
used herbal supplements and used a wider variety than residents in nursing homes. The was a
difference found in prescription of supplements between the three nursing homes. A small
percentage of independent living women were using vitamin D at or over the UL. Further
research is warranted to examine other variables that influence the use of VMS by older adults.
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Appendix A: Classification System for Dietary Supplement Categories
Major Categories
Category
Multi-vitamin, multi-

Definition

Examples

3 or more vitamins and 1 or more mineral

Centrum Silver

2 or more vitamins and no minerals and

B-complex

mineral (MVMM)
Multi-vitamin (MV)

was not considered a MVMM
Multi-mineral (MM)

2 or more minerals, no vitamins, not

Magnesium and Zinc

considered a MVMM, and calcium was
not primary ingredient
Herbals

Botanical ingredient, such as melatonin

Cranberry, Melatonin

and coenzyme Q-10.
Minor Categories
Category
Fatty acids

Definition
Omega-3 or fatty acids as primary

Examples
Fish oil, flax seed

ingredient
Calcium—containing

Calcium as the primary ingredient, with or

Calcium, calcium and

without other minerals or vitamins; not

vitamin D,

part of a MVMM. This contains antacid
products if calcium is the primary
ingredient.
Joint Supplements

Glucosamine, chondroitin or a
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Glucosamine and/or

Protein and sports

combination

chondroitin,

Protein, amino-acids, or intended to

Creatine, Lysine,

enhance athletic performance.
Fiber and colon health

Fiber as primary ingredient or laxative in

Psyllium

name. Probiotics are classified in this
group
Other
Single nutrient
supplements

Single nutrient supplement products not

Vitamin A, vitamin E,

included in other categories

iron, magnesium,
vitamin D

(Bailey et al., 2013 © American Medical Association.)
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Appendix B: Theoretical Framework for the Study

Individual
Characteristics and
Experiences

Behavior-Specific
Cognitions and
Affect

Prior Related
Behavior

Perceived Benefit
of Action

IV- Use of
supplements in past.

IV- Expectations
regarding aging

Personal Factors
(potential control
variables)

•Age
•Educational level
•Comorbidity

Self-Efficacy
IV- Self-efficacy scale

IV = Independent Variable
DV = Dependent Variable
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Specific Behavioral
Outcome

DV- Supplement
Use

Appendix C: Permission for Use of Self-Administered Comorbidity Questionnaire

(Dr. Katz has given permission via email received on March 3, 2016, see below.)

Permission granted, Barbara. Please simply cite the paper of Sangha et al in work that uses the
instrument.
Wishing you every success on the project,

Jeff

Jeffrey N. Katz, MD, MSc
Professor of Medicine and Orthopedic Surgery, Harvard Medical School
Clement B. Sledge and Thomas S. Thornhill Chair in Orthopedic Surgery
Brigham and Women's Hospital
75 Francis Street -- OBC 4th floor
Boston, MA 02115
Phone 617-732-5338, Fax 617-525-7900
jnkatz@partners.org
www.oracore.org
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Appendix D: Materials for Recruitment
Flyer

Women over 65
Research Study Survey about
Vitamins, Mineral, and Herbal Supplements
Next Week ________________
Time ____________________
Bring your vitamins, mineral and herbal supplements with you!
Questions? Call
Barb Hekel 309-472-1679
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Reminder Announcement
“I have an announcement for …(date)…….. for the women. You have an opportunity if you are
interested to be a part of a research study. The research study will be looking at the use of
vitamins, mineral and herbal supplements. A nurse will be coming …(date)…….. with surveys
and will be here from ……………..to ………………….time. If you are interested bring in your
vitamin, mineral, and herbal supplements to make it easier to fill out the survey. The surveys
take 10-45 minutes to complete. The nurse will be here to help answer any questions, and if you
need assistance filling out the survey she will help you.”

Thank you for being the key contact person. Please feel free to pass out the flyer and if you need
more please call me.
Please call me if you have any questions or problems. I will call as we arranged for planning on
what days and times work best. Thank you!
Barb Hekel RN
309-472-1679
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Information Session Outline
Information Session for
INFLUENCE OF EXPECTATIONS OF AGING ON OLDER WOMENS’ USE OF DIETARY
SUPPLEMENTS USING THE HEALTH PROMOTION THEORY
SPI will plan with key contact person at each site to determine informational session day
and time. Each site will vary determined by site necessities and key contact person’s input. For
example, at the Church, the informational session will take place at the beginning of the Young
at Heart Adult Bible Fellowship. Flyers will be handed out and some left with the key contact
person for the class. At senior dining, have discussed with the Director that the informational
session could occur on senior dining days at the beginning or end of the time.
SPI will conduct the information sessions. Information session will cover the following
information
•

A brief overview of the study:

Over 100 million Americans use vitamin, mineral and herbal supplements (Cohen, 2012).
The use of vitamin, mineral and herbal supplements is expected to increase due in part to interest
in preventative health and maintenance of health. The purpose of the study is to describe what
vitamin, mineral and herbal supplements older women use, how much vitamin D is being taken,
and if certain factors influence vitamin, mineral and herbal supplement use by older women.
These factors include past vitamin, mineral and herbal supplement use, expectations of aging,
and self-efficacy.
•

Survey and Confidentiality

The information will be gathered by survey. The information will be collected in a
manner so the responses cannot be linked back to the person and the information on surveys will
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be treated as confidential. This survey will ask you questions about your; past and current
vitamin, mineral, and herbal supplement use; medical diagnosis; expectations of aging; belief in
ability to use supplements, and background questions. This will take approximately 10 to 45
minutes of your time. If someone with visually impairment would like to participate, I will be
happy to read the consent information and if the person wishes to continue will read the survey
and mark the indicated responses.
•

Eligibility for the study: female, 65 and older, speak and read English, live in
independent living setting, no known memory loss, and will to participate in
study.

•

Give the place, day and time for the survey

•

Reminder to bring vitamin, mineral and herbal supplements that they have taken
the last 30 days with them to help complete survey

•

Answer any questions

•

Expect Information Session to be 5-10 minutes’ total time.
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Information Session Handout
University of Wisconsin – Milwaukee
Study Title: INFLUENCE OF EXPECTATIONS OF AGING ON OLDER WOMENS’USE OF
DIETARY SUPPLEMENTS USING THE HEALTH PROMOTION THEORY
Hello, my name is Barb Hekel. I am a PhD student at the University of Wisconsin at
Milwaukee. I am a nurse and returned to school to become a nursing professor. I am working
on my doctoral thesis and I am studying supplement usage and gerontology, the study of aging.
Did you know over 100 million Americans use supplements and some of you may take a
supplement or know someone who does. People take supplements for a wide variety of reasons
and the most common are to improve or maintain health. I am interested in studying supplement
use by older adults. There are questions about what supplements people take and what factors
influence supplement use.
I am requesting your assistance. In order to complete my research, I’d like to get some
information from you. I have a survey that will ask you some questions about your use of
supplements. Site was chosen to participate in this research study. Your answers in the survey
will provide information on what supplements you are taking and how your use of supplements,
your own abilities, and your beliefs on aging impacts supplement use. Your responses are very
important as well as completeness and accuracy.
The purpose of this survey is to ask what vitamin, mineral, and herbal supplements you
use, how many of you take vitamin D and how much, and about things that may impact your use
of supplements. The things that may impact your supplement use that are on this survey are; past
use of supplements, how you feel about aging, and your belief in your own ability which is
called self-efficacy to use supplements. I am looking for women to fill out the survey. The
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women need to be willing to read the consent form, speak English, live at home or an apartment,
be 65 years or older, and have no memory problems. Again it is really important that the survey
is completely filled out and it will take between 10 and 45 minutes. I will be here _DATE and
TIME_____ and you can bring in the supplements you are taking to help fill out the survey.
The survey does not ask for any information that would identify you. The survey is
unsigned and confidential. The survey has been approved by the University of Wisconsin’s
Human Research Protection Program Institute Review Board. The survey asks some background
questions such as medical diagnosis and education level. You may choose not to take part in this
study, or if you decide to take part, you can change your mind later and withdraw from the study.
You are free to not answer any questions or withdraw at any time. Your decision will not change
any present or future relationships with the University of Wisconsin Milwaukee. This survey is
voluntary.
Thank you very much.
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Appendix E: Consent to Participate in Survey Research
University of Wisconsin – Milwaukee
Study Title: INFLUENCE OF EXPECTATIONS OF AGING ON OLDER WOMENS’USE OF
DIETARY SUPPLEMENTS USING THE HEALTH PROMOTION THEORY
Person Responsible for Research: PI-Dr. Christine Kovach: SPI- Barbara E. Hekel
Study Description: The purpose of this research study is to study what vitamin, mineral, and herbal
supplements are being taken and also specific factors which influence the use of these supplements.
These factors include past vitamin, mineral and herbal supplement use, expectations of aging, and selfefficacy. Approximately100 women will participate in this study. If you agree to participate, you will be
asked to complete a survey. This survey will ask you questions about your; past and current vitamin,
mineral, and herbal supplement use; medical diagnosis; expectations of aging; belief in ability to use
supplements, and background questions. This will take approximately 10 to 45 minutes of your time.
Risks / Benefits: Risks that you may experience from participating are considered minimal. There are
no costs for participating. There are no benefits to you other than to further research.
Confidentiality: Identifying information such as medical diagnosis, race, ethnicity, income and age will
be collected for research purposes. Your responses will be treated as confidential and all reasonable
efforts will be made so that no individual participant will be identified with her answers. The research
team will label your information with a number which will have no link to your name. All study results
will be reported so that no one viewing the results will ever be able to match you with your responses.
Data from this study will be saved on a non-networked, password-protected computer kept in a personal
office only used by the Student Primary Investigator. Surveys will be kept in a locked file drawer in the
Student Primary Investigator’s personal office and destroyed after 5 years. Beyond this study de-identified
data will be kept on a statistical software file for potential use in a secondary study or teaching. Only the primary

investigator, the student investigator, and doctoral committee will have access to the data from your
information. However, the Institutional Review Board at UW-Milwaukee or appropriate federal agencies
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like the Office for Human Research Protections may review this study’s records.
Voluntary Participation: Your participation in this study is voluntary. You may choose not to take part
in this study, or if you decide to take part, you can change your mind later and withdraw from the study.
You are free to not answer any questions or withdraw at any time. Your decision will not change any
present or future relationships with the University of Wisconsin Milwaukee.
Who do I contact for questions about the study: For more information about the study or study
procedures, contact the Primary Investigator Dr. Christine Kovach at (414)708-4454 or
ckovach@uwm.edu or the student primary investigator Barbara E. Hekel at (309)472-1679 or
behekel@uwm.edu.
Who do I contact for questions about my rights or complaints towards my treatment as a research
subject? Contact the UWM IRB at (414)229-3173 or irbinfo@uwm.edu.
Research Subject’s Consent to Participate in Research: By completing this survey, you are

indicating that you have read the consent form, are female and 65 years or older, have no
memory problems, and that you voluntarily agree to participate in this research study.
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